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Custome lothsome to the eye, hatefull to the nose, harmefull to the braine, dangerous to 
the lungs, and in the blacke stinking fume thereof, neerest resembling the horrible Stigian 
smoke of the pit that is bottomelesse.
 King James I of England
 1566 - 1625
The history of smoking starts in the Americas and dates back to as early as 
5,000 BC.1 Native Americans not only used tobacco for religious and recreational 
purposes, it was also often part of rituals such as healing practices. Experienced 
medicine men used tobacco as a painkiller for ear- and toothache. In addition, a 
mix of tobacco and local vegetation was thought to be a particularly good rem-
edy for tuberculosis and asthma. With the arrival of Europeans in the sixteenth 
century, the consumption, cultivation, and trading of tobacco quickly spread. 
Tobacco smoking was then adopted for pleasure or as a socializing tool. With the 
modernization of cigarette consumption, adverse health effects became increas-
ingly noticeable.
The first formal statistical evidence on the association between tobacco and 
lung cancer was identified in Germany in the late 1920s.2 Thereafter, scientific 
studies on the health effects of smoking continued, and British epidemiologists 
published the clear relationship between smoking and cancer in the British 
Medical Journal in 1954.3 After years of intensive research this resulted in a wide 
recognition of the negative influence of tobacco smoking on overall health. Po-
litical action against the usage of tobacco was prompted and resulted in multiple 
governmental policies which were all aimed at the discouragement of tobacco 
usage. Nowadays, it is widely recognized that tobacco smoking is one of the 
largest contributors to non-communicable disease, primarily including cancers, 
cardiovascular and chronic lung diseases, which account for 63% of all deaths 
worldwide.4 For this reason, the World Health Organization (WHO) indicates the 
tobacco epidemic as one of the biggest public health threats the world has ever 
faced.5
Proven (cost-)effectiveness of many tobacco control measures has led to sub-
stantial political involvement in all parts of the world. In 2003, the Framework 
Convention on Tobacco Control of the WHO summarized these measures into a 
policy package called ‘MPOWER’ which has currently been ratified by 177 coun-
tries. The six evidence-based measures include: 1) Monitoring tobacco use and 
prevention policies, 2) Protecting people from the hazardous effects of tobacco 
smoke, 3) Offering help to smokers who want to quit, 4) Warning people for the 









































taxes on tobacco. Despite substantial progress in many countries – a third of the 
world’s population is now covered by at least one of these measures – tobacco 
use continues to be the leading global cause of preventable death.4
The global prevalence of daily tobacco smoking was approximately 18.6% in 
2012; 31.3% for men and 6.2% for women aged 15 years and older.6 Prevalence 
rates are substantially higher in developing countries than in developed coun-
tries. At the beginning of the 21st century, 80% of the approximately one billion 
smokers worldwide live in low- and middle-income countries, such as Armenia, 
Indonesia, and Russia, where daily smoking among men rises up to 54.0%, 55.8%, 
and 48.8%, respectively.6 In Northern and Western Europe, North America and 
the Western Pacific region, tobacco use is on a decline. However, a still relatively 
high prevalence of tobacco smoking is measured in the Netherlands when com-
pared to other developed countries; 22.4% of Dutch adults aged 15 years or older 
smoked in 2012, compared to only 18.4% in New Zealand, 17.2% in the United 
States, 15.9% in Iceland, and 12.3% in Sweden.6
SmokIng CeSSaTIon
The UN High-Level Meeting on Non-Communicable Diseases in New York identi-
fied tobacco control as the “most urgent and immediate priority” intervention to 
reduce the prevalence of non-communicable diseases.7 However, smokers report 
substantial difficulties when attempting to give up smoking; smoking is more 
than an ingrained habit. The substance nicotine, which is present in all types of 
cigarettes, has a highly addictive character and is known to elicit reinforcing ef-
fects, such as relaxation, reduced stress, enhanced vigilance, improved cognitive 
function, mood modulation, and lower body weight. In addition, smokers report 
negative reinforcing effects of nicotine which refer to withdrawal symptoms in 
the context of physical dependence, such as nervousness, restlessness, irrita-
bility, anxiety, impaired concentration, impaired cognitive function, increased 
appetite, and weight gain.8;9
Yet the positive health effects of giving up smoking are instantly noticeable: 
blood pressure and pulse rate stabilize within 20 minutes, carbon monoxide 
levels in blood drops within eight hours, and the ability to smell and taste is 
enhanced within 48 hours. Excessive risks of coronary heart diseases and lung 
cancer death rates are decreased by 50% within one and five years after cessa-










































Therefore, it may come as no surprise that, overall, 80% of the smokers report 
their willingness to quit in the nearby future.12;13 The percentage of smokers 
reporting a quit attempt in a given year is estimated to range from 28-46%.12-14 
Without any support most relapses occur within eight days after the quit at-
tempt due to nicotine craving and insufficient plans regarding how to cope with 
these moments of craving or temptation.15 Evidence-based behavioural support 
delivered by healthcare professionals, nicotine replacement therapy (NRT), and 
stop-smoking medication can assist smokers and facilitate smoking abstinence.16 
In recent years, a series of randomized controlled trials, reviews, and reviews of 
reviews have been performed on the effectiveness of various types of smoking 
cessation interventions. The following interventions were found to significantly 
benefit long-term quit rates compared to no intervention or a placebo: tailored 
(written) quit smoking advice17-19, individual (telephone) counseling18-22, group 
behavioural interventions18;19, tailored self-help interventions18;20, pharmaco-
therapy, including bupropion18;19;23;24, varencline24, nortriptyline19;23-25, multiple 
types of NRT18;19;24;26;27, as well as a combination of behavioural interventions and 
pharmacotherapy.28;29 Additionally, meta-analyses show the cost-effectiveness 
of different forms of cessation support, such as NRT26;30, stop-smoking medica-
tion31;32, telephone counseling26;33-35, and face-to-face (motivational interviewing) 
cessation interventions36, when compared to unsupported cessation.
general praCTICe
In the Netherlands, every citizen has to be registered with a general practitioner 
(GP). When encountering a health problem patients first visit their GP, who is 
freely accessible and acts as a gatekeeper for specialized medical care.37 Nearly 
80% of the total population visits their GP on a yearly basis with an average of 
four visits each year.37-39 The standard general practice in the Netherlands con-
sists of 2,350 patients and an average consultation has a length of ten minutes40, 
which results in considerable time pressure and workload for GPs. To reduce the 
workload of GPs and improve the quality of care for chronically ill patients, with 
a special focus on lifestyle counseling, practice nurses (PNs) were introduced in 
Dutch general practice in 1999.41 PNs work under the supervision of GPs, manage 
their consultations independently, and base their clinical practice on guidelines 
developed by the Dutch College of General Practitioners (NHG) and on other 
multidisciplinary guidelines. The collaboration between GPs and PNs provides 
a good basis for identifying smokers, motivating them to quit, and delivering 









































Guideline on smoking cessation care
The first Dutch multidisciplinary guideline for the treatment of tobacco depen-
dence in health care was published in 2004.42 Subsequently, the NHG developed 
the first guideline for the treatment of tobacco dependence in general practice in 
2007.43 This guideline is based on the widely accepted 5A-Model.44-48 The model 
recommends GPs to actively Ask patients about their smoking behaviour. If a 
patient smokes, GPs are urged to provide a patient-tailored Advise to quit, which 
emphasizes the relevance of quitting and provides a direct link with the current 
health status of the patient. Evidence shows that this intervention is time-
efficient and can increase cessation rates with 2-3% compared to unassisted quit 
rates.49;50 Although this effect may seem small from a clinician’s point of view, it 
has the potential to result in substantial positive effects on public health level if 
systematically provided.
Regardless of the smoker’s motivation to quit, GPs are recommended to provide 
the patient with information on the possibilities of quit smoking support in gen-
eral practice and offer them a follow-up appointment. The GP can also provide 
the patient with educational leaflets. GPs are further recommended to Assess the 
patient’s willingness to quit and register the smoking status and degree of the 
patient’s quit intention systematically in the electronic patient record. Patients 
who indicate their unwillingness to quit are asked their permission to discuss 
smoking cessation during a future consultation.
If patients do indicate their willingness to quit, the guideline urges GPs to 
directly Assist them with intensive quit smoking support, which anticipates both 
psychological and physiological withdrawal symptoms. Previous unsuccessful 
quit attempts are evaluated and potential difficult moments are summarized 
in a quit plan which describes how the patient will cope with these moments 
in advance. The GP should assess the patient’s degree of nicotine dependence 
in order to evaluate suitable pharmacological support such as NRT, bupropion, 
nortriptyline, or varenicline. According to the guideline, patients who contem-
plate smoking cessation are assisted with a behavioural intervention aimed 
at increasing their level of motivation. During this intervention, the guideline 
recommends GPs to discuss the experienced advantages and disadvantages of 
smoking, alongside the advantages of quitting. An essential component of this 
intervention is the exploration of the barriers to cessation, such as fear of failure, 
craving, and weight gain. The guideline informs GPs how to deal with these often 
mentioned barriers. Finally, GPs are recommended to Arrange a follow-up ap-
pointment or a referral to the PN or external quit smoking support if they are 









































Studies have shown that a successful implementation of the 5A-Model for 
smoking cessation care in general practice reduces smoking rates in patients 
compared to no intervention.46-48 Nevertheless, the introduction of innovations 
in healthcare, such as the 5A-Model for the treatment of tobacco dependence in 
Dutch general practice, is widely known to be a complex process.51 
ImplemenTaTIon gap
A study published in 2010 found that, over the years, lifestyle counseling has 
been given more priority in Dutch general practice.53 Nevertheless, smoking is 
currently discussed in only a minority of all consultations (8.3%).53 In addition, 
around 80% of all smokers and 40% of smokers who discuss smoking with their 
GP do not receive a quit smoking advice.54 With regard to more intensive quit 
smoking support, GPs do not routinely refer their patients to PNs or external 
quit support.53;55 Also, these professionals apply motivational interviewing tech-
niques only to a minor extent.53;55 Apparently, a substantial gap exists between 
the evidence-based knowledge on the treatment of tobacco dependence and 
real-world practices of primary care professionals.
GPs report numerous factors that influence their uptake of clinical guidelines 
for smoking cessation care. Figure 1 depicts a five-level social-ecological model 
in order to better understand these factors. This model looks beyond the indi-
vidual GP and considers the complex interplay between all factors that influence 
the implementation of smoking cessation care in general practice. These factors 












Figure 1. Social-ecological model: a theoretical framework depicting levels that influence the imple-










































The first level of the model identifies GP-related determinants of implementa-
tion, including GPs’ attitudes and beliefs, such as doubts regarding the (cost-)
effectiveness of routinely intervening on their patients’ smoking behaviour56-58, a 
lack of sufficient skills to deliver quit smoking support56;57;59 or low confidence in 
these skills57, and a lack of health education or training.58-61
Patient level
The second level comprises patient-related determinants of implementation, 
including the absence of smoke-related complaints59;62, reluctance of the pa-
tient to discuss smoking cessation63-65, a high nicotine dependence, and a lack 
of motivation to quit.56;58-60 This level also includes the interaction between GPs 
and patients which may influence the likelihood of a successful implementa-
tion of smoking cessation care. These factors include GPs’ fear for resistance of 
patients56;66, unpleasant personal experiences57, and concerns about the doctor-
patient relationship.58
Organization level
The third level addresses determinants of implementation within the general 
practice, including a lack of time56-58;60, the presence of a PN, and availability of 
quit smoking interventions within the own organization.56
Community level
The fourth level of the social-ecological model includes determinants of imple-
mentation within the community. These include a lack of overview of health 
promoting programmes in the community, a lack of accessible and affordable 
quit smoking programmes, and a lack of collaboration between general practices 
and hospitals.56
Public policy level
The fifth level looks at broader societal determinants that help to create a climate 
in which the delivery of smoking cessation care in general practice is facilitated. 
The most important factors include a lack of or unclearness regarding the reim-
bursement for quit smoking support56;67 and a lack of financial compensation for 









































FaCIlITaTIon oF guIdelIne ImplemenTaTIon
A number of theoretical frameworks have been developed in order to assess 
implementation processes, explain implementation problems, and inform im-
plementation interventions.68-74 Several of these frameworks integrate behaviour 
change theories that can be used to design implementation interventions.74;75 The 
field of psychology includes an extensive body of evidence regarding such theo-
ries to predict and change human behaviour. In the past decade, researchers in 
this field have acknowledged that clinical behaviour of healthcare professionals 
can be regarded as a form of human behaviour.75-79 Therefore, a growing number 
of interventions that aim to facilitate guideline implementation in healthcare 
integrate such behaviour change theories. These theory-driven interventions 
aim to improve guideline-recommended clinical behaviours of healthcare pro-
fessionals, thereby increasing the number of patients who receive care according 
to these guidelines.
aIm oF dISSerTaTIon
The overall aim of this dissertation is to examine the implementation of guide-
line-recommended smoking cessation care in general practice. The five-level 
socio-ecological model is the conceptual framework that guides this disserta-
tion. All empirical studies adress one or more factors related to the GP, patient, 
organization, community, or public policy level, which determine the implemen-
tation of smoking cessation care in general practice. Chapter two discusses the 
results of a meta-analysis on the effectiveness of training health professionals in 
smoking cessation care. Chapter three addresses the effectiveness of a pragmatic, 
practice-tailored training programme for GPs in which several determinants of 
implementation were targeted. Chapter four examines whether action planning 
among GPs is an effective strategy to increase the provision of guideline-recom-
mended smoking cessation care. Chapter five discusses the extent to which smok-
ers express negative statements about quitting when primary care professionals 
provide guideline-recommended smoking cessation care. Additionally, this chap-
ter examines the degree to which smokers’ negative statements about quitting 
impede or facilitate the use of guideline-recommended smoking cessation care 
by GPs and PNs. Finally, chapter six discusses the results of a population-based 
study on the effects of two national tobacco control interventions (the introduc-
tion of the GP guideline for smoking cessation care in 2007 and the introduction 
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Cigarette smoking is one of the leading causes of preventable death worldwide. 
There is good evidence that brief interventions from health professionals can in-
crease smoking cessation attempts. A number of trials have examined whether 
skills training for health professionals can lead them to have greater success in 
helping their patients who smoke.
Objectives
To determine the effectiveness of training health care professionals in the de-
livery of smoking cessation interventions to their patients, and to assess the ad-
ditional effects of training characteristics such as intervention content, delivery 
method and intensity.
Search methods
The Cochrane Tobacco Addiction Group’s Specialised Register, electronic data-
bases and the bibliographies of identified studies were searched and raw data 
was requested from study authors where needed. Searches were updated in 
March 2012.
Selection criteria
Randomized trials in which the intervention was training of health care profes-
sionals in smoking cessation. Trials were considered if they reported outcomes 
for patient smoking at least six months after the intervention. Process outcomes 
needed to be reported, however trials that reported effects only on process out-
comes and not smoking behaviour were excluded.
Data collection and analysis
Information relating to the characteristics of each included study for interven-
tions, participants, outcomes and methods were extracted by two independent 
reviewers. Studies were combined in a meta-analysis where possible and re-
ported in narrative synthesis in text and table.
Main results
Of seventeen included studies, thirteen found no evidence of an effect for 
continuous smoking abstinence following the intervention. Meta-analysis of 14 
studies for point prevalence of smoking produced a statistically and clinically 








































Training health professionals in smoking cessation care 25
0.004). Meta-analysis of eight studies that reported continuous abstinence was 
also statistically significant (OR 1.60, 95% CI 1.26 to 2.03, p= 0.03). Healthcare 
professionals who had received training were more likely to perform tasks of 
smoking cessation than untrained controls, including: asking patients to set a 
quit date (p< 0.0001), make follow-up appointments (p< 0.00001), counseling of 
smokers (p<0.00001), provision of self-help material (p< 0.0001) and prescription 
of a quit date (p< 0.00001). No evidence of an effect was observed for the provi-
sion of nicotine gum/replacement therapy.
Conclusions
Training health professionals to provide smoking cessation interventions had a 
measurable effect on the point prevalence of smoking, continuous abstinence 
and professional performance. The one exception was the provision of nicotine 
gum or replacement therapy, which did not differ between groups.
InTroduCTIon
Every year approximately 5.4 million people die from tobacco-related diseases, 
translating to 1 in every 10 deaths among adults worldwide.1 Approximately 80% 
of those deaths are from people living in less developed countries and by 2030 
this figure will increase to more than 8 million per year if no action is taken.1 
If current trends continue on this trajectory, an estimated 500 million people 
alive today will be killed by tobacco. In the 27 countries that form the European 
Union, over 25% of cancer deaths and 15% of all deaths can be attributed to 
smoking . Smoked tobacco is known to cause up to 90% of all lung cancers and 
is a significant risk factor for strokes and fatal heart attacks. In addition, tobacco 
use is linked to the development and treatment of many oral diseases2;3 includ-
ing oral cancer, delayed wound healing and peridentitis contributing to loss of 
teeth and edentulism.4;5
Description of the intervention
Health professionals are at the forefront of tobacco epidemics as they consult 
millions of people and can encourage them to quit smoking.6 In developed coun-
tries, more than 80% of the population will see a primary care physician at least 
once a year, with doctors perceived to be influential sources of information on 
smoking cessation.6-8 It has been reported that most dentists and dental hygien-
ists believe the lack of skills and training is a significant barrier to effectively 









































Providing training in smoking cessation care is one possible method for 
increasing the number and quality of delivered interventions by primary care 
health professionals, and a variety of training methods are available.12-14 To date, 
individual studies have shown an effect of training on physician’s activities, but 
there have been doubts about the extent to which this translates into changes 
in patient behaviour and actual smoking abstinence.15-17 Training health pro-
fessionals to deliver smoking cessation messages has been known to increase 
the frequency with which interventions are offered to patients in the clinical 
context.18
How the intervention might work
Provision of advice and support to smokers by healthcare professionals in 
primary care settings has been shown to be the most cost-effective preventive 
service and has a small but significant effect on cessation rates.19-21 Even though 
these rates appear low from the perspective of many clinicians, they could 
translate into a substantial public health benefit if consistently provided, as ap-
proximately 70-80% of adults have contact with a health care practitioner, usu-
ally in primary care, at least once each year.6-8;22 It is therefore disappointing that 
despite ongoing developments in this field worldwide, the number of patients 
who report receiving advice on smoking cessation from health professionals is 
still low.23
Why it is important to do this review
On a worldwide scale, tobacco use currently costs hundreds of billions of dollars 
each year.24 Data on the global impact of tobacco is incomplete, however it is 
known to be high, with annual tobacco related health care costs being US$81 
billion for the USA, US$7 billion for Germany and US$1 billion for Australia.25
The first systematic review on this topic was published over a decade ago 
and showed that training health professionals to provide smoking cessation 
interventions had a positive effect on professional performance. However, there 
was no strong evidence that it changed smoking behaviour of patients.26 Since 
then, a number of new trials have examined whether specific skills training for 
health professionals leads them to overcome frequently mentioned barriers and 
to have greater success in helping their patients to quit smoking.
We therefore systematically identified and reviewed the evidence from new 
published randomized controlled trials that have studied the effects of training 
and supporting health care professionals in providing smoking cessation advice. 
Furthermore, we assessed the effects of training characteristics, such as the 








































Training health professionals in smoking cessation care 27
Objectives
The aim of this review was to assess the effectiveness of training health care 
professionals to deliver smoking cessation interventions to their patients, and to 
assess the effects of training characteristics (such as contents, setting, delivery 
and intensity).
meThodS
Criteria for considering studies for this review
Types of studies
We considered only randomized controlled trials.
Types of participants
We considered trials in which the unit of randomization was a healthcare prac-
titioner or practice, and that reported the effects on patients who were smokers.
Types of interventions
We considered interventions in which healthcare professionals were trained in 
methods to promote smoking cessation among their patients. To be included 
in the review studies had to have allocated healthcare professionals to at least 
two groups (including one which received some form of training) by a formal 
randomization process. Studies that used historical controls were excluded. We 
included studies that compared a trained group to an untrained control group, 
and studies that examined the effectiveness of adding prompts and reminders 
to training.
Types of outcome measures
The primary outcome measure was abstinence from smoking six months or 
more after the start of the intervention, assessed as:
•	 point	prevalence	 (defined	as	not	 smoking	at	 a	 set	 period	 (e.g.,	 seven	days)	
prior to the follow-up), and
•	 continuous	abstinence	 (defined	as	not	 smoking	 for	 an	extended/prolonged	
period at follow-up)
The strictest available criteria to define abstinence were used. In studies where 









































met the criteria for biochemically confirmed abstinence were regarded as being 
abstinent. Those lost to follow-up were regarded as being continuing smokers. 
Secondary ‘patient level’ outcome measures included process variables such as 








Secondary ‘physician level’ outcome measures include the number of referrals 
made (to local smoking cessation services). To be included in the review, studies 
had to assess changes in the long term smoking behaviour of patients. Stud-
ies which only assessed the effect of training on the consultation process were 
excluded.
Search methods for identification of studies
We identified potentially relevant study reports from the Cochrane Tobacco Ad-
diction Group Specialised Register. This Register includes reports of trials and 
other evaluations of interventions for smoking cessation and prevention, based 
on regular highly sensitive searches of multiple electronic databases including 
MEDLINE, EMBASE, PsycINFO and CENTRAL, and hand searches of conference 
abstracts. For details of search strategies and dates see the Cochrane Tobacco 
Addiction Group Module in the Cochrane Library. The most recent search of the 
Register was in March 2012. Records were identified from the Register as poten-
tially relevant if they included the free text terms ‘training’ or ‘trained’ or the 
MeSH keywords ‘Education, Premedical’ or ‘Education, Professional’ or ‘Inservice 
Training’ or ‘Physician’s Practice Patterns’ or ‘Dentist’s Practice Patterns’ or 
‘Delivery of Health Care’ or ‘Comprehensive Health Care’ or ‘Critical Pathways’ 
or ‘Disease Management’ or the EMBASE indexing terms ‘clinical education’ or 
‘continuing education provider’ or ‘continuing education’ or ‘medical education’ 
as indexing terms. We conducted an additional search of MEDLINE (via OVID, to 
2012 Feb week 5) exploding the same MeSH keywords in combination with the 
terms for smoking cessation and controlled trials used in the regular search of 
MEDLINE for the Specialised Register. Records included definite and probable 








































Training health professionals in smoking cessation care 29
Data collection and analysis
Selection of studies
Two reviewers (KC, MV) pre-screened all study reports identified from the Spe-
cialised Register (limited to papers published after 1999 for this update). Articles 
were rejected if the title and/or abstract did not meet the inclusion/exclusion 
criteria. In instances where the study could not be categorically rejected, the 
full text was obtained and screened. Reference lists of screened articles were 
scanned for other potentially relevant articles. Two reviewers then independent-
ly assessed the relevant studies for inclusion (KC and MV), with discrepancies 
resolved by consensus.
Data extraction and management
A combination of two reviewers independently extracted data from published 
reports (KC, MV, and MB). Disagreements were resolved by referral to a third 
party. No attempt was made to blind any of these reviewers to either the results 
of the primary studies or the intervention the subjects received. The data extrac-





each condition), method of identification/enrolment
•	 Number	of	patients	per	therapist	(range	and/or	average)
•	 Description	of	intervention	and	control	conditions
•	 Definition	 of	 abstinence	 for	 smoking	 cessation	 outcome(s),	 duration	 of	
follow-up, method of biochemical validation if used
•	 Secondary	outcomes	reported
Data was extracted and entered into Review Manager for the following outcome 
variables, where reported:
•	 Point	 prevalence	 abstinence	 at	 longest	 follow-up	 (preferred	 outcome	 for	











































We also extracted data on process outcomes where reported. These included 
patient reported or documented delivery of interventions, such as: setting a quit 
date, making a follow-up appointment, number of smokers counselled, provi-
sion of self-help materials, prescription of nicotine replacement therapy and/or 
prescription of a quit date.
Assessment of risk of bias in included studies
Two reviewers independently assessed the full text versions of all included papers 
for risk of bias using the Cochrane Handbook guidelines, using a domain-based 
evaluation.27 In addition, extra criteria developed by the Cochrane EPOC Group 
(2009) were used to address potential sources of bias related to clustering effects. 
These domains included sequence generation, allocation concealment, blind-
ing for participants, blinding for outcome assessors, incomplete outcome data, 
selective reporting, imbalance of outcome measures at baseline, comparability 
of intervention and control group characteristics at baseline, protection against 
contamination, selective recruitment of participants and any other sources of 
potential biases. The risk of bias was assessed for each domain as ’high risk’, ’low 
risk’, and ’unclear risk’ (using the guidelines from Table 8.5.c of the Cochrane 
Handbook27). Two of three reviewers (KC, MV or MB) independently assessed 
the included studies for risk of bias. Conflicts were resolved by consensus or by 
referring to a third party if disagreement persisted.
Unit of analysis issues
The trials included in the review used cluster randomization. Outcomes relate to 
individual patients whilst allocation to the intervention is by provider or practice, 
and ignoring this may introduce unit of analysis errors. Using statistical methods 
which assume for example that all patients’ chances of quitting are independent 
ignores the possible similarity between outcomes for patients seen by the same 
provider. This may underestimate standard errors and give misleadingly narrow 
confidence intervals, leading to the possibility of a type 1 error. All trials were ex-
pected to be cluster randomized studies, with analysis performed at the level of 
individuals whilst accounting for the clustering in the data. This was performed 
by using a random effects model for pooled meta-analysis as recommended in 
the Cochrane Handbook (Chapter 16.3.3)27 and checked by a statistician (AE). 
For those studies which did not adjust for clustering the actual sample size was 
replaced with the effective sample size (ESS), calculated using a rho= 0.02.28 
Trials may use a variety of statistical methods to investigate or compensate 
for clustering; we have recorded whether studies used these and whether the 
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homogenous via a combination of the statistical I² test in addition to homogene-
ity expressed in the visual inspection of a Funnel plot we meta-analysed using 
a fixed effect model. However in the presence of significant heterogeneity (as 
defined below under ‘Data Synthesis’) the random effects model was used. In the 
case of multi-arm trials each pair-wise comparison was included separately, but 
with shared intervention groups divided out approximately evenly among the 
comparators. However, if the intervention groups were deemed similar enough 
to be pooled, the groups were combined using appropriate formulas in the Co-
chrane Handbook.27
Dealing with missing data
Missing participant data were evaluated on an available case analysis basis 
as described in Chapter 16.2.2 of the Cochrane Handbook.27 Missing standard 
deviations were addressed by imputing data from the studies within the same 
meta-analysis or from a different meta-analysis as long as these use the same 
measurement scale, have the same degree of measurement error and the same 
time periods (between baseline and final value measurement, as per Chapter 
16.1.3.2 of the Cochrane Handbook)27. Where statistics essential for analysis 
were missing (e.g. group means and standard deviations for both groups are 
not reported) and could not be calculated from other data, we attempted to 
contact the authors to obtain data. Loss of participants that occurred prior to 
performance of baseline measurements was assumed to have no effect on the 
eventual outcome data of the study. Losses after the baseline measurement were 
taken were assessed and discussed. Studies that had more than 30% attrition 
(i.e., deaths and withdrawals) were reported in text only and excluded from the 
meta-analysis. We made an attempt to contact all authors for verification of 
methodological quality, classification of the intervention(s) and outcomes data. 
We attempted to contact the second author if we were unsuccessful in contact-
ing the first author.
Assessment of heterogeneity
The review was expected to have some heterogeneity due to factors such as 
differing characteristics of clinics, practices and medical surgeries, differences 
in intervention characteristics and varying measurement tools used to assess 
outcomes. The Chi² and I² statistic27 were used to quantify inconsistency across 
studies. The presence of significant heterogeneity was further explored through 


















































•	 ‘length	 of	 follow-up’	 (i.e.,	 >6	 to	 <9	months,	 >9	 to	 <12	months,	 >12	 to	 <24	
months), and
•	 ‘risk	 of	 bias’	 (i.e.,	 high	 risk	 of	 bias	 for:	 <	 2	 domains,	 3	 –	 5	 domains,	 6	 -	 8	
domains	or	>	9	domains).
The likelihood of false positive results among subgroup analyses increase with 
the number of potential effect modifiers being investigated.27 As such we have 
adjusted these analyses using a Holm-Bonferroni method using α= 0.05.
Assessment of reporting biases
With the inclusion of more than ten included studies, potential reporting biases 
were assessed using a funnel plot. Asymmetry in the plot could be attributed to 
publication bias, but may well be due to true heterogeneity, poor methodologi-
cal design or artefact. Contour lines corresponding to perceived milestones of 
statistical significance (p= 0.01, 0.05, 0.1 etc.) were applied to funnel plots, which 
may help to differentiate between asymmetry due to publication bias from that 
due to other factors.27
Data synthesis
For dichotomous outcomes the fixed effect model with an odds ratio (OR) was 
calculated with 95% confidence interval (CI), which was synthesised using in-
verse variance. However for outcomes with greater than 10 included studies a 
test for heterogeneity was conducted using a combination of two methods. If 
heterogeneity	was	 found	 (defined	as	 the	 I²	 test	>60%	and	visual	 inspection	of	
the funnel plot indicating no clustering of large or small studies) the random 
effects model was used in place of the fixed effect model, as suggested by the 
Cochrane Handbook (Section 9.5.2 and 9.5.3).27 Reasons for heterogeneity are 
further explored in the discussion. When studies appeared homogenous, the 
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For continuous outcomes, a fixed effect model with a weighted mean dif-
ference (WMD) or standardised mean difference (SMD) with 95% confidence 
intervals were calculated as appropriate. However, in the presence of significant 
heterogeneity (as defined above) the random effects model was used in place of 
the fixed effect model.
Sensitivity analysis
Sensitivity analysis was conducted on studies with an unclear or high risk of bias 
for sequence generation and/or allocation concealment.
reSulTS
Description of studies
Table 1 (p. 58) shows the characteristics of included studies.
Results of the search
Of 381 articles screened, 17 studies met all of the inclusion criteria (see Figure 1).
Included studies
Design
All 17 included studies used a randomized controlled trial design with clustering 
and eleven studies also adopted nesting of participants within practices/hospi-
tals.4;15;17;29-35 One study incorporated a 2x2 factorial design with randomization 
to: training plus incentive, training plus medication, training plus incentive and 
medication or usual care.12
Sample sizes
In total 28,531 patients were assessed at baseline (following randomization) 
with 21,031 remaining in the studies at final follow-up. Authors report a total of 
1,434 individual health professionals recruited at baseline (across a known 260 
practices) with follow-up available for 1,204. Sample sizes for individual studies 
were medium to large, with the smallest number of patients (randomized at 
baseline) found in the Wang 1994 study (n= 93) and the largest in the Kottke 1989 
study. The smallest sample at follow-up remained with the Wang 1994 study (n= 
82), and the largest remained with the Kottke 1989 study (n= 5266). At the health 
professional level, the Hymowitz 2007 study had the largest number of residents 









































had the smallest number of residents at baseline and follow-up (n= 27 for both). 
Seven studies also reported baseline cluster sizes at the practice level: Lennox 
1998 (n= 16); Sinclair 1998 (n= 62); Swartz 2002 (n= 50); Joseph 2004 (n= 20); 
Hymowitz 2007 (n= 16); Twardella 2007 (n= 82); and Gordon 2010 (n= 14).
Setting
Eleven of the 17 studies were conducted in the USA, one in Canada34, one in Tai-
wan36, one in Scotland37, one in the United Kingdom35, one in Switzerland38 and 
one in Germany.12 Two studies were performed in a dentistry setting4;30, whilst 
the remaining 15 were conducted within primary care clinics, HMO (Health 
283 records identified 































1 study identified through 
hand searching 
bibliographies 
8 studies included from the 
previous version of this 
review ’30 May 2000’ 
194 articles excluded from 
screening of title and 
abstract 
288 full-text articles 
assessed for eligibility (after 
4 updates removed) 
57 articles (51 studies) 
excluded but relevant: 
 18 consultation process only 
 11 not randomized 
 11 smoking-related outcome 
data not reported 
 10 no control group 
 1 smokeless tobacco only 
94 articles required full-text 
screening 
37 articles (17 studies) 
included in qualitative 
(narrative) synthesis 
15 of 17 studies were able 
to be included in 
quantitative synthesis 
(meta-analysis) for the 
primary outcome 
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Maintenance Organisation) medical centres15;39, VAMC’s (Veterans Affairs Medi-
cal Centres)40 and one in a pharmacy setting.37
Participants
At the health professional level, two studies were performed with dentists4;30, six 
studies included only primary care physicians12;15;17;29;33;34, two studies were con-
ducted with residents31;38, three studies incorporated a combination of primary 
care physicians and internists15;32;36, one study used pharmacists37, whilst the 
remaining three studies used a combination of health professionals including 
physicians, nurse practitioners, physician assistants, psychologists, pharmacists 
and other health visitors.35;39;40
The individual patients in 16 of the 17 included studies were those visiting 
their health professional during the recruitment phase of each study. They were 
recruited during standard GP, dentist or outpatient visits, emergency depart-
ment visits or from waiting rooms. The Hymowitz 2007 study was the only one 
to perform the training in a paediatric setting, targeting the parents/guardians 
of children visiting 16 primary care clinics.31
Interventions
Treatment type
Six studies provided patients with a counseling plus nicotine replacement ther-
apy intervention arm.12;29;30;34;37;40 The two Cohen et al studies had a second inter-
vention arm of counseling plus a reminder for physicians to ask about smoking 
(chart prompt), and a third intervention arm combining the counseling, nicotine 
replacement therapy and chart prompt.29;30 Another study12 also had three in-
tervention arms: counseling plus nicotine replacement therapy; counseling plus 
a monetary incentive to the physician following study completion per success-
ful smoke-free participant (€130); and a counseling plus nicotine replacement 
therapy plus incentive arm. The Wilson 1988 study had two intervention arms 
in addition to usual care: counseling and nicotine gum (as mentioned above) 
and a second arm of nicotine gum plus usual care (i.e., physicians were not 
trained in counseling).34 Three studies included multiple intervention methods 
to curtail smoking including counseling, nicotine replacement therapy, request 
for additional follow-up appointments and provision of self-help materials4;15;16, 
whilst one study combined three of those four (counseling, nicotine replacement 
therapy, and self-help materials.38 Five studies used counseling alone32;33;35;36;39 










































The level of training intensity for health professionals ranged from one 40-min-
ute session in the Unrod 2007 study, to four or five day long sessions in the Joseph 
2004 study. Nine studies had a training session for one day or less: Wilson 1988 
(four hours), Cohen (Dent) 1989 (one hour), Cohen (Doc) 1989 (one hour), Kottke 
1989 (6 hours), Lennox 1998 (one day), Sinclair 1998 (two hours), Twardella 2007 
(two hours), Unrod 2007 (40 minutes) and Gordon 2010 (three hours). Four studies 
had two separate sessions: Strecher 1991 (two, one hour sessions scheduled two 
weeks apart), Wang 1994 (two sessions of unknown duration), Cornuz 2002 (two, 
four hour training sessions scheduled two weeks apart) and Swartz 2002 (two, 20 
minute training sessions and another session of unknown duration, where resi-
dents were able to practice counseling techniques with standardised patients). 
Four studies had three or more sessions: Cummings (Priv) 1989 and Cummings 
1989 both had three, one hour sessions over a four to five week period, Hymowitz 
2007 had four, one hour sessions, four times a year and Joseph 2004 had four to 
five, day long sessions within six months.
Mode of intervention delivery
Three different modes of intervention delivery were used being groups ses-
sions, one-on-one or a combination of the two. Two studies only used one-on-
one sessions33;40, eleven studies delivered the intervention in a group setting 
only4;12;15;17;31;32;34-37;39 with an eighth study using group delivery as the primary 
mode, however doctors who were unable to attend received a private session in 
their office.15 Finally three studies used both modes of intervention delivery29;30;38, 
with health professionals in the two Cohen et al studies provided the option of a 
group or individual session.29;30
Theoretical model - behavioural change technique
Nine studies used behavioural change theories to underpin the intervention 
techniques. These included the ’stages of change’ (also known as the trans-
theoretical) model12;17;32;35-38 and the ’5A’ (Ask, Assess, Advise, Assist and Arrange) 
approach.4;33 Three studies incorporated prompting or reminders to ask about 
tobacco use29-31 and four provided feedback to the health providers, for example 
number of patients counselled.33;38-40
Type of professional being trained
Two studies only focused on dentists29;30, one focused on pharmacists37, and the 
remaining fourteen studies all involved doctors. Five of these fourteen studies 
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tion of physicians and internists.15 Three other studies included training to other 
health care workers as well as doctors: Lennox 1998 also involved nurses and 
other health visitors; Swartz 2002 also trained nurse practitioners, physicians 
assistants and other health professionals; and, in addition to doctors, Joseph 
2004 included nurses, psychologists and pharmacists.
Length of follow-up
Eight studies reported follow-up periods between six and nine months 
post intervention4;29;30;32;33;35-37, eleven studies presented 12 month follow-up 
data4;12;15;17;29;30;34;36;38-40 and two studies assessed extended follow-up periods of 
14 months35 and four years.31 However, only two-year post intervention data was 
available for Hymowitz 2007 at the time of writing.
Outcomes
Smoking abstinence was assessed in all included studies through self-report of 
either continuous abstinence (no smoking for an extended period of time) or 
point prevalence (for example, no smoking for seven days prior to the time of 
outcome collection). Of the eight studies that reported continuous abstinence, 
six also reported a point prevalence measure of abstinence.4;15;16;34;35;37 Ten of the 
included studies used biochemical validation through either exhaled carbon 
monoxide29;30;32;38, serum cotinine12;17, saliva cotinine33;34 or a combination of 
exhaled carbon monoxide and serum cotinine.15;16 A number of secondary out-
comes measures were reported by some studies including: patients asked to set 
a quit date; patients asked to make a follow-up appointment; number of smokers 
counselled; number of smokers receiving self-help material; number of smokers 
receiving nicotine gum/replacement therapy; and number of smokers prescribed 
a quit date. Two studies reported n-values as a total across both intervention and 
control arms29;30 and six studies reported n-values as percentages, which had to 
be transformed into whole numbers.31;33;34;38-40 As such there is likely to be some 
small variance between actual n-values and those reported in these analyses, 
but this is not significant. Seven studies had multiple intervention arms, which 
were considered similar enough to be pooled together, two in the Wilson 1988, 
Kottke 1989 and Wang 1994 studies and three intervention arms in the Cohen 
(Dent) 1989, Cohen (Doc) 1989, Strecher 1991 and Twardella 2007 studies. One 
study did not report the n-value for subjects at randomization, and hence this 
was calculated based on the number eligible for study and the number at follow-
up.32 The Kottke 1989 study reported all outcome data as continuous variables, as 









































in the Hymowitz 2007 study were unable to be pooled as only change scores from 
baseline were presented.
Excluded studies
Sixty-five studies (71 articles) were excluded for the following reasons: 21 in-
cluded consultation process only, 18 did not include a control group, 13 failed to 
measure smoking related outcome data, 12 were considered to be inadequately 
randomized and one only reported on smokeless tobacco use.
Risk of bias in included studies
Key methodological features are summarised in Figure 2.
Random sequence generation (selection bias)
Five studies reported adequate methods of sequence generation12;15;31;33;38, two 
had inadequate methods17;32 whilst the remaining ten did not provide enough in-
formation to assess risk of bias for sequence generation and were hence judged 
to be at unclear risk in this category. Adequate methods included the use of a 
random number generator or coin toss, whilst unclear methods were described 
as being ’random’ in design, however methods were not described. The Kottke 
1989 study required some physicians to be re-assigned due to inappropriate al-
location methods during assignment. For the Strecher 1991 study appropriate 
randomization did not occur as residents were randomly assigned by clinic half-
day session to one of four groups, which risks introducing bias. All 17 trials used 
cluster randomization, with five studies inadequately accounting for potential 
clustering effects in the data, requiring manual clustering adjustments.15-17;34;36 
Only two studies17;31 reported outcome data at the level of randomization. No 
authors reported that differences in the method of analysis affected the results.
Allocation concealment (selection bias)
Allocation concealment was unclear in all 17 included studies as authors did 
not describe methods of allocation concealment. Authors of the Lennox 1998 
study report that physicians were randomly and blindly allocated to control or 
intervention groups, however the methods were not described. Another study 
mentioned that an independent research assistant concealed the result of 
randomization until two weeks before the intervention, when residents were 
provided with details about training sessions, however, methods of concealment 
























































































































































Blinding of participants (performance bias and detection bias)
Only one study reported adequately blinding participants to the intervention38, 
as residents were not informed about the aim of the trial and were advised only 
that a survey on cardiovascular risk factors and prevention would be conducted. 
Authors announced that a training programme in clinical prevention that in-
cluded sessions on smoking cessation and management of dyslipidemia was 
being conducted. Authors also report that patients were blinded to the aim of the 
study and group allocation of their physician. Due to the nature of the interven-
tion, blinding of participants was not possible for the remaining 16 studies. An 
attempt was made to blind physicians in the Unrod 2007 study, with physicians 
learning their group assignment only after signing the informed consent, how-
ever they were not blinded during the study intervention period and follow-up.
Blinding of outcome assessors (performance bias and detection bias)
Three studies reported methods blinding of outcome assessors that we judged at 
low risk of bias. Authors of Cummings (Priv) 1989 stated that ’outcome assessors 
were blinded’, authors of the Joseph 2004 study report interviewers collecting 
patient outcomes were blinded to subject treatment status and authors in the 
Strecher 1991 study report that telephone interviewers, who were blinded to 
residents’ and patients’ group assignments, obtained the patient reports. The 
remaining 14 studies did not report any attempts to blind outcome assessors 
and as such are unclear for this category.
Incomplete outcome data (attrition bias)
Incomplete outcome data was adequately addressed in three studies4;15;16 and 
unclear in the remaining 14 studies. The Cummings (Priv) 1989 and Cummings 
1989 studies reported that missing data was accounted for in analyses, whilst 
the Gordon 2010 study reported the use of multiple imputation procedures to 
account for missing data with participants lost to attrition discussed in the text. 
All unclear studies failed to mention if there was any missing outcome data and 
if so, how this was addressed when reporting results.
Selective reporting (reporting bias)
Selective reporting was evident in three studies4;31;33, unclear in three studies17;32;36 
and not detected in the remaining eleven studies. Although all pre-specified out-
comes were addressed in the four year follow-up for the Hymowitz 2007 study, 
the authors mention that outcome data for year one was omitted in order to pro-
vide a ’cleaner look’ at the progress of the data. In the Unrod 2007 study, smoking 
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have been assessed in this study) was not reported. The Gordon 2010 authors 
report that secondary participant outcomes were examined with no significant 
differences on any variables, and that therefore they were not presented in the 
publication. Also, receipt of intervention was reported in text as percentages, 
however no information regarding this outcome was reported for the control.
Imbalance of outcome measures at baseline
One study did not report data for baseline smoking and made no mention of 
statistical analyses to potentially adjust for any imbalances36, as such the risk 
of bias category was assessed as unclear. All remaining studies adequately ad-
dressed imbalances of outcome measures at baseline. Thirteen studies accounted 
for baseline imbalances through analysis of covariance, regression analyses or 
other analysis techniques, whilst three studies reported outcomes at baseline to 
be similar across groups and as such did not require adjustment.16;35;37
Comparability of intervention and control group characteristics at baseline
Five studies had unclear comparability between intervention and control groups 
at baseline12;15;29;30;34 and the remaining twelve studies adequately addressed any 
differences found between groups via appropriate analysis methods.
Protection against contamination
Two studies reported contamination.4;32 In Gordon 2010, authors reported 
contamination due to a tax increase on cigarettes in New York, which resulted 
in a drop in smoking prevalence from1 8.4% in 2006 to 15.8% in 2008. Authors 
believed that this tax increase contributed to the unusually high rate of smoking 
cessation in the usual care patients, thereby affecting the relative impact of the 
intervention. Authors of the second study, Strecher 1991, mention that “all four 
groups worked closely with one another at each site”, leading to the possibility 
of contamination, however they also state that “…the effects appeared to be 
slight.” Nine studies had unclear risk of bias for contamination with insufficient 
information to permit a judgement of yes or no, whilst the remaining six studies 
reported no potential contamination during the study period.15-17;34;35;38
Selective recruitment of participants
Although no studies were identified as having selectively recruited participants, 
this could not be completely ruled out for eleven studies, which were deter-
mined to have an unclear risk of bias for this outcome.4;12;15;17;29;30;32;34;36;37;39 The 









































a potential concern. The remaining six studies adequately reported recruitment 
methods and were determined as having a low risk of bias.
Other bias
No other biases were identified for the 17 included studies.
Effects of interventions
Intervention effectiveness was assessed in all seventeen included studies 
through smoking prevalence, as well as through multiple secondary outcomes. 
All data were analysed as per the pre-defined methodology outlined in the 
Methods section. For a summary of intervention effectiveness for each of these 
outcomes see Table 2.
Overall summary of smoking behaviour
Four out of 13 studies detected significant intervention effectiveness in training 
health professionals to influence point prevalence of smoking in their patients 
at primary follow-up.4;12;29;38 Out of the eight studies reporting continuous absti-
nence at primary follow-up, only one reported a statistically significant effect 
in favour of the intervention.4 Fifteen of the 17 included studies (the exceptions 
being Kottke 1989 and Hymowitz 2007) could be included in a meta-analysis for 
the primary outcome of smoking (see Appendix 1: Analysis 1.1a and 1.1b). Using 
a fixed effect model there was a statistically and clinically significant effect in 
favour of the intervention for point prevalence abstinence (OR 1.36, 95% CI 1.20 
to 1.55, 14 trials, I² = 57%) and continuous abstinence (OR 1.60, 95% CI 1.26 to 
2.03, 8 trials, I² = 59%). Using only the stricter outcome of continuous abstinence 
for studies reporting both types of cessation, a pooled estimate for all 15 trials 
gave a similar estimate (OR 1.60, 95% CI 1.35 to 1.89, I² = 55%, data not dis-
played). Since the heterogeneity in this analysis approached the level at which 
we proposed a random-effects model we did a sensitivity analysis; the point 
estimates were similar and the wider confidence intervals continued to exclude 
no effect. The trial contributing most evidently to the heterogeneity, particularly 
for the continuous outcome, was Lennox 1998 in which the point estimates for 
both abstinence outcomes favoured the control group. Two studies could not be 
included in the meta-analyses. In the Kottke 1989 study at one year follow-up 
almost half of the participants in each group who were smoking at baseline 
reported quit attempts for at least 24 hours during the previous year, with a 
mean duration of cessation of two months. No differences between the three 
groups were identified. For the Hymowitz 2007 study there was an increase in the 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8.5% increase over baseline levels), however the change from baseline failed to 
achieve statistical significance. Among parents associated with standard train-
ing, the change was only 0.8%.
As per pre-specified methodology, a funnel plot examined the primary outcome 
of smoking cessation using contour lines to assess the presence of reporting 
biases. No publication biases were identified (Figure 3).
Overall summary of secondary outcomes
Asked to set a quit date for stopping (quit date)
Nine studies reported the effect of training health professionals on the number 
of patients being asked to set a quit date, eight of which could be included in the 
meta-analysis producing a significant result (random effects OR 4.98, 95% CI 2.29 
to 10.86; see Appendix 1: Analysis 1.2). Only three of the seven studies crossed 
the line of no effect32;38;39 but there was a very high level of heterogeneity (I² = 
90%) suggesting that not all interventions had the same impact on this outcome. 
Subgroup analyses suggest that some of the heterogeneity might be due to 
whether or not the patient intervention included an offer of NRT. The two stud-
ies that reported this outcome and did not include NRT showed no difference 
between groups.32;39 The other studies showed more consistent evidence that 
Figure 3. Funnel plot of comparison: the effect of training health professionals on patient smoking 
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intervention increased numbers although the size of effect remained variable. 
Contrary to what might have been expected, the studies where training took 
only a single session29;30;34 had higher effect sizes compared to the five studies us-
ing multiple sessions. Duration of training was similar for the three sub-groups 
being examined as was intervention delivery via one-on-one compared to group 
sessions. There was a large amount of variability between the use of prompting 
and provision of feedback, however this difference was not significant. Interven-
tion delivery by a doctor (six studies) or dentist (one study) produced a larger ef-
fect size compared to delivery by a healthcare worker39, which may also explain 
some of the heterogeneity. When comparing follow-up periods, studies reporting 
between six and nine months29;30;32 and between nine and 12 months (seven 
studies) produced similar effect sizes and large amounts of variability. Studies 
judged to be at lower risk of bias were more likely to show evidence of an effect 
(seven studies) compared to studies with between three and five categories rated 
at high risk of bias32, however the between group analysis did not suggest that 
this was a source of heterogeneity.
Given a follow-up appointment
There was a significant increase in the intervention arm for patients being 
asked to make a follow-up appointment, as reported in seven studies available 
for meta-analysis (random effects OR 3.34, 95% CI 1.51 to 7.37; see Appendix 1: 
Analysis 1.3), although significant heterogeneity was observed (I² =92%). When 
comparing interventions using NRT with those that used counseling alone, an 
I² of 96% was observed, meaning any results from a pooled analysis would be 
too unreliable. As such only a visual analysis of odds ratios and confidence 
intervals are presented, showing similar variability between sub-groups. Sub-
group analyses for treatment intensity suggest that some of the heterogeneity 
might be due to whether or not the training sessions were single or multiple. 
Two studies that employed single sessions33;34 were more likely to show an ef-
fect (although variability was observed), compared to five studies using multiple 
sessions, which produced a smaller effect estimate with less variability. When 
comparing the duration of the training, significant heterogeneity was once again 
observed between groups, with studies presenting large amounts of variability, 
resulting in a pooled estimate being unreliable for comparison. There was little 
difference between delivery by one-on-one compared to group sessions, and due 
to significant heterogeneity (I²=96%) the pooled comparison of prompting and 
provision of feedback was not possible, although a visual display shows vari-
ability is mostly due to the Unrod 2007 study. Similar to other outcomes, delivery 









































patients were likely to have a follow-up appointment compared to intervention 
delivery by a healthcare worker (one study), however the Swartz 2002 study was 
present in both sub-groups as the intervention included delivery by both a doc-
tor and healthcare worker, as such a statistical between group comparison was 
not performed. Reporting of results at different follow-up periods were similar 
between sub-groups, although the five studies with follow-up between nine and 
12 months had similar distributions with the exception of the Wilson 1988 study, 
which significantly favoured the intervention and had wide confidence intervals. 
No between group differences were observed for quality of the studies.
Counselled
Fourteen of the fifteen studies reporting on the number of smokers counselled 
were meta-analysed. Overall, a statistically and clinically significant effect in 
favour of the intervention was observed (OR 2.28, 95% CI 1.58 to 3.27, p< 0.00001; 
see Appendix 1: Analysis 1.4), assessed using the random effects model due to sig-
nificant heterogeneity (I²= 93%). An investigation into the causes of heterogeneity 
found no differences between counseling with and without nicotine replacement 
therapy, however implementation via multiple sessions or single sessions did 
produce between group differences, with a larger effect size for single session 
delivery. Duration of intervention delivery also produced significant differences 
with total exposure of between 40 minutes and two hours producing a larger 
effect size compared to durations of between two and four hours and greater 
than four hours. Mode of intervention delivery (one-on-one compared to group 
sessions) produced very similar effect sizes, as did the provision of feedback and 
prompting to aid intervention delivery by the health professional. The type of 
health professional being trained may contribute to the heterogeneity with the 
one study evaluating dentists30 producing a larger effect size compared to those 
with doctors and other health professionals which showed a more conservative 
effect with narrow confidence intervals. When examining follow-up periods, 
there was a slightly larger effect and more variability in the studies reporting 
results between six and nine months compared to results between nine and 
twelve months and 12 and 24 months. No sub-group differences were observed 
when analysing studies based on risks of bias.
Given self-help materials
The number of smokers receiving self-help material increased significantly in 
favour of the intervention for the nine studies able to be included in the meta-
analysis (OR 3.52, 95% CI 1.90 to 6.52, p< 0.0001; see Appendix 1: Analysis 1.5). 








































Training health professionals in smoking cessation care 47
be included in the meta-analysis, did increase significantly across both groups 
over the four year study period when compared to baseline values (intervention 
28.8%, control 17.6%) however, this interaction was not statistically different 
between groups. The other study unable to be meta-analysed17 also produced a 
statistically significant effect (p< 0.001). Significant heterogeneity was observed 
in the meta-analysis (I²= 91%) which was explored through subgroup analyses. 
The type of treatment did not show a significant difference between groups, al-
though the counseling plus nicotine replacement therapy group did have a larger 
effect size compared to counseling alone. Likewise, no differences were observed 
for single compared to multiple session delivery or duration of delivery, although 
the Cornuz 2002 study with a total exposure over four hours did produce a very 
large effect with wide confidence intervals. No differences were observed for the 
mode of intervention delivery or provision of prompting or feedback to aid health 
professionals in the provision of self-help materials. The one study39 which in-
cluded healthcare workers for intervention delivery produced less of an effect 
compared to the pooled result of studies using doctors. No difference between 
sub-groups was observed for length of follow-up although studies identified as 
having less risk of bias did have a larger effect size compared to those with larger 
amounts of bias.
Offered nicotine gum/replacement therapy
Nine studies were pooled to assess the number of smokers receiving nicotine 
gum/replacement therapy. The meta-analysis did not produce evidence of an 
effect (OR 1.57, 95% CI 0.87 to 2.84, p= NS; see Appendix 1: Analysis 1.6), but 
significant heterogeneity was detected (I²=91%). The Hymowitz 2007 study also 
assessed this outcome with few parents in either condition reporting that resi-
dents prescribed nicotine replacement therapy (intervention 7.6%, control 5.9%). 
An exploration into the possible sources of heterogeneity found no difference 
between interventions containing counseling with or without nicotine replace-
ment therapy, however surprising results were observed with much larger effect 
sizes for single session intervention delivery compared to multiple session, which 
could account for some of the heterogeneity. No differences were observed be-
tween sub-groups for treatment intensity, mode of intervention delivery, use of 
feedback or prompting, type of professional being trained or length of follow-up. 
However studies with less risk of bias did produce larger effect sizes compared to 
studies with three to five sources of bias identified, which could also contribute 









































Prescribed a quit date
Only three studies reported on smokers being prescribed a quit date.16;32;34 Pooling 
these together produced a statistically and clinically significant effect in favour 
of the intervention (OR 14.18, 95% CI 6.57 to 30.61, p< 0.00001; see Appendix 1: 
Analysis 1.7) with minimal observed heterogeneity. As such, sub-group analyses 
were not necessary for this outcome.
Cost effectiveness of interventions
Cost effectiveness data was presented in one study38, with the incremental cost of 
the intervention reported to amount to (U.S.) $2.58 per consultation by a smoker. 
When considering ’cost per life-year saved’, this translated to (U.S.) $25.40 for 
men and $35.20 for women, with one-way sensitivity analyses yielding a range 
of $4.00 to $107.10 in men and $9.70 to $148.60 in women. The Joseph 2004 study 
reported that the dollar spent per 1000 primary care patients did increase in the 
intervention sites and decrease in control sites, however this was not significant. 
Number of referrals made. No studies reported on the number of referrals made 
to local smoking cessation services.
Statistical analyses and cluster adjustments
All 17 studies used a cluster randomized design for practical reasons, with the 
unit of randomization being the health care practitioner or practice. However, in 
15 of the 17 studies patients were the unit of analysis. Hymowitz 2007 and Kottke 
1989 were the exceptions, reporting outcomes at the level of randomization (the 
doctor/resident). The majority of studies that reported outcomes at the level of 
patient accounted for potential clustering effects within their reported results, 
with four studies (three in the late 1980’s15;16;34 and one in the mid-1990’s36) being 
the exceptions. The two Cummings et al studies did perform clustering analyses, 
however they were not included in the published results as they were seen to 
have had no effect on the final outcome. As such, the data for these studies 
were manually adjusted for potential clustering effects as per the pre-specified 
methodology outlined in the unit of analysis issues section of this review.
Sub-group analyses
Multiple sub-group analyses have been considered as per the predefined meth-
odology to further explore heterogeneity. When considering these outcomes 
the level of statistical significance should be considered at p<0.01, to account 
for potential false positive results (as per the Bonferroni adjustment described 
Assessment of heterogeneity), which increase with the number of potential 
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sessed at the 99% level for all sub-group analyses. Significant heterogeneity was 
determined	through	a	combination	of	the	I²	statistic	(I²	>60%),	Chi²	statistic	and	
visual inspection of the Forest plots, and was present for all outcomes with the 
exception of ’Smoking cessation at longest follow-up’ and ’Number of smokers 
prescribed a quit date’ where significant heterogeneity was not identified. In the 
presence	of	heterogeneity	based	on	the	I²	statistic	of	>	96%,	the	pooled	estimate	
has been removed, as the outcomes are considered too different to be combined 
in meta-analysis. Likewise, when a comparison contained the same study in dif-
ferent sub-groups, the pooled estimate was not used.
dISCuSSIon
Summary of main results
Seventeen completed studies (total 28,531 subjects) assessed the benefits of 
interventions to train health professionals to provide smoking cessation initia-
tives to their patients. Whilst some methodological variations occurred between 
studies in relation to intervention, delivery mode, type of health professional 
and duration, they were all aimed at training health professionals to help their 
patients stop smoking. The primary outcome of smoking cessation was presented 
in pooled meta-analyses as point prevalence (14 studies) and continuous absti-
nence (eight studies). A statistically and clinically significant effect in favour 
of the intervention was observed for both of these outcomes at final follow-up 
(see Table 2 for a summary of findings for the main comparison). All secondary 
outcomes (with one exception) produced a statistically and clinically significant 
effect in favour of the intervention at final follow-up. These outcomes include 
asking patients to set a quit date, asking patients to make follow-up appoint-
ments, counseling of smokers, provision of self-help material and prescription of 
a quit date. No evidence of an effect was observed for the secondary outcome of 
providing patients with nicotine gum/replacement therapy. No studies were able 
to be meta-analysed to assess the cost effectiveness of interventions.
Overall completeness and applicability of evidence
In the context of current practice, this review should be used to provide readers 
with an outline of what interventions have a proven effect, and where resources 
need to be directed for future investigations. Studies which incorporated multi-
ple intervention components such as provision of nicotine replacement therapy, 
requests for follow-up appointments and provision of self-help material were 









































Surprisingly, health professionals who were trained using only a single session 
and in a group setting were just as likely if not more likely to have patients quit 
smoking as those being trained with multiple delivery sessions and one-on-one 
training (i.e., face to face with the trainer). Similarly, the duration of training 
for the health professional of between 40 minutes to two hours was just as ef-
fective, and in some cases more so, than a duration of greater than two hours. 
Studies with multiple follow-up periods and closer monitoring of outcomes by 
investigators (including the provision of feedback) were more successful than 
those of lesser intensity. Smoking cessation interventions delivered by a doc-
tor or dentist were more likely to produce successful quit attempts than those 
delivered by other health care workers. To ensure methodological rigour, future 
studies should aim to incorporate the following into the study design:
•	 Report	patient	level	outcomes	(e.g.,	smoking	cessation)	as	well	as	health	pro-
fessional outcomes (e.g., physician report of number of smokers counselled) 
rather than providing details only relating to the consultation process
•	 Adequate	methods	of	randomization	and	allocation	concealment
•	 Report	smoking	related	outcome	data	both	pre	and	post	intervention
•	 Incorporate	 a	 control	 group	 which	 adequately	 matches	 the	 demographic	
characteristics of the intervention population.
Quality of the evidence
Study quality was a potential issue in this review with many of the studies being 
of unclear methodological design. It is extremely difficult to blind participants 
in relation to what intervention they will be receiving, as there are two levels to 
consider: the health professional and the patient. All 17 included studies had 
unclear allocation concealment whilst only five studies adequately reported 
methods of random sequence generation, two had a high risk of bias with the 
remaining ten studies being unclear. Overall, the body of evidence identified per-
mits a moderately robust conclusion regarding the objectives of this review, with 
17 included studies (28,531 participants). Evidence presented in the summary of 
findings table (Table 2) was downgraded to take into account:
•	 limitations	 in	 design:	 methods	 of	 randomization,	 allocation	 concealment	
and/or blinding were not described or inadequate for the majority of studies 











































Training health professionals in smoking cessation care 51
Potential biases in the review process
A potential bias in the review process is exclusion of studies examining interven-
tions that train health professionals in smoking cessation that are of question-
able methodological design. This review does sacrifice inclusion of some relevant 
information, however the trade-off is a meta-analysis of higher quality evidence 
on which future investigations can be based. Some of the pertinent information 
from these studies is discussed below under agreements and disagreements 
with other studies or reviews though results should be interpreted with caution. 
Another limitation to the review is the under-reporting of the intervention for 
included studies. This means that some studies may have indeed included ad-
ditional intervention components that, had we known they existed, would have 
led us to classify the study differently within the sub-groups. One key strength of 
the review process to address potential biases is the use of two experienced and 
independent review authors who assessed the studies for risk of bias, although 
this can do little to account for biases which occur in the methodological designs 
of the included studies.
Agreements and disagreements with other studies or reviews
A compilation of systematic reviews and surveys of key informants were pub-
lished as a special edition in the journal ’Drug and Alcohol Review’ in 2009, relat-
ing to the education and training of health professionals and students in tobacco, 
alcohol and other drugs.41 The first published survey of 21 key informants from 
eight countries found a high level of consistency in the content of the smoking 
cessation interventions, with 72% of programmes using the 5 A’s (Ask, Assess, 
Advise, Assist, Arange) model, 64% using the stages of change (trans-theoretical) 
model, 84% including pharmacotherapies, with 84% having some reference to 
clinical practice guidelines.6 Only five of the seventeen included studies in our 
review had reference to any particular behavioural change technique, however 
it is quite likely that the majority of studies are based around some kind of 
theoretical behavioural change context, which is not reported in the publication. 
These results are similar to those reported elsewhere.41 The authors identified a 
lack of interest (with other continuing education topics considered to be a higher 
priority) and lack of funding for interventions to be the major barriers for the up-
take and sustainability of training programmes.6 Some possible solutions were 
provided to address these barriers including raising awareness of the importance 
of smoking cessation for the health of patients and incorporating education on 
smoking cessation into vocational courses for specialties. Another systematic 
review of postgraduate smoking cessation training for physicians in 28 European 









































total of 170 postgraduate training programmes.42 The key implications reported 
by the authors were that postgraduate training in smoking cessation may not be 
reaching physicians and was not rigorously evaluated. To combat this problem 
multiple authors suggest that future research needs to incorporate methods of 
disseminating effective educational activities with the intention of increasing 
participation.42;43 It is also imperative that health professional organisations ad-
vocate for the systematic implementation of comprehensive tobacco cessation 
training programmes to increase the number of patients receiving tobacco cessa-
tion interventions.44 Another study using direct observation of physician-patient 
encounters found similar results and concluded that strategies are needed to 
assist physicians to incorporate systematic approaches that will standardise 
smoking cessation care.45 In this investigation, discussions around tobacco were 
more common in practices that utilised standard forms for recording smok-
ing status and during new patient visits. Interestingly, the authors also found 
that discussions around tobacco use occurred less often among physicians in 
practice for more than 10 years and with older patients45, which is similar to an 
observational study by Bertakis et al. investigating the factors associated with 
physician discussion of tobacco use with patients.46 Considerable resistance was 
also observed in a cohort of physicians receiving academic detailing to promote 
tobacco-use cessation counseling in dental offices. Dental staff members (in-
cluding receptionists, office managers, dental assistants and dental hygienists) 
were reluctant to participate in the interventions due to increased paperwork, 
having to deal with uncooperative patients, and the perception that only a few 
patients use tobacco anyway and that counseling does not work.38;47 However, 
the resistance observed did decrease as follow-up visits progressed and staff 
became more comfortable with the intervention and the procedures involved. 
This evidence suggests that through the provision of first-hand experience 
prior to guiding patients through the same process, physicians may feel more 
comfortable in implementing smoking cessation interventions into standard 
practice, which has the potential to be highly cost-effective. One of the included 
studies by Cornuz et al. reported that training residents in smoking cessation 
counseling is very cost-effective and may be more efficient than the majority of 
currently accepted tobacco control interventions.38 This has also been supported 
by more recent systematic reviews and investigations.19-21 As such, the provision 
of counseling, advice and/or offers of assistance to the patient has the potential 
to significantly increase the number of quit attempts, which subsequently has 
the potential to reduce health related costs as well as morbidity and mortal-
ity associated with ongoing chronic tobacco use. The previous version of this 
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The authors also stated that effects of training on process outcomes increased 
if prompts and reminders were used, however they concluded that there was no 
strong evidence that training health professionals to provide smoking cessation 
interventions changed smoking behaviour. With the addition of nine studies 
(more than half the initial number of inclusions), the findings of this review have 




Overall, a moderately large amount of methodologically rigorous evidence has 
been presented to support the effectiveness of training health professionals in 
smoking cessation. The following programme characteristics could be consid-
ered for individuals involved in future clinical practice initiatives:
•	 Combination	 of	multiple	 intervention	 components	 including	 the	 provision	
of counseling, offer of follow-up appointments, setting or being prescribed a 
quit date and provision of self-help material
•	 A	one-off	group	training	session	for	health	professionals	of	between	one	to	
two hours duration, providing there is adequate follow-up and monitoring of 
progress. This will need to include provision of follow-up feedback to health 
professionals and resources such as patient self-help materials, with consid-
eration given to other intervention components as mentioned above.
•	 Consider	organisational	factors	to	ensure	that	smoking	cessation	messages	
are reliably delivered. Training can be expensive, and simply providing pro-
grammes for health care professionals, without addressing the constraints 
imposed by the conditions in which they practise, is unlikely to be a wise use 
of health care resources.
Implications for research
Multi-component investigations incorporating new pharmacological interven-
tions for smoking cessation (such as varenicline tartrate and bupropion) or other 
cessation aids (such as electronic cigarettes) alongside physician training should 
be considered to determine if any additional benefit in long-term abstinence 
can be obtained. Future research needs to ensure that adequate methodological 













































So as to enable interventions to be replicated in clinical practice, it is also impor-
tant that authors of future trial reports describe the content of the training in 
sufficient detail, for example detailing the educational methods, strategies and 
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Table 1. Characteristics of included studies
Cohen (Dent) 1989  
Methods Country: United States of America, Indianapolis area
Design: Randomized controlled trial; Nested; Clustered
Objective: To improve the effectiveness of dentists helping their patients quit smoking
Methods of analysis: A generalized linear model was used to analyse the results of the 
quit-smoking rates and a scale-factor was used to reflect the expected extra variance in 
quit rates caused by between-dentist variability; Chi-squared statistic based on changes 
in the deviance function for a series of nested models was used to test for main effect and 
interactions; Two-way analyses of variance were calculated on the weighted data for the 
amount of time spent in counselling patients about their smoking
Clustering adjustment made: Yes - Generalised linear model allowed a scale-factor to reflect 
the extra variance expected to be inflated due to variability between dentists
Significance of cluster adjustment: Not reported
Participants Therapist description: Dentists
Eligible for study: n= 54
Randomized: n= 50
Completed: Gum n= 9, reminder n= 10, gum & reminder n= 12, control n= 13 (total n= 44)
Age: Not reported
Gender: Not reported
Patient description: n= 1027 patients from American private dental practices
Eligible for study: n= 1027
Randomized: n= 1027
Completed: n= 647
Age: Mean = 37.1 (SD + 10.4) (total population only)
Gender: Males= 43.2% males (total population only)
Interventions Setting: American private dental practices
Training of those delivering the intervention to the health professional: Not reported
Intervention description: Three intervention groups: Training & nicotine gum, training & 
reminder (chart prompt), combined training with prompt & nicotine gum
Control description: Training alone (advice, quit date, follow up check); Dentists provided 
a booklet containing the four-step care protocol and were encouraged to counsel their 
patients who were smokers
Duration of intervention: One hour
Intervention delivered by: General dentist
Intensity: One lecture
Outcomes Pre-specified outcome data: Point prevalence of cessation at 12 months; Number advised to 
quit; Number asked about setting a quit date
Follow-up period: Twelve months total: 6 months (defined as the smoking status determined 
at any visit that occurred at least 3 months after the initial appointment but not more 
than 9 months); 12 months (defined as the smoking status determined at any visit that 
occurred at least 9 months and 1 day and up to 15 months after the initial visit)
Notes Process measures: Outcomes reported in Cohen 1987; Patients not having a visit during the 
6 or 12 month periods were assumed to be smokers
Validation: Expired carbon monoxide
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Cohen (Doc) 1989  
Methods Country: United States of America
Design: Randomized controlled trial; Nested; Clustered
Objective: Evaluation of a RCT of interventions designed to improve effectiveness of 
physicians and dentists in helping their patients quit smoking
Methods of analysis: Analysis of variance performed on percentages; Stepwise multiple 
regression analyses performed using the weighted number of minutes as the criterion 
to determine the extent to which the amount of counselling time was a function of the 
health professionals’ initial attitudes and habits; Chi-squared analysis used to test main 
effects and interactions; Generalised linear interactive modelling (GLIM) software used
Clustering adjustment made: Yes - Generalised linear model allowed a scale-factor to reflect 
the extra variance expected to be inflated due to variability between physicians
Significance of cluster adjustment: Not reported
Participants Therapist description: n= 112 primary care physicians (including n= 97 physicians in 
training)
Eligible for study: Not reported
Randomized: Total= 97 internal medicine residents and 15 faculty general internists
Completed: Total= 97 internal medicine residents and 15 faculty general internists
Age: Not reported
Gender: Not reported
Patient description: n= 1420 patients receiving primary care, not selected by motivation to 
quit
Eligible for study: Participation refusal rate was 9.7% of all eligible patients contacted
Randomized: n= 1420
Completed: n= 1091 medical patients
Age: 18 to 64 years; Mean = 46.2 + 11.6 years
Gender: Male= 37%; Female= 63%
Interventions Setting: General medicine (primary care) clinic of a city-county teaching hospital in the 
USA
Training of those delivering the intervention to the health professional: Registered internist
Intervention description: Three intervention groups: Training & nicotine gum, training & 
reminder (chart prompt), combined training with prompt & nicotine gum
Control description: Training alone (advice, quit date, follow up check); Physicians provided 
a booklet containing the four-step care protocol and were encouraged to counsel their 
patients who were smokers
Duration of intervention: One-hour lecture or personalised instruction
Intervention delivered by: David M Smith, registered internist
Intensity: One, one hour lecture maximum
Outcomes Pre-specified outcome data: Point prevalence of abstinence at 12 months; Patients who did 
not have an appointment in the period regarded as smokers; Rates also reported giving 
returnees as denominator; Number advised to quit; Number asked about setting a quit 
date; Had their doctor talked to them about smoking
Follow-up period: Six and 12 months (12 months defined as patients visited 9 and 15 
months after the initial visit)
Notes Process measures: Outcomes reported in Cohen 1987; Patients not having a visit during the 
6 or 12 month periods were assumed to be smokers
Validation: Expired carbon monoxide










































Cornuz 2002  
Methods Country: Geneva and Lausanne, Switzerland, Europe
Design: Randomized controlled trial; Clustered
Objective: To assess the efficacy of an educational program based on behavioural 
theory, active learning methods, and practice with standardized patients in helping 
patients abstain from smoking and changing physicians’ counselling practices
Methods of analysis: To compare baseline characteristics of patients and physicians’ 
practices between groups, the authors used the chi-quare or Fisher exact tests for 
categorical data and the t-test or Wilcoxon rank-sum test for continuous data; To 
test the effectiveness of the training on the outcomes, the authors performed a 
logistic regression with generalized estimating equation to stratify by clinic and 
adjust for clustering on residents; Intention-to-treat analysis was performed for 
abstinence from smoking, in which smokers lost at follow-up were considered to be 
continuing smokers; Because smoking abstinence was validated in a sub sample of 
the study participants, the authors used simulation to perform sensitivity analysis 
of the likelihood of smoking cessation
Clustering adjustment made: Yes - to test the effectiveness of the training on the 
outcomes, the authors performed a logistic regression with generalized estimating 
equation to stratify by clinic and adjust for clustering on residents
Significance of cluster adjustment: Not reported
Participants Therapist description: Resident physicians; All residents were at the end of 
postgraduate training in general internal medicine or family medicine
Eligible for study: n= 35
Randomized: Intervention n= 17; Control n= 18
Completed: Intervention n= 17; Control n= 18
Age: Median 31 years
Gender: 18 females and 17 males
Patient description: Patients aged 16 to 75 years who consulted one of the outpatient 
clinics for a follow-up or an emergency visit
Eligible for study: n= 1456
Randomized: Intervention n= 115; Control n= 136
Completed: Intervention n= 77; Control n= 100
Age: Range 16 to 75 years; Mean + SD: Intervention 35.1 + 14 years; Control 36.9 + 15 
years
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Interventions Setting: Two general internal medicine clinics of the university hospitals of 
Lausanne and Geneva, Switzerland; Both sites are public service clinics that provide 
adult ambulatory care to approximately 25,000 outpatient visits per year
Training of those delivering the intervention to the health professional: Teachers 
are two authors, who are experienced physicians active in both clinical practice 
and teaching; Both were previously trained in smoking cessation counselling 
through a Master of Public Health course and are considered as national experts in 
smoking cessation
Intervention description: The training program is based on 5 principles: 1) recent 
evidence-based content on tobacco use and cessation, 2) behavioural theory 
(stage-of-change model), 3) pharmacological therapy, 4) educational methods 
focusing on active skills training, and 5) tobacco control context; Session 1: Video-
clips observations, interactive workshops and role plays; Sessions 2: practice with 
standardized patients; At the end of the first session, participants received a set 
of documents (reference manual, two algorithms of counselling strategies and 
pharmacological therapy, record sheet for consultations with smokers, brochures 
for patients and patient instructions for NRT)
Control description: Training in management of dyslipidaemia with equal contact 
time to the intervention; This course taught residents about through the Swiss 
guidelines on screening for and diagnosis/management of high blood levels of 
cholesterol; Residents that were trained in smoking cessation attended the lesson 
on dyslipidaemia 4 months later, and vice versa
Duration of intervention: Two, 4 hour sessions scheduled 2 weeks apart
Intervention delivered by: Not specified though face-to-face workshops took place
Intensity: Two, half-day sessions; Total contact time 8 hours
Outcomes Pre-specified outcome data: Self-reported abstinence from smoking, 1 week point 
prevalence of abstinence; score of overall quality of counselling based on use of 14 
counselling strategies; patient willingness to quit; and daily cigarette consumption; 
socio-demographic data, cardiovascular risk factors, smoking history, nicotine 
dependence, smoking intervention
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: Exhaled carbon monoxide testing at one clinic
Cummings (Priv) 1989  
Methods Country: United States of America
Design: Randomized controlled trial; Nested; Clustered
Objective: To test if physicians who are trained to use the 'Quit for Life' (QFL) program are 
more effective in helping patients to quit smoking
Methods of analysis: Chi-squared test for proportions and t-tests for means; Multiple 
logistic regression (for proportions) and ordinary least-squares (for means) and calculated 
adjustment rates from the partial slopes associated with a dummy variable; Individual 
patients were the unit of analysis
Clustering adjustment made: No adjustment to presented data but separate analyses tested 
clustering effects
Significance of cluster adjustment: Clustering effects were tested in separate analyses; 










































Participants Therapist description: Primary care physicians in private practice
Eligible for study: n= 844
Randomized: Intervention n= 31; Control n= 28
Completed: Intervention n= 20; Control n= 18
Age: Not reported
Gender: Intervention females n= 4; Control females n= 2
Patient description: n= 916 smoking patients not selected by motivation to quit
Eligible for study: Not reported
Randomized: Intervention n= 470; Control n= 446
Completed: Intervention n= 360; Control n= 364
Age: Intervention mean = 43 years; Control mean = 45 years
Gender: Intervention mean = 53%; Control mean = 61%
Interventions Setting: Private primary care internal medicine and family practice (primary care) in San 
Francisco, USA; Local hospitals at times that fit with the schedules of the participating 
physicians; Four who were unable to attend the second sessions received the training 
privately in their office
Training of those delivering the intervention to the health professional: Not described
Intervention description: Training (personalised advice, quit date, one follow up visit, self 
help materials and nicotine gum)
Control description: Normal care (no training)
Duration of intervention: Three, one hour seminars
Intervention delivered by: Internist or psychologist
Intensity: Three, one hour seminars; second seminar one or two weeks after the first; third 
seminar four to twelve weeks later
Outcomes Pre-specified outcome data: Demographic characteristics; smoking history; how much do you 
want to quit smoking; how confident are you that you will not be smoking one year from 
now; pressure to quit from family and friends; was smoking discussed; did you receive a 
self-help booklet; did you receive a follow-up appointment about smoking
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: Expired carbon monoxide and serum cotinine
Manual adjustment for potential clustering effects performed in the meta-analyses for 
primary outcome data
Cummings 1989  
Methods Country: San Francisco, California, United States of America
Design: Randomized controlled trial; Clustered
Objective: To test whether physicians who receive a continuing education program about 
how to counsel smokers to quit would counsel smokers more effectively and have higher 
rates of long-term smoking cessation among their patients that smoke
Methods of analysis: Chi-square for proportions and t-tests for means were used for 
significance measures; Binomial test for difference between paired proportions used 
to calculate confidence intervals for changes in attitudes and self-reported counselling 
practices of physicians in the experimental group before and after training; To analyse 
differences between the groups in patient reports about physicians counselling and rates 
of abstinence, large-sample difference-of-proportions and difference-of-means tests 
were used; To determine significance of intervention among those patients who had the 
greatest desire to quit, an interaction was tested between assignment to the experimental 
or control group and the smoker’s rating of his or her desire to quit; Multiple logistic 
regression analysis used to determine significance for specific counselling strategies by 
experimental group physicians for abstinence levels
Clustering adjustment made: No - The individual patient was the unit of analysis for these 
results; However, patients were clustered by physician and physicians were clustered by 
work station; "…Therefore for simplicity, we present the results with the patient as the 
unit of analysis" 
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Participants Therapist description: Physicians
Eligible for study: n= 189 internists
Randomized: n= 81; Control n= 41; Intervention n= 40
Completed: n= 81; Control n= 41; Intervention n= 40
Age: Not reported
Gender: Control: 27% female; Intervention 30% female
Patient description:
Eligible for study: n= 2056; Control n= 1032; Intervention n= 1024
Randomized: n= 2056; Control n= 1032; Intervention n= 1024
Completed:   n= 2012; Control n= 1008; Intervention n= 1004
Age: Control 45 years; Intervention 46 years
Gender: Control 53% female; Intervention 58% female
Interventions Setting: Four Health Maintenance Organisation (HMO) medical centres in northern 
California
Training: Three, one hour group tutorials
Training of those delivering the intervention to the health professional: Not stated but delivered by 
internist or psychologist
Intervention description: Training (personalised advice, quit date, one follow up visit, self 
help materials and nicotine gum)
Control description: Normal care (no training)
Duration of intervention: Three sessions over a five to fourteen week period
Intervention delivered by: Internist or psychologist
Intensity: Three, one hour sessions
Outcomes Pre-specified outcome data: long-term abstinence from smoking (≥ 9 months); Number of 
smokers counselled; Asked to set a quit date; Asked to make a follow up appointment; 
Number receiving self help materials; Number receiving nicotine gum; Number of 
smokers prescribed a quit date
Follow-up period: Point prevalence abstinence at 12 months
Notes Process measures: None reported
Validation: Expired carbon monoxide and serum cotinine
Manual adjustment for potential clustering effects performed in the meta-analyses for 
primary outcome data
Gordon 2010  
Methods Country: United States of America
Design: Randomized controlled trial; Nested; Clustered
Objective: With consideration to the oral health effects associated with chronic tobacco use, 
the dental visit provides a "teachable moment" during which the dental team can relate oral 
health and systemic problems to tobacco use and provide evidence-based brief interventions 
to patients who use tobacco in lower socio-economic areas
Methods of analysis: Analysis of variance with clinics as a random, nested factor within 
condition and patients nested within clinic for both outcomes, for all participants, and 
within each racial/ethnic group; Logistic regression used for baseline measures of tobacco 
use with condition included as a covariate
Clustering adjustment made: Yes: ICC and analysis of variance with nesting









































Participants Therapist description: Federally funded public health dental clinics in lower socio-economic 
areas
Eligible for study: Not reported
Randomized: Intervention n= 7 practices; Control n= 7 practices
Completed: Intervention n= 7 practices; Control n= 7 practices
Age: Not reported
Gender: Not reported
Patient description: Dental patients aged 18 years and older who were seen for a non-
emergency visit to the clinic and were self-identified current tobacco users (within the past 
7 days)
Eligible for study: n= 2751 completed informed consent and baseline survey
Randomized: Intervention n= 1434; Control n= 1203
Completed: Six weeks Intervention n= 1214; Control n= 1026; 7.5 months Intervention n= 990; 
Control n= 885
Age: Total sample only: Mean = 40.5 + 12.6 years
Gender: Total sample only: Female= 45.8% n= 1508
Interventions Setting: Baseline survey completed in the clinic and were mailed follow-up surveys at 6 
weeks and 7.5 months (lower socio-economic areas)
Training of those delivering the intervention to the health professional: Not reported
Intervention description: '5A approach' (Ask, Advise, Assess, Assist and Arrange): Ask - ask all 
patients about their tobacco use at every visit; Advise - relating the oral effects of tobacco 
use to the patients’ oral health status and advising patients to quit tobacco; Assess - setting 
a quit date, discussing pharmacotherapy, providing free self-help materials and free nicotine 
replacement therapy; Arrange - arranging for follow-up by mail or phone for patients setting 
a quit date; Each intervention practice was provided with a supply of nicotine patches and 
lozenges, as well as printed patient self-help materials and information on the local tobacco 
quit line, which providers were asked to give to all tobacco-using patients
Control description: Usual care - delayed intervention control; Following the study period 
control clinics received the in-service workshop and received all the intervention materials
Duration of intervention: One workshop
Intervention delivered by: Dentists, dental hygienists and dental assistants
Intensity: One, 3 hour workshop
Outcomes Pre-specified outcome data: Tobacco cessation, reduction in tobacco use, number of quit 
attempts, change in readiness to quit, number of cigarettes smoked per day, level of nicotine 
dependence
Follow-up period: Seven and a half months (6 months post-enrolment plus a 6 week grace 
period)
Notes Process measures: Intervention subjects only - 66.5% reported receiving the reading materials 
and the majority of patients reported reading them (96.7%); 16.9% reported using nicotine 
replacement therapy and 10.9% reported receiving quit line counselling
Validation: No bio-chemical validation
n-values re-calculated for meta-analysis to permit intention-to-treat analysis for primary 
outcome data
Hymowitz 2007  
Methods Country: United States of America
Design: Randomized controlled trial; Nested; Clustered
Objective: The primary aim of the study was to compare the effects of the two training 
conditions on resident tobacco intervention as measured by annual resident tobacco 
survey and OSCEs, baseline, and end-of-study patient and parent/guardian tobacco 
surveys, and a survey of program graduates who enter paediatric practice
Methods of analysis: Due to training site being the unit of randomization, analyses were 
based on aggregated data rather than on individuals; Likert scales were calculated as 
means; Two-stage mixed model relationship was used for waves of residents at baseline 
and 2 year follow-up
Clustering adjustment made: No – However data were analysed based on aggregated data 
to account for unit of analysis issues; authors state that this will provide “…an unbiased 
estimate of the intervention effect and standard error.” (also known as a ‘mean analysis’)
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Participants Therapist description: Paediatric residents undergoing training in the New York/New Jersey 
metropolitan area
Eligible for study: n= 16 Paediatric residencies; n= 2069 Residents
Randomized: n= 16 residency training programs; 3rd year residents n= 140 in intervention 
arm; n= 135 in control arm
Completed: n= 14 residency training programs; 3rd year residents n= 136 in intervention 
arm; n= 99 in control arm
Age: Approximately 33 years of age for overall population; Intervention mean = 32.3 + 5.1 
years; Control mean = 33.7 + 5.7 years
Gender: Intervention female= 69.1%; Control female= 59.3%
Patient description: Parent/Guardian: Parents of the patients visiting the primary care clinics
Eligible for study: n= 1770
Randomized: Intervention n= 849; Control n= 776
Completed: Intervention n= 724; Control n= 617
Age: Overall= 29.88 + 8.65 years
Gender: Female= 85.8%
Patient description: Children: Patients (children) visiting the primary care clinics
Eligible for study: n= 550
Randomized: Intervention n= 255; Control n= 300
Completed: Intervention n= 255; Control n= 300
Age: Intervention 14.89 + 1.84 years; Control 15 + 2.16 years
Gender: Intervention female= 55.3%; Control female= 60%
Interventions Setting: New York/New Jersey metropolitan area; Continuity clinic (primary care clinic) 
served as the venue for resident tobacco-intervention activities
Training of those delivering the intervention to the health professional: Not specified
Intervention description: Special training – ‘Solutions for Smoking’ was the main teaching 
tool; Also provided with assistance with clinics (e.g., take-home educational and 
behavioural-change materials available in the waiting areas, anti-tobacco posters, 
marking charts of smokers etc); Packets of educational and behavioural materials 
designed for mothers of newborns, adolescent smokers, parents who smoke etc.; Seminar 
series provided opportunities to distribute program materials, highlight key concepts 
and aspects of the background material, and utilise role-laying to help residents acquire 
interviewing, counselling and tobacco-intervention skills; Power point presentations 
were used during these seminars on environmental tobacco smoke, smoking cessation 
and prevention of smoking onset and solutions for smoking audio/visual vignettes to 
demonstrate and model state-of-the-art counselling and intervention skills
Control description: Standard training – Background reading material that included the 
clinical practice guideline 'Treating Tobacco Use and Dependence' and 'American 
Academy of Pediatrics Statement on Tobacco'; A manual entitled 'Clinical Interventions 
to Prevent Tobacco Use by Children and Adolescents'; A journal article on approaches to 
tobacco prevention and control in clinic and office settings; Standard training sites did 
not receive assistance with clinic mobilisation or have access to companion intervention 
material; They did receive pamphlets and related material to facilitate intervention on 
tobacco; Seminar also conducted the same as the intervention group with the exception 
of vignettes to demonstrate counselling and intervention skills
Duration of intervention: One hour seminars, four times per year
Intervention delivered by: Unclear, though the manuscript mentions ‘training directors’; 
Seminars delivered by senior investigators from the New Jersey Medical School
Intensity: One hour seminars, four times per year
Outcomes Pre-specified outcome data: Primary outcome measures included changes in resident tobacco 
intervention activities and skills in the area of environmental tobacco smoke, tobacco-
use prevention and tobacco-use cessation; Demographic information, knowledge and 
attitudes about tobacco prevention and control, tobacco-intervention activities during the 
past year, use of specific tobacco-intervention skills and strategies, and beliefs about the 
efficacy of tobacco intervention in patients and parents
Follow-up period: Four years in total; Outcome data for participants only published for 2 
year follow-up
Notes Process measures: Sixty percent of residents in the special training condition reported 
review of ‘Solutions for Smoking’, although a higher proportion attended the seminar 
series (80%) and had access to companion intervention material in the clinic









































Joseph 2004  
Methods Country: United States of America
Design: Randomized controlled trial; Clustered
Objective: To test the effect of modest intensity, practical systems changes that might 
increase the delivery of smoking cessation treatment within VAMCs (Veterans Medical 
centres); Authors hypothesized that an intervention addressing common barriers to 
delivery of smoking cessation treatment at the organisation level (as opposed to provider 
or patient level) might be an effective strategy to improve compliance with guideline 
recommendations; The trial was designed to test the effectiveness of this intervention
Methods of analysis: McNemar odds on change to assess differences in the change between 
intervention groups; Pearson chi-squared statistic to compute the significant of the 
resulting odds ratio between the intervention and control group; Differences in smoking 
cessation rates were determined via the Pearson Goodness-of-Fit chi-squared statistic; 
Change scores were used for continuous variables and the relative difference in change 
was measured using the Wilcoxon rank sum test; Logistic regression was used for binary 
outcomes; SAS glimmix macro was used to incorporate the design effect and allow for the 
binary outcome
Clustering adjustment made: Yes - SAS glimmix macros used to incorporate the design 
effects
Significance of cluster adjustment: Not reported
Participants Therapist description: Physicians, nurses, psychologists and pharmacists were present at the 
training meeting
Eligible for study: n= 164 VAMCs (Veteran Medical Centres) nationwide
Randomized: Intervention n= 10; Control n= 10
Completed: Intervention n= 10; Control n= 10
Age: Not reported
Gender: Not reported
Patient description: A random selection of patients who had seen their primary care 
provider (at VAMCs) within 6 weeks were phoned for baseline surveys; Current smokers 
were identified and underwent 1 year follow-up also via phone
Eligible for study: Cohort n= 5793; Eligible n= 5367
Randomized: Intervention n= 2112; Control n= 2142
Completed: Intervention n= 641; Control n= 783
Age: Baseline - Intervention 64.6 years; Control 63.1 years; Follow-up - Intervention 64.9 
years; Control 63.8 years
Gender: Baseline (male) - Intervention 96.1%; Control 95.3%; Follow-up - Intervention 
95.8%; Control 98.0%
Interventions Setting: Veterans Affairs Medical Centers (VAMCs)
Training of those delivering the intervention to the health professional: Registered nurse who was 
trained in smoking cessation methods and had considerable administrative experience 
within Veteran Affairs
Intervention description: Intervention sites received 5 copies of the AHCPR Smoking 
Cessation Guideline for distribution; Plus a multi-component intervention designed to 
increase implementation of 3 specific Guideline recommendations: 1) documentation 
of tobacco use status in the medical record 2) delivery of intervention to all smokers 
and 3) liberal use of smoking cessation medications; The organisational support 
included a training meeting, site visits and a study interventionist at the co-ordinating 
site in Minneapolis; Removal of formulary restrictions were encouraged for smoking 
cessation aids as were the requirements for attendance at a cessation class to access 
pharmacotherapies; Bupropion SR was suggested as an addition to formulary; However 
approaches were individualised for each site
Control description: Control sites also received 5 copies of the AHCPR Smoking Cessation 
Guideline for distribution
Duration of intervention: Authors state intervention lasted through a 6 month period, 
however level of exposure for participants not specified
Intervention delivered by: Registered nurse face-to-face through 2 to 3 site visits within the 
first 6 months to communicate with directors of primary care, pharmacy service chiefs, 
smoking cessation co-ordinators and primary care nurses, as well as the 2 day training 
meeting
Intensity: One, 2 day training meeting held in Minneapolis for the site-based principal 
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Outcomes Pre-specified outcome data: General health, smoking history/status, nicotine dependence, 
services provided at the last primary care visit, mood, alcohol use and demographics, 
provision of counselling, referred to a smoking cessation clinic, provided advice or 
medications and cessation discussed (documented in medical records)
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: No bio-chemical validation
Kottke 1989  
Methods Country: United States of America
Design: Randomized controlled trial, cluster
Objective: "…the task of Doctors Helping Smokers was to be the development and 
testing of a program to help physicians incorporate currently identified smoking 
cessation intervention into their practice routine." Hypothesis: that physicians 
trained in a workshop would be more effective in helping their smoking patients 
quit than would similar volunteer physicians who received only patient education 
materials or a group of physicians that received no assistance
Methods of analysis: Data presented as proportions were analysed with the chi-
squared analysis; Data reported as means and SDs were analysed with analysis of 
variance; Life-table analysis used to examine relapse patterns of the patients who 
attempted to quit smoking
Clustering adjustment made: Physicians unit of analysis; Multivariate regression used 
to adjust for confounding effects of differences among the groups of doctors and 
their patients
Significance of cluster adjustment: Not reported
Participants Therapist description: n= 109 family practitioners
Eligible for study; n-value: 1110; n= 109 physicians returned postcards
Randomized; n-value: Workshop group n= 27; No-assistance group n= 17; Materials 
group n= 22
Completed; n-value: Workshop group n= 27; No-assistance group n= 17; Materials 
group n= 22
Age: Workshop group 37.9 + 9.7; No-assistance group 39.5 + 7.7; Materials group 44.3 
+11.7
Gender: Workshop group F=22.2%; No-assistance group F=9.1%; Materials group 
f=11.8%
Patient description: n= 1653 primary care smoking patients not selected by motivation 
to quit
Eligible for study; n-value: Not reported
Randomized; n-value: 6053 total (89.4% of patients whose names were submitted by 
the physicians)
Completed; n-value: 87% of the n= 6053 were available for follow-up; 86.8%, 87.5% and 
86.8% for the workshop, materials and no-assistance groups respectively
Age: 18 to 70 years; Mean =slightly over 40









































Interventions Setting: Private family practice (primary care) in Minnesota, USA; workshop site not 
described though likely centralised
Training of those delivering the intervention to the health professional: Not described
Intervention description: Two intervention groups: Materials group - physicians given 
self-help manuals to distribute; Workshop group - self-help manuals plus 6 hour 
group workshop
Control description: Normal care
Duration of intervention: Workshop group: 6-hour workshop given on two occasions. 
Workshop started in the morning with two presentations of 30-minutes about 
the effects of smoking, chronic disease and organisation for smoking cessation 
interventions; 1-hour presentation on doctor-patient intervention skills; 1-hour 
introduction to smoking cessation techniques; Two 1-hour small-group workshop 
sessions on counselling sessions and planning for smoking cessation interventions 
and 30-minutes for summary and discussion; Materials group: 100 copies of Quit-
and-Win, a smoking cessation manual
Intervention delivered by: Not described
Intensity: Workshop: 6-hr workshop given on 2 occasions; Materials group: None; No 
assistance: None
Outcomes Pre-specified outcome data: Physicians: Characteristics, knowledge, skills, confidence 
and beliefs about smoking cessation in relation to their performance during the 
trial
Patients: demographics, smoking habits, health status, details about visit with 
physician, prevalence of smoking in their social environment and support received 
from spouse or others who were emotionally important to them; Four questions 
about extent tot which they felt in control of their life, the confidence they felt 
about handling personal problems, extent that “things were going [their] way,” and 
the extent to which difficulties were piling up; serum cotinine levels
Follow-up period: 12-months
Notes Process measures: None
Validation: Serum cotinine
Not able to be meta-analysed due to unit of analysis being the practitioners instead 
of the individuals
Lennox 1998  
Methods Country: United Kingdom
Design: Randomized controlled trial; Nested; Clustered
Objective: To assess the impact of the training intervention on both health 
professionals and smoking subjects
Methods of analysis: Comparison of binary outcomes were analysed using the chi-
squared test; Logistic and multiple regression analyses were carried out where 
appropriate for these outcome measures; Comparisons of continuous outcomes 
were analysed using t-tests and multiple linear regression; Confounders were 
adjusted including age, sex and deprivation score for the regression analysis as well 
as for indicators for the intervention group
Clustering adjustment made: Yes - GLMM (Generalised linear mixed model) approach 
used for regression techniques which added the general practice as a random 
factor nested within the treatment groups to the other fixed-effect factors
Significance of cluster adjustment: Regression techniques used to explore clustering 
effects for variables significant in individual level analyses; No significant 
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Participants Therapist description: n= 16 general practices with training for doctors, nurses and 
health visitors
Eligible for study: n= 26 practices
Randomized: n= 16 practices
Completed: n= 16 practices
Age: Not reported
Gender: Not reported
Patient description: Smoking patients of the practices identified from questionnaires 
to random sample
Eligible for study: Not reported
Randomized: Number of patients surveyed: Intervention n= 6631; Control n= 6631; 
Number of patients responding: Intervention n= 5022; Control n= 5217; Number of 
smokers identified: Intervention n= 1381; Control n= 1207
Completed: Eight months - Intervention n= 941; Control n= 864; 14 months - 
Intervention n= 898; Control n= 795
Age: Not reported
Gender: Not reported
Interventions Setting: Primary care medical practices in Aberdeen, UK
Training of those delivering the intervention to the health professional: Two authors 
conducted the training, one a senior health promotion officer experienced in group 
work with primary health care teams and the other a GP
Intervention description: One day training workshop based on stages of change model
Control description: Usual care control group
Duration of intervention: Six identical one day training workshops were held within a 
three week period based on stages of change model
Intervention delivered by: Two authors, one a senior health promotion officer 
experienced in group work with primary health care teams and the other a GP
Intensity: One day training workshop
Outcomes Pre-specified outcome data: Changes in attitudes, self-reported behaviour, change 
in readiness to change, cessation attempt made, point prevalence, continuous 
abstinence
Follow-up period: Eight and 14 months post workshop for patient questionnaires
Notes Process measures: Some subjects did not attend their practice during the study and 
therefore were not exposed to the effects of the training
Validation: No bio-chemical validation










































Sinclair 1998  
Methods Country: Scotland
Design: Randomized controlled trial
Objective: To evaluate a training workshop for community pharmacy personnel to 
improve their counselling in smoking cessation based on the stage-of-change model
Methods of analysis:To demonstrate the differences between intervention and control 
groups, parametric tests (t-tests for quantitative variables) and non-parametric 
tests (Mann-Whitney tests for quantitative variables) were used. Multiple logistic 
regression was carried out for the binary outcomes of point prevalence at one month, 
and continuous abstinence at four and nine months, and to assess the effect of 
potential confounders
Clustering adjustment made: Yes; authors mention that the effect of cluster 
randomization was assessed by firstly calculating the degree of intra-cluster 
correlation for each of the binary outcomes of abstinence. Secondly, regression 
techniques, adding the pharmacy as a random factor nested within the treatment 
groups to the other fixed effect factors, were considered leading to a generalised 
linear mixed model. The authors mention that intra-cluster correlations for the 
outcomes at each time point were calculated. The estimated values were less than 
0.0001 and therefore negligible
Significance of cluster adjustment: No; authors mention that trends in outcome were not 
affected by potential confounders or adjustment for clustering
Setting: Residents and physicians in Family Medicine, Taiwan
Training: Two lessons
Randomization: Stratified by number of years in practice (method not stated)
Participants Therapist description:
Eligible for study; n-value: n= 76 pharmacies
Randomized; n-value: Intervention n= 32 pharmacies; Control n= 30 pharmacies
Completed; n-value: Intervention n= 32 pharmacies (specify: n= 94 (54 assistants, 40 
pharmacists); Control n= 29 pharmacies
Age: Not described
Gender: Intervention: 54 female assistants; 25 female pharmacists; Control: not 
described
Patient description:
Eligible for study; n-value: n= 775 smokers
Randomized; n-value: Intervention n= 224; Control n= 268
Completed; n-value: Intervention n= 159; Control n= 188
Age: Intervention 41.7 (17-74); Control 41.5 (17-77)
Gender: Intervention 61.2% men; Control 62.7% men
Interventions Setting: Eight workshops were scheduled with a choice of dates, times and location 
(Aberdeen or Elgin - the major population centres which are located 70 miles apart at 
opposite ends of the study area)
Training of those delivering the intervention to the health professional: Not described
Intervention description: Training in stages of change approach to smoking cessation
Control description: Usual care
Duration of intervention: two-hour workshop
Intervention delivered by: Not described
Intensity: One workshop
Outcomes Pre-specified outcome data: self-reported point prevalence smoking cessation rates at 
one month; self-reported continuous abstinence from zero to four months and from 
zero to nine months; the pharmacy support process (registration, counselling and 
client record)
Follow-up period: 1, 4, 9 months; Point prevalence of abstinence at 12 months
No process outcomes
Notes Validation: none
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Strecher 1991  
Methods Country: United States of America
Design: Randomized Controlled Trial; Factorial design; Nested; Cluster
Objective: The study evaluated the effectiveness of training and prompting under 
realistic conditions, including: the use of simple and generalisable interventions; 
training conducted by existing faculty; and evaluation at several sites with 
residents from three primary care specialties
Methods of analysis: Contingency tables with chi-squared tests, t-tests, and analysis 
of variance (ANCOVA) were used to investigate the pre-test equivalencies of the 
four groups and all outcomes for selected other variables; ANCOVA compared the 
effects of the two interventions, alone and in combination, whilst controlling for 
pre-test scores and physician speciality
Clustering adjustment made: No
Significance of cluster adjustment: N/A (Physician speciality adjusted for but not 
individual physician clustering effects)
Participants Therapist description: 250 residents in internal medicine, family practice and 
paediatrics
Eligible for study; n-value: 261
Randomized; n-value: 250; Tut (Tutilage) and Pro (Prompt) n= 66; Tut only n= 66; Pro 
only n= 60; Control n= 58




Patient description: 937 patients from American primary care medical practice
Eligible for study; n-value: 937; Tut and Pro n= 250; Tut only n= 243; Pro only n= 228; 
Control n= 225
Randomized; n-value: 843
Completed; n-value: 659; Tut and Pro n= 184; Tut only n= 156; Pro only n= 162; Control 
n= 157
Age: 17 to 75 years; Mean age = 45 years
Gender: Female =63%
Interventions Setting: American primary care residency programmes (physicians in training)
Training of those delivering the intervention to the health professional: Not specified though 
one of the authors in each instance conducted the tutorial
Intervention description: Three intervention groups: Tutilage only (minimal contact 
counselling); Prompt only (chart-reminder and advice sheet); Tutilage and Prompt
Control description: Normal care
Duration of intervention: Only held once, two sessions in total - the first included slide 
presentations the second group discussions
Intervention delivered by: One of the authors, usually a clinic director or a faculty 
member conducted the tutorial
Intensity: Tutorial: two sessions - initial one-hour long, second session two weeks 
later
Outcomes Pre-specified outcome data: Self-administered questionnaires requesting self-reports 
on smoking-cessation counselling frequency, content, attitude and training; 
patients were asked about smoking habits and physicians advice to stop smoking
Follow-up period: 6-months
Notes Process measures: None
Validation: Expired CO; Bio-chemical verification was obtained where possible
The three intervention groups were combined for meta-analyses to produce the 
single 'Intervention' sample; n-values re-calculated for meta-analysis to permit 









































Swartz 2002  
Methods Country: United States of America
Design: Randomized controlled trial; Clustered
Objective: Primary goal of this study was to determine if in-person feedback 
intervention, compared to mailed feedback, would lead to a higher use of tobacco 
treatments by patients who smoke
Method of Analysis: Odds ratios, 95% confidence intervals and p-values were 
calculated to evaluate intervention effects on patient and provider behaviour; 
Unadjusted models and models adjusted for age, insurance at baseline, practice 
speciality and region of the state were calculated using logistic regression; All 
analyses were completed with SAS statistical software
Clustering adjustments made: Yes – survey logistic procedures
Significance of clustering: Not reported
Participants Therapist description: Primary care providers with practices of at least 75% internal 
medicine or family medicine clinicians providers combined with Medicaid 
and HMO panel size of at least 200 adults; n= 176 were physicians, n= 26 nurse 
practitioners, n= 20 physician assistants, n= 3 unknown classification
Eligible for study: n= 150 practices; n= 230 providers within the 50 practices recruited 
were eligible
Randomized: n= 50 practices; n= 225 providers
Completed: n= 50 practices; n= 179 providers
Age: Not reported
Gender: Not reported
Patient description: Patients were adults receiving primary care by a study practice 
aged 18 years and older who were seen within the prior year
Eligible for study: n= 17318 identified as receiving primary care by a study practice; 
n= 11547 eligible
Randomized: n= 7461 completed baseline survey; n= 1238 patients identified as 
smokers at baseline
Completed: n= 807 reporting provider visit in the year proceeding follow-up; n= 516 
smokers with baseline and follow-up surveys reporting one serious quit attempt
Age: Intervention mean age= 41.9 years; Control mean age= 42.9 years
Gender: Intervention male= 26.4%; Control male= 23.2%
Interventions Setting: Maine Medicaid and Maine HMO, USA
Training of those delivering the intervention to the health professional: Not reported
Intervention description: Experimental study practices received two educational office 
sessions, with data feedback presented during the first visit; Second visit reinforced 
the guidelines and discussed office systems to improve tobacco treatment
Control description: Control practices received information and feedback data by mail
Duration of intervention: For the intervention: Two educational office sessions, the 
second occurred five months after the first
Intervention delivered by: One nurse practitioner well-versed in motivational 
interviewing and tobacco guidelines
Intensity: Twenty minute slide presentation followed by feedback and discussions 
for the first visit; Second visit discussions time not stated
Outcomes Pre-specified outcome data: Reports of provider asking about tobacco, advice to quit, 
spending time talking about smoking or quitting, discussing tobacco treatment 
medications, and discussing counselling services or programs; Smokers were 
asked about serious attempts at quitting for 24 hours or longer, use of medication 
or counselling to aid quitting, and use of any tobacco in the previous week (7 day 
point prevalence)
Follow-up Period: Fifteen to 18 months later which corresponded to 12 months 
following the practice intervention
Notes Process measures: None reported
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Twardella 2007  
Methods Country: Germany
Design: Randomized controlled trial; Nested; Clustered; Factorial design 2x2
Objective: The aim of this study was to examine whether and to what extent 
structural changes could enhance promotion of smoking cessation in general 
practice. In particular, we aimed to investigate the effect of the following strategies 
on smoking cessation rates: (1) specific training of general practitioners in methods 
of promoting smoking cessation and a financial incentive to general practitioners 
for each recruited patient who successfully quits; and (2) specific training of general 
practitioners in promotion of smoking cessation and the cost-free prescription of 
drugs proved effective in supporting smoking cessation
Methods of analysis: Primary end-point data were assessed on an intention-to-treat 
basis; smoking abstinence at 12 months was assessed using a mixed logistic 
regression model accounting for cluster randomization including a random effect 
for medical practice in the model; baseline imbalances between intervention arms 
were adjusted using multivariate analyses; the effect of drug use during follow-up, 
as recorded by general practitioners, was evaluated in a bivariate mixed logistic 
regression model
Clustering adjustment made: Yes - mixed logistic regression model, using PROC 
NLMIXED in "SAS V8.1" (including a random effect for medical practice)
Significance of cluster adjustment: Not reported
Participants Therapist description: General practitioners in the Rhine-Neckar region located in 
southwest Germany
Eligible for study: n= 174 met the inclusion criteria
Randomized: Total= 94 general practitioners from n= 82 practices; Usual care: n= 
21 therapists (20 practices); Training + incentive: n= 24 therapists (21 practices); 
Training + medication: n= 23 therapists (21 practices); Training, incentive + 
medication: n= 26 therapists (20 practices)
Completed: n= 59 practices; Usual care: n= 14 practices; Training + incentive: n= 16 




Patient description: Patients visiting the practices and who smoked at least 10 
cigarettes per day and aged between 36 to 75 years, were recruited by participating 
general practitioners, irrespective of intention to quit smoking and conditional on 
written informed consent
Eligible for study: n= 587
Randomized: n= 587; Usual care: n= 76; Training + incentive: n= 146; Training + 
medication: n= 144; Training, incentive + medication: n= 221
Completed: n= 488; Usual care: n= 61; Training + incentive: n= 123; Training + 
medication: n= 121; Training, incentive + medication: n= 183
Age: Range 36 to 75 years; <45 years: Usual care n= 30; Training + incentive n= 55; 
Training + medication n= 59; Training, incentive + medication n= 95; 45 to 54 years: 
Usual care n= 24; Training + incentive n= 63; Training + medication n= 44; Training, 
incentive + medication n= 86; > 55 years: Usual care n= 22; Training + incentive n= 
28; Training + medication n= 41; Training, incentive + medication n= 40
Gender: Female: Usual care n= 38; Training + incentive n= 74; Training + medication 









































Interventions Setting: Not reported
Training of those delivering the intervention to the health professional: Not reported
Intervention description: Three intervention groups: Training + incentive – Two hour 
cost-free group tutorial for general practitioners in methods of promoting smoking 
cessation including stages of change model, approaches for counselling in general 
practice and potential of pharmacological support; Financial remuneration of €130 
after study completion per smoke-free participant; Training + medication – Same 
group tutorial as above plus general practitioners could offer cost-free prescription 
of drugs proved effective in supporting smoking cessation; Training, incentive + 
medication – All of the above
Control description: Usual care
Duration of intervention: A single 2 hour tutorial available at two session times
Intervention delivered by: Not reported
Intensity: Two Hour workshop
Outcomes Pre-specified outcome data: Primary outcome measure - Self-reported point prevalence 
of smoking abstinence obtained at 12 months follow-up
Second outcome measure - Continuous smoking abstinence for at least 6 months 
(183 days) at 12 months follow-up; Frequency of the use of methods to support 
smoking cessation among patients during the follow-up period as reported by 
general practitioners
Follow-up period: Twelve months
Notes Process measures: None reported
Validation: Serum cotinine
Other: Definition of abstinence - Participants were categorised as ‘at least 6 months 
abstinent’ if they were smoke free at 12 months follow-up, validated by serum 
cotinine, and, according to self-report, had stopped smoking at least 6 months 
before the date of follow-up
The three intervention groups were combined for meta-analyses to produce the 
single 'Intervention' sample
Unrod 2007  
Methods Country: United States of America
Design: Randomized controlled trial; Nested; Clustered
Objective: To bolster the rate at which physicians delivered smoking cessation 
services and to increase patients' quit rates
Methods of analysis: Descriptive statistics for characterisation of sample at 
baseline; Pearson's chi-squared test and independent sample t-test to measure 
differences between groups; Hierarchic generalised linear model analysis of 
variance controlling for baseline variables used to measure physician performance; 
Abstinence analysed via generalised linear model
Clustering adjustment made: Yes - Mixed linear modelling with physician as clustering 
variable used for smoking related outcomes
Significance of cluster adjustment: Not reported
Participants Therapist description: Primary care physicians recruited from the four largest 
metropolitan boroughs, Bronx, Brooklyn, Manhattan and Queens
Eligible for study: n= 579
Randomized: Intervention n= 35; Control n= 35
Completed: Intervention n= 35; Control n= 35
Age: Mean = 51.1 + 8.1 years (total population only)
Gender: Males= 74% (total population only)
Patient description: Patients in primary care physician waiting rooms who were 
identified as smokers
Eligible for study: n= 5826
Randomized: Intervention n= 270; Control n= 248
Completed: Intervention n= 237; Control n= 228
Age: Intervention mean= 43.5 + 14.7 years; Control mean= 42.8 + 14.2 years
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Interventions Setting: Training conducted during a 40 minute visit to the physicians’ office
Training of those delivering the intervention to the health professional: Not reported
Intervention description: Physician training in brief smoking cessation counselling 
based on the 5As Clinical Practice Guideline algorithm; Patients and physicians 
provided with a one page report containing smoking-related information 
and recommendations based on the information provided during the patient 
assessment
Control description: Physicians in the control condition were not given any training 
and were instructed to continue their usual smoking cessation practices; Patients 
completed the same assessments but did not receive the report (being the one page 
report characterising patients smoking habits)
Duration of intervention: One session only
Intervention delivered by: Health educator
Intensity: One, 40 minute session
Outcomes Pre-specified outcome data: Patients asked - Did your doctor… ask whether you 
smoke, ask whether you are ready to quit, advise you to quit smoking, help you to 
quit smoking, help you set goals about quitting, give you written materials about 
quitting, refer you to a quit smoking program, talk to you about quit-smoking 
medications, make a follow-up appointment to discuss smoking
Primary outcome measure - 7 day point prevalence abstinence; Longest quit 
attempt (in days); Total number of 25 hour quit attempts, stage-of-change 
progression
Follow-up period: Six months
Notes Process measures: None reported
Validation: For sub-group of participants - Saliva-cotinine test; Fourteen of 16 
samples confirmed abstinence (88%)
n-values re-calculated for meta-analysis to permit intention-to-treat analysis for 
primary outcome data
Wang 1994  
Methods Country: Taiwan
Design: Randomized Controlled Trial
Objective: To assess the stages-of-change model in cigarette smoking and practice 
guidelines for practicing cigarette smoking cessation counselling in a short training 
program, designed to make physicians more willing to help their patients to quit 
smoking and increase success rates
Methods of analysis: All data were analysed using either the chi-square or Fisher’s 
exact tests
Clustering adjustment made: No









































Participants Therapist description: Residents and physicians in Family Medicine
Eligible for study; n-value: Not reported
Randomized; n-value: Group one: lessons n= 9, Group two: posters n= 9, Group three: 
usual care n= 9
Completed; n-value: Group one: lessons n= 9, Group two: posters n= 9, Group three: 




Eligible for study; n-value: Not reported
Randomized; n-value: n= 93, Group one: n= 39, Group two: n= 26, Group three: n= 28
Completed; n-value: n= 82, Group one: n= 35, Group two: n= 24, Group three: n= 23
Age: Group one: <40 n= 14, 40-59 n= 17, > 60 n= 8; Group two: <40 n= 14, 40-59 n= 8, 
> 60 n= 4; Group three: <40 n= 7, 40-59 n= 12, > 60 n= 9
Gender: Group one: male n= 38 female n= 1; Group two: male n= 24 female n= 2; 
Group three: male n= 27 female n= 1
Therapists: 27 physicians
Patients: 93 patients
Interventions Setting: Not reported
Training of those delivering the intervention to the health professional: Not reported
Intervention description: Two intervention groups: Training - stages of change model 
and practice guidelines; Poster - used as a reminder to give advice
Control description: Usual care
Duration of intervention: Group one: two lessons; Group two: provided with poster 
only; Group three: no intervention
Intervention delivered by: Not reported
Intensity: Group one: two lessons; Group two: provided with poster only; Group 
three: no intervention
Outcomes Pre-specified outcome data: Demographic data, cigarette-smoking habits and health 
beliefs
Follow-up period: 6-months; Point prevalence of abstinence at 12 months
No process outcomes
Notes Validation: None
Process measures: None reported
Manual adjustment for potential clustering effects performed in the meta-analyses 
for primary outcome data; The two intervention groups were combined for meta-
analyses to produce the single 'Intervention' sample; n-values re-calculated for 
meta-analysis to permit intention-to-treat analysis for primary outcome data
Wilson 1988  
Methods Country: Canada
Design: Randomized controlled trial; Nested; Clustered
Objective: To investigate the effects of a smoking cessation workshop on physician 
practices and on patients’ smoking behaviour
Methods of analysis: Analysis of covariance – Obtained by averaging patient values 
within the practice; Analysis of differences between groups – If there was no 
difference between the usual care and gum only groups (untrained cohorts) these 
would be combined and compared with the gum plus (trained cohort); Regression 
analysis performed on practice unit, adjusting for the effects of predictor variables 
and treatment
Clustering adjustment made: No - None reported
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Participants Therapist description: Psysicians
Eligible for study: n= 460 Family physicians
Randomized: n= 90 Physicians
Completed: n= 83 Physicians; Usual care n= 27; Gum only n= 29; Gum plus n= 27
Age: Usual care: Mean = 41.64 years; Gum only: Mean = 41.77 years; Gum plus: Mean 
= 40.57 years
Gender: Usual care: Male 92.6%; Gum only: Male 93.1%; Gum plus: Male 81.5%
Patient description:
Eligible for study: Not stated as n-value; Participation consent rates were: Usual care 
91%; Gum only 83%; Gum plus 76%
Randomized: Not reported
Completed: Usual care n= 601; Gum only n= 726; Gum plus n= 606 (total n= 1933)
Age: <25 years: Usual care 22%; Gum only 19%; Gum plus 17%; 25 to 44 years: Usual 
care 50%; Gum only 54%; Gum plus 56%; ≥ 45 years: Usual care 27%; Gum only 27%; 
Gum plus 27%
Gender: Male: Usual care 39%; Gum only 42%; Gum plus 33%
Interventions Setting: Clinical practice setting – Participation during routine physician 
consultation; Based in Ontario, Hamilton
Training of those delivering the intervention to the health professional: Not described; CME 
Protocol
Intervention description: Two intervention groups: Gum only - Physicians instructed 
to approach patients in their usual manner about quitting smoking and to offer 
nicotine gum as an aid to quitting; Gum Plus Training - Gum in addition to training
Control description: Usual care
Duration of intervention: One, 4 hour training workshop to Gum plus physician cohort
Intervention delivered by: Not described
Intensity: Control - Not explicitly reported; Gum only - Not explicitly reported; Gum 
plus - One, 4 hour workshop for physicians; For patients - Use of gum, 1 to 6 follow 
up visits and quit dates
Outcomes Pre-specified outcome data: Three month self-reported sustained abstinence prior to 
bio-chemically validated cessation at 12 months; smoking behaviour, cessation 
attempts and nicotine gum use measured by telephone interviews; Physicians 
performance measured by patient flow sheets and patient telephone exit 
interviews
Follow-up period: Point prevalence of abstinence at 12 months
Notes Process measures: None reported
Validation: Salivary cotinine
The two intervention groups were combined for meta-analyses to produce the 
single 'Intervention' sample; Manual adjustment for potential clustering effects 










































Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cohen (Dent) 1989 39 / 771 8 / 256 2,8 1,65 0,76 3,58
Cohen (Doc) 1989 63 / 1065 5 / 355 1,7 4,40 1,76 11,03
Cornuz 2002 15 / 115 7 / 136 1,4 2,76 1,09 7,04
Cummings (Priv) 1989 26 / 386 30 / 364 7,0 0,80 0,47 1,39
Cumming 1989 67 / 837 60 / 840 13,4 1,13 0,79 1,63
Hymowitz 2007 158 / 1394 79 / 1155 18,7 1,74 1,31 2,31
Joseph 2004 32 / 280 39 / 295 8,2 0,85 0,51 1,40
Lennox 1998 100 / 1381 93 / 1207 22,5 0,94 0,70 1,25
Sinclair 1998 55 / 187 51 / 223 8,0 1,41 0,90 2,19
Strecher 1991 61 / 413 42 / 394 8,9 1,45 0,95 2,21
Swartz 2002 69 / 503 3 / 74 1,1 3,76 1,15 12,28
Twardella 2007 32 / 270 20 / 248 4,5 1,53 0,85 2,76
Unrod 2007 10 / 54 1 / 23 0,3 5,00 0,60 41,59
Wilson 1988 15 / 158 5 / 75 1,5 1,47 0,51 4,20
1,36 1,20 1,55
0,01 0,1 1 10 100
Favours control Favours intervention
Analysis 1.1a. Smoking cessation at longest follow-up (point prevalence)
 
Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cummings (Priv) 1989 12 / 386 9 / 364 8,0 1,27 0,53 3,04
Cummings 1989 22 / 837 13 / 840 11,2 1,72 0,86 3,43
Gordon 2010 74 / 1394 22 / 1155 20,2 2,89 1,78 4,68
Lennox 1998 32 / 1381 37 / 1207 34,2 0,75 0,46 1,21
Sinclair 1998 22 / 187 16 / 223 11,4 1,73 0,88 3,39
Strecher 1991 33 / 502 8 / 157 10,1 1,31 0,59 2,90
Twardella 2007 32 / 503 1 / 74 1,4 4,96 0,67 36,85
Wilson 1988 12 / 158 3 / 75 3,3 1,97 0,54 7,21
1,60 1,26 2,03
0,01 0,1 1 10 100
Favours control Favours intervention
Analysis 1.1b. Smoking cessation at longest follow-up (continuous abstinence)
 
Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Swartz 2002 343 / 413 317 / 394 14,7 1,19 0,83 1,70
Strecher 1991 16 / 156 3 / 47 10,8 1,68 0,47 6,02
Cornuz 2002 9 / 115 3 / 136 10,5 3,76 0,99 14,25
Cummings (Priv) 1989 84 / 218 18 / 148 14,1 4,53 2,58 7,95
Cummings 1989 146 / 388 39 / 348 14,6 4,78 3,23 7,07
Cohen (Dent) 1989 83 / 486 5 / 161 12,5 6,43 2,56 16,14
Wilson 1988 53 / 158 2 / 75 10,0 18,42 4,35 78,00
Cohen (Doc) 1989 275 / 816 5 / 273 12,7 27,25 11,12 66,78
4,98 2,29 10,86
0,01 0,1 1 10 100
Favours control Favours intervention
Analysis 1.2. Patients asked to set a quit date
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Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cornuz 2002 8 / 115 4 / 136 11,8 2,47 0,72 8,42
Cummings (Priv) 1989 42 / 218 16 / 148 14,9 1,97 1,06 3,65
Cummings 1989 59 / 388 17 / 348 15,2 3,49 1,99 6,12
Strecher 1991 76 / 156 17 / 47 14,7 1,68 0,86 3,29
Swartz 2002 164 / 413 151 / 394 16,1 1,06 0,80 1,41
Unrod 2007 128 / 270 24 / 248 15,5 8,41 5,19 13,65
Wilson 1988 84 / 158 3 / 75 11,9 27,24 8,23 90,13
3,34 1,51 7,37
0,01 0,1 1 10 100
Favours control Favours intervention
Analysis 1.3. Patient asked to make a follow-up appointment
 
Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cohen (Dent) 1989 350 / 486 60 / 161 7,4 4,33 2,97 6,31
Cohen (Doc) 1989 691 / 816 112 / 273 7,6 7,95 5,84 10,81
Cornuz 2002 45 / 115 39 / 136 6,9 1,60 0,94 2,71
Cummings (Priv) 1989 221 / 343 151 / 339 7,6 2,26 1,66 3,07
Cumming 1989 392 / 783 352 / 785 7,9 1,23 1,01 1,50
Hymowitz 2007 30 / 142 15 / 90 6,3 1,34 0,67 2,66
Joseph 2004 165 / 280 162 / 295 7,5 1,18 0,85 1,64
Lennox 1998 420 / 529 355 / 474 7,6 1,29 0,96 1,74
Sinclair 1998 113 / 133 99 / 159 6,7 3,42 1,93 6,08
Strecher 1991 114 / 156 27 / 47 6,3 2,01 1,02 3,96
Swartz 2002 114 / 413 82 / 394 7,6 1,45 1,05 2,01
Twardella 2007 257 / 377 32 / 54 6,7 1,47 0,82 2,64
Unrod 2007 207 / 270 131 / 248 7,4 2,93 2,01 4,28
Wilson 1988 123 / 158 23 / 75 6,5 7,95 4,28 14,74
2,28 1,58 3,27
0,01 0,1 1 10 100
Favours control Favours intervention
Analysis 1.4. Number of smokers counselled
 
Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cornuz 2002 16 / 115 1 / 136 5,5 21,82 2,85 167,27
Cummings (Priv) 1989 126 / 343 32 / 339 13,1 5,57 3,64 8,52
Cumming 1989 195 / 783 66 / 785 13,5 3,61 2,68 4,87
Hymowitz 2007 41 / 142 16 / 90 12,1 1,88 0,98 3,60
Strecher 1991 19 / 156 6 / 47 10,3 0,95 0,35 2,53
Swartz 2002 155 / 413 142 / 394 13,6 1,07 0,80 1,42
Twardella 2007 107 / 377 8 / 54 11,4 2,28 1,04 4,99
Unrod 2007 87 / 270 17 / 248 12,6 6,46 3,71 11,25
Wilson 1988 77 / 158 2 / 75 7,9 34,70 8,23 146,30
3,52 1,90 6,52
0,01 0,1 1 10 100
Favours control Favours intervention










































Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cummings (Priv) 1989 29 / 218 29 / 148 11,8 0,63 0,36 1,11
Cumming 1989 40 / 388 36 / 348 12,2 1,00 0,62 1,60
Hymowitz 2007 11 / 142 5 / 90 9,1 1,43 0,48 4,25
Joseph 2004 59 / 280 56 / 295 12,4 1,14 0,76 1,71
Sinclair 1998 219 / 224 248 / 268 9,6 3,53 1,30 9,57
Strecher 1991 28 / 156 6 / 47 9,9 1,49 0,58 3,86
Swartz 2002 127 / 275 117 / 241 12,7 0,91 0,64 1,29
Twardella 2007 82 / 377 4 / 54 9,4 3,47 1,22 9,90
Wilson 1988 615 / 1064 108 / 458 12,9 4,44 3,47 5,69
1,57 0,87 2,84
0,01 0,1 1 10 100
Favours control Favours intervention
Analysis 1.6. Number of smokers receiving nicotine gum/replacement therapy
 
Study name Events / Total Statistics for each study MH odds ratio and 95% CI
Relative MH odds Lower Upper 
Intervention Control weight ratio limit limit
Cumming 1989 63 / 388 4 / 348 52,1 16,67 6,00 46,32
Strecher 1991 9 / 156 1 / 47 21,4 2,82 0,35 22,82
Wilson 1988 53 / 158 2 / 75 26,6 18,42 4,35 78,00
14,18 6,57 30,61
0,01 0,1 1 10 100
Favours control Favours intervention
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This study examined the effectiveness of low-intensity, practice-tailored train-
ing for general practitioners (GPs) aimed at personal and organizational barriers 
that arise when routinely asking patients’ smoking status, advising to quit, and 
arranging follow-up.
Methods
A cluster-randomized controlled trial with 49 GPs and 3,401 patients (677 smok-
ers). Two patient groups participated: 2,068 patients (433 smokers) at baseline 
and 1,333 patients (244 smokers) post-intervention. At follow-up, 225 smokers 
of both groups participated. The primary outcome was GP smoking cessation 
counseling (asking about smoking status, advising to quit, prescribing pharma-
cotherapy, and referring for behavioural support). Secondary outcomes were 
GPs’ attitudes toward smoking cessation care, patients’ intention to quit, and 
long-term quit rates. Outcomes were measured with GP self-report and patient 
report.
Results
Patients of trained GPs reported more often being asked about smoking behaviour 
compared to patients of untrained GPs (OR = 1.94, 95% CI = 1.45–2.60). According 
to GP self-report, the training increased the provision of quit-smoking advices 
(difference 0.56 advice per day; 95% CI = 0.13–0.98) and the ability and intention 
of providing smoking cessation care. We found no effect on GPs’ arrangement of 
follow-up, smokers’ intention to quit, and long-term quit rates.
Conclusions
After 1 hour of training, we found significant differences between trained and 
untrained GPs on the frequency in which they asked about smoking (patient 
reported) and advised smokers to quit (GP self-reported). The training did not 
increase prescriptions of pharmacotherapy, referrals to behavioural support, or 
quit rates. Future training methods should focus on the GPs’ ability, tools, and 








































GP training in smoking cessation care 85
InTroduCTIon
General practitioners (GPs) play a key role in the delivery of smoking cessation 
interventions to their patients. Even a GPs’ minimal intervention of advising 
smokers to quit has the potential to significantly benefit smokers’ motivation to 
quit and smoking abstinence.1;2 Guidelines recommend that GPs put into practice 
a systematic approach of asking every patient about tobacco use, advising all 
smokers to quit, assessing smokers’ willingness to make a quit attempt, assisting 
smokers with treatment and referrals, and arranging follow-up contacts.3-10 In 
spite of the well-documented effectiveness of these guidelines1;6;9, many GPs fail to 
routinely implement them.11-13 This results in a substantial evidence-practice gap.
Several factors may affect the implementation of smoking cessation care (SCC) 
in general practice, related to the health professional and the organisation.14-16 
Personal barriers of GPs that impede the implementation of tobacco support are 
doubts and concerns regarding their ability to deliver SCC, and the effectiveness 
and the appropriateness of SCC.17-20 Also, organisational barriers may hamper 
guideline implementation, as GPs often report role confusion, time and financial 
constraints.20 For this reason, interventions aimed at enhancing the implemen-
tation of SCC guidelines should be multifaceted and tailored to the needs of the 
health professional and organisation.2;18;21-25
Training health professionals in improving SCC has been shown to benefit 
the implementation of counseling tasks, such as asking patients to set a quit 
date and providing self-help materials, as well as patient smoking abstinence.26 
However, these training programmes often fail to address organisational con-
straints that impede full implementation of smoking cessation guidelines.26 
Since smoking cessation counseling varies widely between general practices27, 
strategies are needed that address the specific constraints GPs deal with in order 
to maximize the implementation of smoking cessation support and patients’ 
smoking abstinence rates.
Therefore, we developed and examined the effectiveness of a new low-intensity, 
practice-tailored training method aimed at improving smoking cessation coun-
seling activities of GPs. This method is tailored to the personal and organisational 
barriers that arise during the implementation of SCC in regular daily practice. In 
the present study we focus on the implementation of routinely asking patients’ 
smoking status, advising smokers to quit, and arranging follow-up. This simpli-
fied approach (also called the A-A-A approach) has recently been introduced in 
healthcare settings where professionals face insurmountable barriers, such as 
a lack of time to provide assistance to smokers who want to quit.28;29 Because 









































to the practice nurse within Dutch general practice, this simplified approach is a 
promising solution to reduce the implementation gap of smoking cessation care 
in general practice.
We hypothesize that our training method will increase GPs’ smoking cessation 
counseling activities, especially the rate at which smokers are identified, advised, 
and referred. Since we focus on the implementation of GPs’ minimal cessation 
intervention, we expect a small but significant effect on smoker’s intention to 
quit. If trained GPs succeed to increase the rate at which smokers are referred 
to intensive cessation support, we expect higher rates of long-term smoking 
abstinence reported by patients of trained GPs.
meThodS
Design
We performed a cluster-randomised controlled trial in general practice. In order 
to account for a lack of independence between the patients of the same GP, the 
GP was the unit of randomisation. GPs were matched according to gender, age 
and practice type and randomly assigned to one of two conditions using a simple 
randomisation procedure (coin tossing) by an independent researcher not in-
volved in the recruitment of the GPs. Patients were unaware of the allocation 
during the entire study period. GPs remained unaware about the allocation until 
after the baseline measurements; thereafter, the GPs were informed about the 
allocation. GPs in both conditions were aware of the aim of the intervention 
during the entire study period. The study was approved by the Medical Ethical 
Board of the Leiden University Medical Centre (P10.125).
Intervention
We earlier conducted a systematic review on the effectiveness of training health-
care professionals in SCC.26 The results of this meta-analysis show that a single, 
short training session is likely to be just as effective as multiple longer sessions. 
Therefore, we developed a single, one-hour training session in order to anticipate 
time constraints GPs often face. The GP training was delivered by a certified 
trainer of the Dutch Expert Centre on Tobacco Control (STIVORO) and was based 
on the 5-A behaviour change model from which we derived the 6 I-Model4;5; an 
Inventory was made of GPs’ current knowledge and skills as well as organisa-
tional and personal barriers regarding SCC and the GP was Informed about the 
effectiveness of SCC in general practice. GPs’ motivation to implement SCC was 








































GP training in smoking cessation care 87
techniques, such as exploring and resolving ambivalence.30 GPs were Instructed 
on knowledge and skills related to the barriers they indicated. Several themes 
could be addressed, such as the content of the SCC guideline, behavioural and 
pharmacological SCC support, skills in motivating smokers to quit, and organi-
sational aspects of SCC, such as task allocation, referral and registration. The 
training concluded with concrete, individual implementation goals which were 
summarized into an action plan. In addition, all GPs received a toolkit, which 
contained a SCC flowchart, a summary of pharmacological support, and leaflets 
for patients. Afterwards, the GP was given the opportunity to receive additional 
feedback support (Intervision). GPs in the control condition continued their 
usual SCC. Usual care can be defined as the SCC that is usually provided by the 
GP when not being trained, which is likely to vary between the GPs.27
Participants
General practitioners
We recruited GPs by letter and a follow-up telephone call. Eligibility criteria were 
the self-reported number of provided stop-smoking advices per week (maximum 
of five31), in order not to select ‘best practice’ GPs only. In addition, we selected 
only one GP per practice in order to prevent contamination. Among 228 GPs who 
returned the screening questionnaire, 64 agreed to participate. Six GPs were 
excluded because they provided on average more than 5 stop-smoking advices 
per week, and another 9 GPs already had a participating colleague in the same 
practice; this resulted in 49 GPs for randomisation. After randomisation, 4 GPs 
(3 intervention, 1 control) were partly excluded from further analyses because 
they did not complete their measurements, leaving 45 GPs for full analysis (22 
intervention, 23 control).
Patients
During the study period (January-August 2011), adult patients visiting participat-
ing GPs in both conditions were asked to complete a questionnaire after consul-
tation. The baseline group consisted of 2068 patients (1002 intervention, 1066 
control) including 433 smokers (195 intervention (19.5%), 238 (22.3%) control) 
who completed the questionnaire during the three weeks prior to the GP train-
ing. The post-intervention group consisted of 1333 patients (630 intervention, 
703 control), including 244 smokers (98 intervention (15.6%), 146 (20.8%) control) 
who completed the questionnaire during the three weeks after the GP training. 
All smoking patients of both the baseline and post-intervention group were sent 









































225 smokers (112 intervention (response rate 38.2%), 113 control (response rate 
29.4%)) (Figure 1).
Outcomes
The primary outcome was GP smoking cessation counseling. Secondary out-
comes were GPs’ attitudes, self-efficacy and intentions towards implementing 
SCC, and patients’ intention to quit and long-term smoking abstinence.
GPs’ smoking cessation counseling
We measured GPs’ smoking cessation counseling by means of GP self-report 
and patient report. At baseline, GPs in both conditions completed a tracking 
list at the end of 2 working days per week, during 3 consecutive weeks. Ques-
tions were about smoking cessation activities during that day (asking, advising, 
prescribing pharmacological aids, and referring for behavioural support). In the 
intervention group, GP training in SCC took place within 2 weeks after this first 
tracking period. One week after the training a second tracking period started 
for GPs in both conditions. On those days that GPs completed the tracking lists, 
all adult patients who visited the participating GPs were asked to complete a 
questionnaire after consultation. These questionnaires included information on 
socio-demographics and GP performance with regard to SCC.
GPs’ attitudes, self-efficacy and intention towards implementing SCC
Secondary endpoints were GPs’ attitudes, perceived self-efficacy and intentions 
regarding routinely implementing SCC, measured with a pre- and post-question-
naire based on previous studies.32-34
Patients’ smoking behaviour
Patients’ intention to quit smoking was dichotomised (0=no intention to quit 
within 6 months, and 1=intention to quit within 6 months). Smoking patients 
were sent a postal questionnaire 9 months after the GP training in order to 
assess long-term smoking abstinence rates. Because patients visit their GP on 
average 4 times per year, we assumed that most smokers in the baseline group 
revisited their GP in this 9-month period and as a consequence were exposed to 
a trained GP (intervention) or non-trained GP (control).35 Therefore, we included 
smokers from both the baseline and post-intervention group in the follow-up 
analyses. We examined self-reported 7-day point prevalence abstinence and 
continuous abstinence.36 In total, 225 smokers completed the 9-month follow-up 
questionnaire (33.7%). Of these responders, 112 smokers consulted a GP in the 







































































































































































































































































































































































































































































































113 smokers consulted a GP in the control group (72 at baseline (30.3%) and 41 
post-intervention (28.1%)).
Sample size
Assuming that 21% of the Dutch adult smokers currently receive a stop-smoking 
advice from their GP12, to detect a doubled proportion of smoking patients re-
ceiving a stop-smoking advice from their GP, with a power of 80% (assuming an 
ICC of 0.013 and a design effect of 1.10437 based on 25 clusters), 112 smoking 
patients per group were required.
Statistical analyses
We compared GP characteristics and practice characteristics between the inter-
vention and control group using the c2-test and independent samples t-test for 
dichotomous and continuous data, respectively. In addition, characteristics of 
patients in the intervention and control group were compared at baseline and 
post-intervention. The impact of the training on GP-reported outcomes was as-
sessed using linear regression analyses, adjusting for values at baseline. Missing 
data were imputed according to the last-observation-carried-forward method, 
assuming that the outcome data did not change post-intervention.38 The im-
pact of the training on GP smoking cessation activities reported by patients 
was analysed using generalised estimating equations (GEE) in order to adjust 
for clustering. In addition, GEE was used to assess smoking abstinence rates of 
patients at follow-up. Smokers lost to follow-up were treated as not refraining 




None of the GP and practice characteristics showed a significant difference 
between the intervention and control condition (Table 1). With regard to demo-
graphics, the sample was similar to the average Dutch GP population.40 After 
adjustment for baseline values, we found a difference for the GP reported mean 
number of stop-smoking advices provided per day post-intervention (difference 
0.56 advice per day; 95% CI=0.13-0.98) (Table 2). There was no significant differ-
ence in the mean number of times GPs asked smokers about smoking status, 
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Patients
Table 3 reports the characteristics of patients at baseline, post-intervention 
and at follow-up. At baseline, more patients in the control group reported a 
chronic airway disease compared to the intervention group (15.4% vs. 12.4%; 
p=0.03). Post-intervention, patients in the control group were younger, more 
often reported a non-Dutch cultural background and being a smoker (Table 3). 
After adjustment for clustering effects and patient background characteristics, 
a time-by-condition interaction was found for patients’ report of being asked 
about smoking status (OR=1.94, 95% CI=1.43-2.60) (Table 2); patients in the 
intervention group who visited their GP post-intervention reported being asked 
about their smoking status more often than patients who visited their GP prior 
to the training. We found no effect on patient’s report of being advised to quit 






Gender, male 16 (64%) 12 (50%)
Cultural background, Dutch 24 (96%) 22 (92%)
Years of employment, > 10 years 19 (76%) 19 (79.2%)
Smoking status
Smoker 0 (0%) 2 (8.3%)
Ex-smoker 8 (32%) 7 (29.2%)
Previous training in SCC 11 (44%) 8 (33.3%)
Age in years (M, SD) 49.9 (8.1) 51.3 (8)
Patients seen per week (M, SD) 115.8 (39.8) 109.5 (46.7)
Hours of work per week (M, SD) 38.3 (9.0) 38.1 (10.4)
Practice characteristics
Type of practice
Single-handed 12 (48%) 10 (41.7%)
Duo 6 (24%) 9 (37.5%)
Group 5 (20%) 2 (8.3%)
Health care centre 2 (8%) 3 (12.5%)
Number of practice nurses
None 1 (4%) 3 (12.5%)
1 practice nurse 17 (68%) 16 (66.7%)
2 or more practice nurses 7 (28%) 5 (20.8%)
Previous training in SCC practice nurse 19 (76%) 14 (58.3%)
GP=general practitioner, SCC=smoking cessation care, M=mean, SD=standard deviation. Differences 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































smoking, being prescribed pharmacotherapy, or being referred for behavioural 
support (Table 2).
GPs’ attitudes, self-efficacy and intention
We found an effect of the training on GPs’ perceived self-efficacy and intention 
towards implementing SCC (Table 2).
Patient’s intention to quit and smoking abstinence
After adjustment for clustering effects and patient background characteristics, 
we found no effects of the GP training on smokers’ intention to quit (Table 2). 
Nine months after the GP training, more patients in the intervention group (base-
line and post-intervention) completed the follow-up questionnaire compared to 
patients in the control group (38.2% vs. 29.4%; p=0.02). We compared patients 
who completed the follow-up questionnaire with patients who did not complete 
the questionnaire. The patients did not differ on the background characteristics 
they filled out in the first questionnaire (age, gender, cultural background, and 
educational level). Also, responders and non-responders did not differ on the 
number of times they reported being asked about their smoking behaviour, were 
advised to quit, were prescribed pharmacotherapy or were referred for behav-
ioural counseling during the GP visit, as indicated in the first questionnaire. 
After controlling for clustering effects and patient background characteristics, 
26.8% of patients in the intervention group reported not having smoked during 
the past 7 days and 10.8% refrained from smoking since they completed the 
first questionnaire (Table 4). In the control group 25.0% and 7.1% of the patients 
reported 7-day point prevalence abstinence and continuous abstinence, respec-
Table 4. Effect of GP training in smoking cessation care on patient smoking behaviour at 9 month 
follow-up with different assumptions about smoking behaviour of non-responders






OR (95% CI) a P
Point prevalence abstinence 26.8% 25.0% 1.07 (0.57-2.00) 0.89
Continuous abstinence 10.8% 7.1% 1.62 (0.60-4.34) 0.34
% non-smokers,  





OR (95% CI) a P
Point prevalence abstinence 10.2% 7.3% 1.33 (0.77-2.31) 0.30
Continuous abstinence 4.1% 2.1% 1.93 (0.77-4.89) 0.16
GP=general practitioner, OR=odds ratio, CI=confidence interval
Generalised Estimating Equations adjusted for clustering effects and patient characteristics








































GP training in smoking cessation care 95
tively. We did not find an effect on long-term patient smoking behaviour (Table 
4). Also, when analysing responders of the baseline and post-intervention group 
separately, no effect of the GP training on long-term smoking abstinence was 
found (data not shown). We performed a sensitivity analysis using the conserva-
tive assumption that non-responders did not change their behaviour and still 
smoked at follow-up.39 This analysis did not change the findings on long-term 
patients smoking abstinence rates (Table 4).
dISCuSSIon
Major findings
This study evaluated the effectiveness of a low-intensity, practice-tailored 
training in smoking cessation care (SCC) for GPs, addressing both personal and 
organisational barriers that arise during the implementation of these counseling 
activities. After the training we found significant differences between trained 
and untrained GPs on the frequency they asked about smoking (according to the 
patients) and gave advice to quit (according to the GPs themselves).
However, we did not find an effect on the arrangement of follow-up support, 
neither on provision of pharmacological therapy, nor on referrals for behavioural 
support. In addition, we found no effects on patients’ intention to stop smoking 
after GP consultation and long-term cessation rates.
Study findings compared to previous research
Our training managed to increase the frequency at which patients reported being 
asked about smoking, and at which GPs reported the provision of stop-smoking 
advices. Compared to several other training programmes that did not find an 
increase in these counseling activities, this is a hopeful outcome.41-43 However, 
we found relatively small rates of smokers for whom GPs had arranged referral 
and follow-up; other studies found rates of behavioural follow-up ranging from 
25-59% and pharmacological prescriptions from 14-37%.41-45
With regard to the long-term effect of the GP training on patients’ smoking 
behaviour, a recent meta-analysis of 14 studies found comparable long-term 
quit rates as a result of training health professionals in smoking cessation care.26 
However, the majority of the individual studies within this meta-analysis did not 
confirm statistical significance between quit rates in the intervention and control 
group, which is in line with our finding. Although our data suggest that trained 
GPs more often advised smokers to quit, they failed to increase referral rates 









































results. A study of McRobbie et al. has shown the effectiveness of a brief training 
session addressing skills for referral of smokers on the number of GP referrals 
to evidence-based cessation support.46 In addition, more and more studies show 
the increasing role and effectiveness of in-practice cessation support delivered 
by practice nurses.47-51 Moreover, referring and connecting smokers to evidence-
based quit lines is likely to increase smoking cessation.29;52
Strengths and limitations
Some limitations with regard to the study design should be considered when 
interpreting the results of our study. First, the exact response rate of patients 
who completed the questionnaire at baseline and post-intervention is unknown. 
Reasons for non-response might be attributed to GPs who did not hand over the 
patient questionnaires, or to patients who forgot or were unwilling to complete 
the questionnaire.
Second, participating GPs relatively often advised their patients to quit at 
baseline (40.2% and 43.8%, respectively, compared to only 21% found in another 
Dutch study.12 An explorative analysis showed that the GPs’ awareness of the 
aim of the intervention and completing tracking lists regarding smoking cessa-
tion counseling might make them more prone to ask about smoking, compared 
to GPs that did not complete tracking lists and were unaware of the study topic 
(data not shown). Despite this possible priming effect, we found an additional 
significant effect of the training on the number of times patients who were asked 
about their smoking status (patient-reported) and advised to quit (GP-reported).
A third limitation is the fact that smoking abstinence at follow-up was self-
reported and lacked biochemical verification due to financial constraints. In 
addition, a large number of patients were lost to follow-up (66.4%), especially 
in the control group (69.9%). Attrition is common in lifestyle intervention trials, 
which may affect the study power, cause bias and threaten generalisability.53
Fourth, the different sources were slightly inconsistent. On the one hand, GPs 
reported an increase in the number of stop-smoking advices. On the other hand, 
patients only reported a significant increase in the number of times they were 
asked about their smoking status. This discrepancy is in line with other stud-
ies, reporting a lack of agreement between patient and provider surveys when 
measuring tobacco counseling actions.54-57 This might be explained by patients’ 
perception of a stop-smoking advice as being embedded in a general discussion 
about smoking behaviour and therefore have escaped their attention. This could 
have led to recall bias and may have contributed to the lack of effect on patients’ 
motivation to quit and long-term smoking cessation. Finally, a minority of the 
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a (trained) practice nurses during the study period, which may have contributed 
to the lack of effect on GPs’ referrals for behavioural cessation support.
Nevertheless, the major strengths are the pragmatic nature of this study (a 
low-intensity and pragmatic training method) in a specific setting (GP practice), 
tested in a cluster-randomised controlled trial preventing contamination be-
tween GPs, with outcome measures being assessed on both short-term GP and 
long-term patient level.
Conclusions
Our low-intensity, practice-tailored training for GPs in the implementation of 
asking patients’ smoking status, advising smokers to quit, and arranging referral 
and follow-up does not lead to an increased patient access to more intensive 
smoking cessation support. Future training methods should also include prac-
tice nurses and focus on the GPs’ role as gatekeeper for referring or connecting 
smokers to cessation support, such as quit lines and practice nurses. This ap-
proach is likely to ensure pharmacological and behavioural cessation support 
and increase patient abstinence rates.
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Strategies are needed to help general practitioners (GPs) to promote smoking 
cessation as recommended by guidelines. This study examines whether the 
quality of action planning among GPs improves their provision of smoking ces-
sation care.
Methods
The effectiveness of a 1-hour training programme was examined in a cluster 
randomized controlled trial in which 49 GPs participated. GPs who followed the 
training (intervention group; n = 25) formulated action plans related to i) enquir-
ing about smoking, ii) advising to quit smoking, and iii) arranging follow-up for 
smokers motivated to quit. GPs also formulated a coping plan for encountering 
smokers not motivated to quit. The quality of these plans (i.e. plan specificity) 
was rated and, 6 weeks after the training, GPs reported on the performance of 
these plans (i.e. plan enactment). Multilevel regression analyses were used to 
examine the effects of plan specificity and plan enactment on patient-reported 
smoking cessation activities of the GPs in the intervention group (n=1632 pa-
tients) compared with the GPs in the control group (n=1769 patients). In these 
analyses, the changes in time (baseline versus post-intervention) were examined 
and compared to the control group.
Results
Compared to the control group, GPs who formulated a highly specific action plan 
during the training asked their patients about smoking more often after the 
training compared to prior to the training (OR 2.11, 95% CI 1.51-2.95). GPs were 
most likely to have asked patients about smoking after the training compared to 
prior to the training when they had enacted a highly specific formulated action 
plan (OR 3.08, 95% CI 2.04-4.64). The effects of GP plan specificity and plan enact-
ment on asking patient about smoking were most prominent among GPs who, at 
baseline, intended to provide smoking cessation care.
Conclusions
A highly specific action plan formulated by a GP on when, how and by whom 
patients will be asked about smoking had a positive effect on GPs’ asking pa-
tients about smoking, especially when these professionals also reported to have 
enacted this plan. This effect was most prominent among GPs who intended to 
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personalised coping plans is recommended to further increase GPs’ provision of 
advice to quit smoking and arranging follow-up support to quit smoking.
InTroduCTIon
Current guidelines recommend that general practitioners (GPs) routinely ask 
patients about smoking, advise them to quit, assess their motivation to quit, 
assist them with quitting, and arrange follow-up quit smoking support (the 5-A 
Model).1;2 However, GPs report difficulties when translating these guidelines into 
practice3-7 resulting in a substantial gap between evidence and practice. A study 
in Dutch general practice showed that 79% of all smokers and 40% of smok-
ers who discussed smoking with their GP, did not receive stop-smoking advice.8 
The development of strategies that facilitate the implementation of guideline-
recommended smoking cessation care may result in more patients being advised 
to quit and being provided with evidence-based quit-smoking support and, 
ultimately, giving up smoking.9-11
Strategies to facilitate the implementation of evidence-based clinical guide-
lines often focus on influencing the behaviour of the healthcare profession-
als.12-15 Efforts to change the clinical behaviour of healthcare professionals often 
involve didactic modes of delivery aimed at educating these professionals.13-15 
However, this approach implies a lack of knowledge and assumes that additional 
knowledge will change the behaviour of healthcare providers, neither of which 
may necessarily be true. In fact, enhancing knowledge alone may not be the best, 
or even an adequate strategy, to influence the clinical behaviour of healthcare 
professionals.16 Similarly, the motivation and/or the beliefs of GPs to routinely 
adopt evidence-based guidelines are not always a reliable predictor of the rou-
tine implementation of these guidelines.17
Psychological theories may provide a basis for identifying the predictors of GP 
behaviour and of behaviour change.16 Clinical practice is a form of human be-
haviour that is sensitive to theory-based strategies that have proven effective in 
patient samples.18-22 However, a systematic review showed that only a minority 
of the 235 interventions that previously aimed to facilitate guideline implemen-
tation by healthcare professionals actually used theory-based strategies.12
One of the well-established theory-based strategies (albeit in other popula-
tions) is the self-formation of ‘conditional plans’, such as action plans and coping 
plans.23;24 Action plans in the form of if-then plans (i.e. ‘implementation inten-
tions’25) link a situational cue to behaviour in order to promote behaviour change 









































than 3 times a year), then I will do Y (I will advise the patient to quit smoking)’. Coping 
plans anticipate potential barriers to behaviour change which impede action plans 
from working. Such plans aim to bridge the gap between the individual’s intention 
to perform the behaviour and the actual performance of that behaviour.26;27
The mechanisms that underlie the effectiveness of action and coping plans 
involve a heightened accuracy and speed of detecting the contextual cue for per-
forming the intended behaviour.28-31 Plans that are more specific are suggested to 
result in a greater improvement of the intended behaviour compared to incom-
plete or vague plans.32;33 In addition, studies have shown that individuals who act 
according to their formulated action plans (i.e. plan enactment) are more likely 
to benefit from their plans, e.g. enacting an action plan to remove all tobacco 
products results in a higher likelihood to actually quit smoking.34;35 The effects 
of plan specificity and enactment on behaviour are strongest among those in-
dividuals who are the most motivated to change the intended behaviour.32-34;36
It has been shown that planning predicts the clinical behaviour of GPs in vari-
ous conditions.37-39 Moreover, an intervention study showed that incorporating 
planning in postgraduate education increased the use of a practitioner-guided 
procedure among mental health professionals.36 However, to our knowledge, no 
studies have examined whether planning improves the provision of evidence-
based smoking cessation care by GPs.
The present study incorporates action planning within a training session for 
GPs, aimed at increasing their provision of smoking cessation tasks as recom-
mended in clinical guidelines, including asking patients about smoking, advis-
ing them to quit, and arranging follow-up quit smoking support for smokers. 
Because GPs often indicate that patients’ lack of motivation to quit may act as a 
barrier to the provision of guideline-recommended smoking cessation care40-43, 
GPs also formulated a coping plan to address this potential barrier.
Based on the reported positive effects of action planning in patient samples44-46, 
we hypothesized that GP action planning would improve their performance of 
these smoking cessation tasks. Secondly, we hypothesized that formulating a 
coping plan for smokers who are not motivated to quit provided GPs with a 
solution for this type of barrier, thereby increasing the provision of smoking ces-
sation care for this group.39;47-51 Since the present GP training includes multiple 
behaviour change strategies, we also examined the nature of action planning 
including plan specificity and plan enactment. In line with previous findings 
on plan specificity and self-reported plan enactment32-36, we hypothesized that 
GPs who formulated a highly specific plan and reported a high level of plan 
enactment would be more likely to provide smoking cessation care post-training. 








































GP action planning to increase smoking cessation care 107




The present paper reports the results of a two-group cluster randomized 
controlled trial in general practice. GPs were randomly assigned to either the 
intervention or control condition. The intervention entailed a 1-hour individual 
training session for GPs in the delivery of smoking cessation care. The training 
was based on behaviour change techniques related to methods that underlie the 
current Dutch guidelines for treating tobacco addiction (the 5-A Model 2;52): 1) 
GPs’ implementation barriers were identified, 2) GPs were provided with state-
of-the-art evidence about the effectiveness of smoking cessation care, 3) GPs’ 
motivation to routinely implement the guideline was identified and improved 
using motivational interviewing techniques, 4) GP instruction was provided and 
tailored to the identified implementation barriers, and 5) GPs were given the op-
portunity to receive additional feedback support. Action planning was the final 
component of the GP training programme. Previously, the effects of the multi-
component training on GPs’ provision of smoking cessation care were tested 
and reported elsewhere.53 Action planning was one of the components of the GP 
training and our initial RCT did not provide insight into the effects of this single 
behaviour change technique. Therefore, the present study focuses on a further 
examination of the effects and nature of action planning among the trained GPs.
Participants
During the study period (January-August 2011) 25 GPs received a 1-hour training 
programme that incorporated action planning. At baseline (pre-intervention) 
these 25 GPs saw 1002 patients, of whom 195 (19.5%) were smokers. Post-inter-
vention, the same GPs saw a different group of 630 patients, of whom 98 (15.6%) 
were smokers. In the control condition, 24 GPs and 1769 patients (baseline: 1066, 
post-intervention: 703) were included, of whom 384 (21.7%) were smoking pa-











































Six weeks prior to the training programme, GPs rated their intention to implement 
guideline-recommended smoking cessation care on a 4-point scale (‘no intention 
to routinely implement smoking cessation treatment within six months’ (0), ‘intention to 
routinely implement smoking cessation treatment within six months’ (1), ‘intention to 
routinely implement smoking cessation care within one month’ (2), and ‘already routinely 
implemented smoking cessation treatment’ (3). To facilitate testing of the hypotheses, 
we used a post-hoc categorisation in line with the principles from the Health 
Action Process Approach54 to classify GPs into three groups depending on their 
response to the question about their intention: 1) ‘GP pre-intenders’ (answer cat-
egory 0; 4 GPs, 393 patients), ‘GP intenders’ (answer category 1 and 2 combined; 
14 GPs, 2211 patients), and ‘GP actors’ (answer category 3; 7 GPs, 797 patients).
Patient-reported provision of smoking cessation care
During the three weeks prior to and after the GP training programme, all patients 
completed a questionnaire immediately after their GP consultation in which 
they rated their GP’s smoking cessation activities during that consultation. This 
questionnaire included the following items: ‘Did your GP ask you about smoking 
during the consultation?’, ‘Did your GP advise you to quit during the consultation’? and 
‘Did your GP refer you to any kind of follow-up quit smoking support during the consulta-
tion’? For each item, patients could answer ‘Yes’ (1) or ‘No’ (0).
Action planning
During the GP training programme, action planning was assessed based on the 
separate plans formulated by the GP for: a) identifying smokers, and b) advising 
smokers to quit. GPs wrote down who was going to perform the activity, when 
the activity was going to be performed, and how the activity was going to be 
registered in the patient’s electronic health record. In addition, GPs formulated 
an action plan for c) arranging follow-up for smokers who are motivated to quit, 
and a coping plan for d) arranging follow-up for smokers who are not motivated 
to quit. In these plans, GPs formulated the what, who and how of each plan. This 
method is comparable to that used in similar studies with patient samples. 32
Specificity of GP plans
The degree of specificity of each of the components of the GPs’ plans (who, when, 
what and how) was assessed using a rating method based on previous studies. 
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(1). The when, what, and how components of the plans were rated on a 4-point 
scale; components were rated as not completed (0) if GPs did not write down any 
plans, and components were rated as being low specific (1) when GPs described 
them in rather general terms, e.g. ‘I will ask my patients about their smoking during 
the consultation’. Components that were specified with moderate precision were 
rated as being moderately specific (2), e.g. ‘I will ask my patients about their smoking, 
routinely once a year’. A component was rated as being highly specific (3) when GPs 
specified their future action with a sufficient amount of precision e.g. ‘I will ask 
my patients about their smoking when they present with smoking-related complaints 
during the consultation’.
Analyses of the when component showed that GPs specified either a particular 
moment (e.g. during the consultation), or a particular type of patient (e.g. pa-
tients with smoking-related complaints), or both; therefore, we decided to rate 
both these types of specifications. As a result, the total specificity score for the 
first two action plans (asking about smoking and advising to quit) ranged from 
0-10, and for the third action plan (dealing with smokers who were motivated to 
quit) and the coping plan (dealing with smokers who were not motivated to quit) 
scores ranged from 0-7 (Appendix 1).
Two researchers independently rated the specificity of all components of the 
GPs’ plans. Kappa statistics were used to estimate the inter-rater agreement; this 
resulted in a high level of agreement between the two researchers for the total 
specificity scores of the GPs’ plans: i.e. for asking about smoking 0.998 (95% CI 
0.995-0.999), for advising to quit 0.940 (95% CI 0.864-0.973), for arranging follow-
up for smokers who are motivated to quit 0.945 (95% CI 0.850-0.978), and for ar-
ranging follow-up for smokers not motivated to quit 0.962 (95% CI 0.907-0.984). 
These high kappa coefficients are probably due to the type of rating method 
used. Disagreements were discussed until consensus was achieved. For analyses, 
the GPs’ total plan specificity scores were categorised into low (1) and high (2) 
scores, using the mean score as a cut-off.
Enactment of GP plans
After the GP training, we were interested in providing the GPs in the intervention 
group with their self-formulated if-then plans and ask them if they had the op-
portunity to enact them. Therefore, six weeks after the GP training programme, 
via a postal questionnaire, the GPs were asked to report the extent of plan enact-
ment (response rate 76%; n=19). In this questionnaire, each GP was provided 
with the four plans that they had previously formulated. GPs were asked to rate 
the extent to which they had enacted each plan using a 5-point scale: ‘plan not 









































within one month’(1), ‘plan not enacted, intending to enact within a week’ (2), ‘plan 
partly enacted (3),‘plan fully enacted (4). For missing data, a negative scenario was 
applied which assumed that GPs who did not complete the questionnaire did 
not enact their plans (score 0). For the analyses, scores for plan enactment were 
categorised into low (1) and high (2) scores using the mean score as a cut-off.
Statistical analysis
Descriptive statistics were used for the characteristics of the GPs and for scores 
on specificity of the GP plan and on plan enactment. To test our hypotheses, 
we linked GP data with patient data and analysed these using two-level logistic 
regression analyses (generalised estimating equations), including data at the GP 
and patient level.
In our model, data at the GP level included scores on plan specificity and plan 
enactment as independent variables. To examine the main effects of these vari-
ables on GPs’ provision of smoking cessation care (patient-reported), all patients 
were classified into three categories, i.e. patients who had a consultation with 
a GP who had formulated a highly specific plan/reported a high level of plan 
enactment (2), patients who had a consultation with a GP who had formulated 
a low specific plan/reported a low level of plan enactment (1), and patients who 
had a consultation with a GP within the control condition (0).
Data at the patient level included GPs’ provision of smoking cessation care, 
as reported by patients, as dependent variables, including being asked about 
smoking, being advised to quit, and being provided with quit smoking follow-up. 
Patient-reported smoking cessation care was included as a dichotomous variable 
(1=yes, 0=no). The model was adjusted for differences between characteristics 
of the patients who visited the GPs in the intervention and control condition 
(gender, cultural background and smoking status).
Univariate analysis was used to examine the main effects of GP plan specificity 
and GP-reported plan enactment on their provision of smoking cessation care 
(as reported by patients). In addition, interaction analysis was used to examine 
whether or not the effects of GP plan specificity on the delivery of care, depended 
on the extent of GP plan enactment. Finally, subgroup analyses were performed 
to examine whether the effects of GP plan specificity and plan enactment on 
delivered smoking cessation care, differed between GPs with different baseline 
intentions to routinely implement smoking cessation care. In all models, we 
included Time (baseline (0)/post-intervention (1)) by Group (control group (0)/
low plan specificity or low plan enactment (1)/high plan specificity or high plan 
enactment (2)) interaction effects since we included different cohorts of patients 
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reSulTS
Sample characteristics
Of the 49 participating GPs, 28 (57.1%) were men and 38 (77.6%) had worked 
more than 10 years as a GP; in addition, the majority worked on average 38 h/
week, had a mean age of 50 years. Most of these GPs worked in collaboration 
with one (n=33; 67.3%) or two (n=12; 24.5%) practice nurses. None of the GP 
characteristics were significantly different between the intervention and control 
condition. A detailed overview of the background characteristics of participating 
GPs and patients is reported elsewhere.53
Specificity and enactment of GP plans
Descriptive data with regard to the specificity of GPs’ plans are presented in 
Table 1. Most GPs completed all components of their action plans and coping 
plan. With regard to the ‘when’ component, most GPs described a type of moment 
for which they planned to ask about smoking or advise to quit, instead of a type 
of patient for who they planned to provide this care. Only a minority of the GPs 
described the type of moment or the type of patient highly specific, such as ‘I’ll ask 
my patient about smoking, when I make a risk profile of the patient’ (moment) or ‘I’ll ask 
all patients with a chronic illness about smoking’ (patient). Only a few GPs described 
highly specific what the planned to do when they would encounter a smoker 
who is motivated or unmotivated to quit, such as ‘When I encounter a smoker who 
is motivated to quit, I will discuss the (dis)advantages of quitting, motivation to quit, and 
I will make a quit plan’ or ‘When I encounter a smoker who is not motivated to quit, I’ll 
ask the patient’s permission to discuss their smoking behaviour again during the next 
consultation’. Most GPs described highly specific how they planned to register the 
activities in the electronic patient record, for example using the ‘International 
Classification of Primary Care’. Most GPs who formulated an action plan for asking 
patients about smoking highly specific also reported a high level of plan enact-
ment (n=6/9, 66.7%). Similar associations were found between GP plan specificity 
and plan enactment in the other action and coping plans. However, some GPs 
who described their plans low specific reported a high level of plan enactment, 
and vice versa.
Effect of GP plan specificity and enactment on provision of smoking 
cessation care
Table 2 and 3 show the effects of plan specificity and plan enactment, respec-
tively, on GPs’ provision of smoking cessation care, contrasting patients seen by 

























































Plan specificity (score) (n=25, 100%) (n=25, 100%) (n=25, 100%) (n=25, 100%)
Who, completed (1) 24 (96.0%) 24 (96.0%) 22 (88.0%) 21 (84.0%)
When (moment) / What*
Not completed (0) 6 (24.0%) 6 (24.0%) 2 (8.0%) 3 (12.0%)
Low specific (1) 13 (52.0%) 14 (56.0%) 6 (24.0%) 8 (32.0%)
Medium specific (2) 3 (12.0%) 4 (16.0%) 13 (52.0%) 5 (20.0%)
Highly specific (3) 3 (12.0%) 1 (4.0%) 4 (16.0%) 9 (36.0%)
Total score, M (SD) 1.12 (0.93) 1.00 (0.76) 1.76 (0.83) 1.80 (1.08)
When (type patient)
Not completed (0) 20 (80.0%) 20 (80.0%) n.a. n.a.
Low specific (1) 0 (0.0%) 1 (4.0%) n.a. n.a.
Medium specific (2) 1 (4.0%) 3 (12.0%) n.a. n.a.
Highly specific (3) 4 (16.0%) 1 (4.0%) n.a. n.a.
Total score, M (SD) 0.56 (1.16) 0.40 (0.87) n.a. n.a.
How register
Not completed (0) 2 (8.0%) 1 (4.0%) 4 (16.0%) 5 (20.0%)
Low specific (1) 4 (16.0%) 5 (20.0%) 7 (28.0%) 6 (24.0%)
Medium specific (2) 2 (8.0%) 6 (24.0%) 8 (32.0%) 10 (40.0%)
Highly specific (3) 17 (68.0%) 13 (52.0%) 6 (24.0%) 4 (16.0%)
Total score, M (SD) 2.36 (1.04) 2.24 (0.93) 1.64 (1.04) 1.52 (1.01)
Total specificity score, M (SD)ª 5.00 (2.10) 4.60 (1.66) 4.28 (1.79) 4.12 (2.03)
Plan enactment (score)
Plan not enacted, not intending to 
in the future (0)
10 (40.0%) 12 (48.0%) 11 (44.0%) 15 (60.0%)
Plan not enacted, intending to 
within one month (1)
2 (8.0%) 2 (8.0%) 0 (0.0%) 1 (4.0%)
Plan not enacted, intending to 
within a week (2)
0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (4.0%)
Plan partly enacted (3) 8 (32.0%) 6 (24%) 3 (12.0%) 3 (12.0%)
Plan fully enacted (4) 5 (20.0%) 5 (20.0%) 11 (44.0%) 5 (20.0%)
Total enactment score, M (SD)b 1.84 (1.70) 1.60 (1.73) 2.12 (1.94) 1.28 (1.72)
GPs = general practitioners, IIs = implementation intentions, M = mean, SD = standard deviation
ª Total specificity scores for action plans ‘asking about smoking’ and ‘advising to quit’ could range
from 0 to 10 and for the action and coping plans ‘arranging follow-up for smokers motivated to quit’
and ‘arranging follow-up for smokers unmotivated to quit’ could range from 0 to 7
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patients (smokers and non-smoking) were included in the analyses but classified 
into patients seen by a GP 1) ‘in the control condition’, 2) ‘who formulated a low 
specific action plan’, and 3) ‘who formulated a highly specific action plan’. With 
regard to GPs’ tasks of ‘advising to quit’ and ‘arranging follow-up’, we present the 
results for the subsets of patients that reported being a smoker.
After adjustment for clustering effects and patient characteristics, we found 
a significant time-by-group interaction effect of action planning on GPs’ asking 
patient about smoking (Table 2); compared to the changes in GPs’ asking about 
smoking in the control group, patients in the intervention group who visited 
their GP post-intervention reported being asked about their smoking status more 
often than patients who visited their GP prior to action planning. We only found 
a significant effect for highly specific action plans (OR 2.11, 95% CI 1.51-2.95). 




All patients (n=3401) N Total % asked N Total % asked
Asked about smoking
Highly specific GP plan 731 29.9% 437 41.0% 2.11 (1.51-2.95)**
Low specific GP plan 271 40.3% 193 42.8% 1.29 (0.82-2.03)
Control group 1066 40.8% 703 37.1% 1
All smokers (n=665) N Total % advised N Total % advised
Advised to quit
Highly specific GP plan 93 37.1% 49 53.3% 2.28 (0.81-6.40)
Low specific GP plan 102 43.3% 49 33.3% 0.62 (0.21-1.80)
Control group 229 43.8% 143 44.1% 1
Smokers motivated to quit (n=214) N Total % arranged N Total % arranged
Arranged for follow-up
Highly specific GP plan 39 15.4% 20 40.0% b
Low specific GP plan 21 28.6% 11 18.2% b
Control group 71 18.3% 52 9.6% 1
Smokers not motivated to quit (n=408) N Total % arranged N Total % arranged
Arranged for follow-up
Highly specific GP plan 39 20.5% 21 14.3% b
Low specific GP plan 82 4.9% 38 7.9% b
Control group 142 4.9% 86 10.5% 1
GPs=general practitioners, OR=odds ratio, CI=confidence interval
a Generalized estimating equations adjusted for clustering and patient characteristics










































Similarly, we only found a positive time-by-group interaction effect of high plan 
enactment on GPs’ asking about smoking (Table 3; OR 3.04, 95% CI 2.10-4.41). 
Further analyses showed that the effect of high plan enactment on GP asking 
about smoking differed according to the degree of specificity of the action plan 
(p<0.001). Compared to the changes in time in the control group, patients who 
visited a GP who formulated a highly specific action plan and reported a high 
level of plan enactment post-intervention were asked more often about their 
smoking behaviour compared to prior to the intervention (OR 3.08, 95% CI 2.04-
4.64) (Table 4).
With regard to GPs’ plans to routinely advise smokers to quit, and to arrange a 
follow-up for smokers who are motivated or not motivated to quit, no significant 




All patients (n=3401) N Total % asked N Total % asked
Asked about smoking
High GP plan enactment 459 34.6% 314 55.7% 3.04 (2.10-4.41)**
Low GP plan enactment 543 31.1% 316 27.3% 1.01 (0.68-1.49)
Control group c 1066 40.8% 703 37.1% 1
All smokers (n=665) N Total % advised N Total % advised
Advised to quit
High GP plan enactment 63 57.1% 33 66.7% 0.85 (0.27-2.65)
Low GP plan enactment 132 39.4% 65 46.2% 1.52 (0.58-3.99)
Control group c 229 43.8% 143 44.1% 1
Smokers motivated to quit (n=214) N Total % arranged N Total % arranged
Arranged for follow-up
High GP plan enactment 35 17.1% 16 18.1% b
Low GP plan enactment 25 24.0% 15 26.7% b
Control group c 71 18.3% 52 9.6% 1
Smokers not motivated to quit (n=408) N Total % arranged N Total % arranged
Arranged for follow-up
High GP plan enactment 35 17.1% 15 13.3% b
Low GP plan enactment 86 7.0% 44 9.1% b
Control group c 142 4.9% 86 10.5% 1
GPs=general practitioners, OR=odds ratio, CI=confidence interval
a Generalized estimating equations adjusted for clustering and patient characteristics
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main or interaction effects of GP plan specificity and plan enactment were found 
on the delivery of smoking cessation care, as reported by the patients (Table 2 
and 3).
GP intention
Table 5 presents results of the analyses of three subgroups of patients, namely 
patients who consulted a GP who reported at baseline to be: 1) a ‘pre-intender’, 2) 
an ‘intender’, or 3) an ‘actor’ regarding the implementation of smoking cessation 
care. For each of these subgroups, we explored whether a more specific action 
plan and a higher plan enactment was associated with a significant increase 
in the percentage of patients reporting being asked about smoking. Consistent 
with our hypothesis, we found no positive main effects of GP plan specificity 
and GP plan enactment among those patients who visited GPs who, at baseline, 
had already fully implemented smoking cessation care (the ‘actors’). Analyses 
showed a positive significant effect of high plan specificity and high plan enact-
ment among those patients who consulted a ‘pre-intender’ GP (Table 5). Among 
patients who consulted an ‘intender’ GP, both high and low plan specificity, as 
well as high plan enactment had a positive effect on asking about smoking. In all 
three patient subgroups we found evidence for the combined effect of high plan 
specificity and high plan enactment on GP asking about smoking.





Asked about smoking N Total % asked N Total % asked
High PS * High PE 359 36.5% 221 57.5% 3.08 (2.04-4.64)**
Low PS * High PE 100 24.0% 93 43.0% 3.00 (1.54-5.86)*
High PS * Low PE 372 21.0% 216 20.8% 1.19 (0.74-1.92)
Low PS * Low PE 171 46.8% 100 37.0% 0.71 (0.40-1.26)
Control group 1066 40.8% 703 37.1% 1
GPs=general practitioners, OR=odds ratio, CI=confidence interval, PS=Plan specificity, PE=Plan enact-
ment
a Includes all patients, both smokers and non-smokers (n=3401)
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dISCuSSIon
Main findings
This study examined the effects of action planning and coping planning within 
a training programme for GPs on their provision of guideline-recommended 
smoking cessation care. In line with our previously reported effects of the GP 
training53, the 25 GPs in the intervention group more often asked patients about 
smoking after formulating an action plan during the training compared to prior 
to the training. In line with our hypothesis, GPs who formulated a highly specific 
action plan asked their patients more often about smoking than GPs with less 
specific plans. Moreover, high plan specificity had a positive effect on GPs’ asking 
patients about smoking when they also highly enacted their plan. The effects of 
plan specificity and plan enactment were particularly present among GPs who 
initially intended to implement smoking cessation care but who had not yet 
routinely implemented such care. No effects of action planning, plan specificity 
and plan enactment were found on GPs’ provision of quit smoking advice and 
arranging follow-up care for smokers who were motivated to quit. In addition, 
no effects were found of GP coping planning on arranging follow-up for smokers 
who were not motivated to quit.
Interpretation of the findings
Our finding that action planning incorporated in a training programme for GPs 
increased the extent to which these professionals asked their patients about 
smoking is in line with earlier results on the positive effects of incorporating 
self-formulated conditional plans in an educational class for healthcare profes-
sionals.36 However, no evidence was found for GP action planning on GPs’ provi-
sion of other tasks, such as advising to quit and arranging follow-up for smokers 
who were motivated to quit. This latter finding does not correspond with general 
evidence for action planning on intended behaviours in patient samples.44-46 
Nevertheless, the percentage of smokers that was advised to quit smoking by 
GPs who formulated a highly specific related action plan post-intervention was 
substantial larger compared to baseline (37.1% versus 53.3%). A comparable 
pattern was observed with regard to the percentage of smokers who were mo-
tivated to quit and for who a follow-up was arranged by the GP (15.4% versus 
40.0%). These substantial positive changes in time were not observed within the 
control group (advised to quit at baseline: 43.8% versus 44.1% post-intervention; 










































The small sample sizes may have impeded statistical confirmation of these 
findings. Another explanation for this may be that GPs might have more dif-
ficulty to act upon other action plans compared to merely asking their patients 
about smoking. The percentage of smokers who report being advised to quit or 
for who follow-up support was arranged in our study is indeed overall lower 
than the percentage of patients who were asked about their smoking behaviour. 
Smokers tend to express more resistance and negative statements about quit-
ting when being advised to quit compared to being asked about their smoking 
behaviour.55;56 In addition, GPs indicate that they lack an overview of health 
promotion programmes in their own neighbourhood to which they can refer 
their patients.40 Therefore, GPs may derive more benefit from training in coping 
plans on how to deal with these difficulties. A second explanation might relate 
to the quality of the action plans, which has shown considerable variability in 
patient samples.17 In the present study, although we rated the specificity of GPs’ 
action plans, a specific plan does not necessarily mean a ‘good’ plan. Indeed, for 
maximal impact of a plan, GPs require the opportunity to enact the plan as often 
as possible. Other aspects of planning, such as opportunity, could be explored in 
future studies. A final explanation may be related to the lack of a prior power 
analysis, which could have described the power required to detect the intended 
effects.
Although coping planning anticipates potential barriers to behaviour (i.e. en-
countering smokers who are not motivated to quit), no effect of GPs’ coping plan 
was found on their provision of guideline-recommended smoking cessation care 
to these smokers. The current guideline for smoking cessation care offers GPs 
a solution for this type of barrier, i.e. asking the smoker’s permission to discuss 
their smoking behaviour during a subsequent consultation.1 Of our 25 GPs, only 
six (24%) formulated this guideline-recommended activity highly specific; this 
might indicate that not all GPs were familiar with this guideline-recommended 
solution, or that this solution may not be appropriate for all GPs. Additionally, 
GPs may face more specific obstacles, such as the resistance of smokers or lack 
of time to provide adequate smoking cessation care. Therefore, we recommend 
that future studies involve GPs in formulating their own obstacles and solutions 
to provide smoking cessation care. A volitional help sheet (providing a list of 
possible obstacles and behavioural responses) is often effective in translating 
individuals’ intention into action and might also be a suitable tool for healthcare 
professionals.48-51
We also examined the effects of plan specificity and self-reported plan enact-
ment on GPs’ provision of smoking cessation care. In line with previous studies 








































GP action planning to increase smoking cessation care 119
ing a highly specific action plan on GPs’ asking about smoking compared to a 
low specific action plan.32;57 We also found evidence for GP-reported high plan 
enactment on the frequency with which GPs asked their patients about smoking. 
This latter finding is in line with de Vries et al.34 and Ziegelmann et al.35 who 
found that a self-reported plan enactment predicted smoking abstinence and 
an increase in physical activity, respectively. Moreover, our analyses showed that 
GPs were most likely to ask their patients about smoking when they enacted a 
highly specific formulated action plan. To our knowledge, this interaction effect 
has not yet been examined and provides additional insight into the mechanisms 
underlying action planning.
All the described effects were present among GPs who, at baseline, intended 
to implement smoking cessation care and were lacking among GPs who, at base-
line, were already categorised as ‘actors’. These findings are in line with theories 
suggesting that action planning is a post-intentional strategy which aims to 
bridge the gap between the individual’s intention to perform the behaviour and 
the actual performance of that behaviour.25;58 At baseline, GPs who indicated that 
they had already fully implemented smoking cessation care in their practice may 
already have a clear idea of when, where and how they will ask their patients 
about smoking. Indeed, highly conscientious individuals might benefit less from 
self-formulated conditional plans as they may already use such approaches.17 
As reported elsewhere, the GP training programme focused on increasing the 
GP’s intention to implement smoking cessation care, and succeeded therein.53 
This might explain why ‘pre-intender’ GPs also benefitted from action planning; 
however, the small size of this subgroup resulted in ORs with a wide confidence 
interval, indicating a low level of precision of this finding.
Study strengths and weaknesses
A strength of the present study is that it explored whether a training programme 
with action planning (a strategy proven effective in patient samples) increases 
the provision of guideline-recommended smoking cessation activities among 
GPs. In addition, we examined the specificity of the plans GPs made and the ex-
tent to which they enacted these plans; these aspects are often neglected within 
planning interventions.17 There is increasing interest in the effects of planning 
interventions on the clinical behaviour of healthcare professionals.59 The present 
study provides further insight into the feasibility of applying this strategy in a GP 
sample and generates new hypotheses that can be examined in future research.
Some limitations should also be mentioned. First, we assessed the effects of 
the GP training incorporating action planning on patient-reported smoking ces-









































or referral for follow-up support as being embedded in a general conversation 
about smoking behaviour; in that case, the smoking cessation activities of the 
GP might have escaped their attention. Such recall bias may have led to a lack 
of effect of action planning on the delivery of these smoking cessation activities. 
Secondly, the precise response rate of patients who completed the questionnaire 
(at baseline and post-intervention) is unknown. Reasons for non-response might 
be attributed to GPs who failed to hand out the patient questionnaires, or to 
patients who forgot or were unwilling to complete the questionnaire. Thirdly, 
the relatively small sample of GPs and smoking patients might have reduced 
the chance of detecting a true effect of action planning, plan specificity and/or 
plan enactment on GPs’ provision of quit smoking advice and referrals. Also, we 
measured GPs’ intention and plan enactment with single item measures. Further 
research is needed to examine the validity of these measures. Finally, during the 
study period, some of the GPs did not have direct access to the smoking cessa-
tion programmes of (trained) practice nurses, which may have contributed to the 
lack of effect on GPs’ referrals.
Conclusions
Action planning within a training programme for GPs improves the frequency 
with which the GPs ask patients about their smoking. Action planning was par-
ticularly beneficial among those GPs who had a pre-existing intention to imple-
ment smoking cessation care. Importantly, a highly specific action plan that was 
well enacted was most likely to result in patients being asked about smoking by 
their GP. Since action planning did not improve the provision of other GP tasks 
regarding smoking cessation care, future studies should further examine the 
effects of coping plans on the provision of these GP tasks. These plans might help 
GPs to anticipate possible barriers that impede them from acting on their inten-
tions. In addition, we recommend that our findings be replicated in randomised 
controlled studies with a larger GP sample and a long-term follow-up.60
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Ask about smoking 0 / 1 0 / 1 / 2 / 3 0 / 1 / 2 / 3 0 / 1 / 2 / 3  (0-10)




Arrange follow-up for smokers 
motivated to quit
0 / 1 / 2 / 3 0 / 1 0 / 1 / 2 / 3 (0-7)
Arrange follow-up for smokers  
not motivated to quit
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To provide insight into the professional-patient interaction during unsolicited 
dialogues about smoking; to examine the extent to which smokers express nega-
tive statements about quitting and the extent to which these statements influ-
ence general practitioners’ (GPs’) and practice nurses’ (PNs’) (dis)continuation of 
guideline-recommended smoking cessation care.
Methods
Fifty-two video-consultations were observed (GP-consultations: 2007-2008; 
PN-consultations: 2010-2011). Dialogues were transcribed verbatim and profes-
sionals’ and patients’ speech units were coded and analysed using sequential 
analyses (n=1424 speech units).
Results
GPs focused on asking about smoking (GPs: 42.4% versus PNs: 26.2%, p=0.011) and 
advising to quit (GPs: 15.3% versus PNs: 3.5%, p<0.001) whereas PNs focused on 
assisting with quitting (GPs: 25.4% versus PNs: 55.2%, p<0.001). Overall, patients 
expressed more negative statements about quitting than positive statements 
(negative: 25.3% versus positive: 11.9%, p<0.001), especially when PNs assessed 
their willingness to quit (OR 3.61, 95% CI 1.44-9.01) or assisted with quitting (OR 
2.23, 95% CI 1.43-3.48).
Practice implications
An alternative approach to smoking cessation care is proposed in which GPs’ 
tasks are limited to asking, advising, and arranging follow-up, such as referrals 
to the PN. This approach seems the least likely to evoke negative statements of 
patients about quitting during dialogues with GPs and is compatible to tasks and 
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InTroduCTIon
Evidence-based guidelines for smoking cessation care recommend general prac-
titioners (GPs) and practice nurses (PNs) to routinely ask patients about smoking, 
advise smokers to quit, assess their motivation to quit, assist them with quitting, 
and arrange follow-up support.1;2 A full implementation of these ‘5 A’s’ signifi-
cantly improves smoking abstinence rates3-5 and is cost-effective.6
Nevertheless, GPs and PNs (see Appendix 1 for description of PNs’ role in Dutch 
general practice) report various barriers to the implementation of these guidelines 
during routine consultation.7-12 Although patients state they are willing to discuss 
their smoking behaviour during a practitioner-initiated dialogue13, GPs and PNs re-
port that smokers regularly express negative statements regarding quitting during 
unsolicited dialogues about smoking, such as a lack of motivation or discipline to 
quit.7-12 These negative statements about quitting impede a structural implemen-
tation of guideline-recommend smoking cessation care.7-12 GPs report a limited 
range of skills for dealing with these negative statements8 and as a consequence, 
tend to avoid these negative statements in order to preserve a good doctor-patient 
relationship.14;15 This is one of the reported reasons for the evidence-practice gap 
regarding the provision of guideline-recommended smoking cessation care in 
Dutch general practice. Results show that, for example, 79% of all smokers and 
40% of smokers who discuss smoking with their GP do not receive a quit-smoking 
advice.16 Therefore, we aim to provide more insight into the interaction between 
primary care professionals and smokers during unsolicited dialogues about smok-
ing. These insights may result in recommendations for primary care professionals 
in how to deal with smokers’ negative statements regarding quitting and help 
them to fully implement guideline-recommended smoking cessation care.
Until now, only a few studies have examined the interaction between primary 
care professionals and smokers. These studies focused on the way patients react 
when GPs link their health issues to their smoking17 or when they are counselled 
to quit smoking based on their readiness to quit.18 To our knowledge, no studies 
have examined the responses of smokers when professionals apply a guideline 
for smoking cessation care. Moreover, the impact of these responses on profes-
sionals’ continuation of guideline adherence is unknown. More insight into this 
interaction may contribute to strategies that can benefit the implementation of 
smoking cessation counseling in general practice.
Therefore, we assess the extent to which: i) professionals use the 5 A’s for smok-
ing cessation care, ii) smoking patients express negative or positive statements 
about quitting when professionals use these 5 A’s, and iii) professionals continue 









































statement about quitting. Based on literature, we hypothesize that an unsolicited 
conversation about smoking will elicit patients’ negative statements about quit-
ting. Furthermore, we hypothesize that patients’ negative statements about quit-
ting will hamper the continuation of guideline adherence, while patients’ positive 
statements about quitting will facilitate it. Since knowledge and skills regarding 
lifestyle counseling are highlighted in the ‘competence profile’ of PNs19, we hypoth-
esize that patients’ negative statements about quitting are less likely to hamper 
guideline adherence in dialogues with PNs compared to dialogues with GPs.
meThodS
Study setting, participants and design
We conducted a cross-sectional study in which we observed video-recordings 
of random real-life routine consultations in general practice. Such video-taped 
consultations are regularly used to observe lifestyle counseling20-25, provide a 
complete record of what actually happens during consultations, and can be 
viewed repeatedly.26 Videos were collected (nationwide) and archived by the 
Netherlands Institute for Health Services Research (NIVEL). Consultations with 
GPs and PNs were recorded during 2007-2008 and during 2010-2011, respectively. 
A detailed overview of the data collection is reported elsewhere.27;28
All video-recordings in which smoking was discussed were selected for the 
present study (n=211). We excluded video-recordings of consultations with 
non-smokers (n=63), ex-smokers (n=70), consultations in which the patient spe-
cifically requested smoking cessation assistance (n=13) and in which patients 
addressed smoking on their own initiative (n=13). This resulted in a set of 52 
videos of 33 primary care professionals (17 GPs and 16 PNs). All PNs were trained 
in motivational interviewing during the study.28 This was not the case for GPs 
and it is unclear whether the participating GPs were trained in motivational in-
terviewing prior to the study. All GPs, PNs and patients were unaware of the fact 
that the recordings and analyses would focus on smoking cessation care. This 
study was conducted according to Dutch privacy legislation in which approval of 
the medical ethics committee was not required.29
Procedure and measurements
After the patients gave their informed consent consultations were recorded. Two 
researchers observed the video-recordings. Subsequently, the dialogues between 
professionals and patients about smoking were transcribed verbatim (MV and 
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sionals. A speech unit is defined as ‘the smallest distinguishable speech segment to 
which a classification may be assigned’.30 The length of a speech unit can vary from 
a single word to a lengthy sentence.
Professionals’ speech units
We coded speech units of professionals which were related to the core com-
ponents of the guideline for smoking cessation care (‘5 A’s’). These included: 1) 
Ask (about the patient’s smoking status, the number of cigarettes, or smoking 
history), 2) Advise (to quit smoking or to smoke less), 3) Assess (the smoker’s 
motivation to quit), 4) Assist (with quitting, which include discussing advantages 
of (quitting) smoking, risks of smoking, barriers to quitting, support options, 
pharmacological support, or a quit plan), and 5) Arrange (follow-up quit-smoking 
support, including referring the smoker to behavioural quit support, arrange a 
telephone follow-up, or ask permission to discuss smoking next time). Appendix 
2 provides an overview of the coding scheme illustrated by examples of speech 
units of primary care professionals and patients.
Patients’ speech units
We coded both negative and positive statement about smoking cessation 
expressed by patients. A negative statement included: 1) barriers to quit, 2) 
disadvantages of quitting, 3) advantages of smoking, and 4) reasons to relapse. 
Patients’ positive statement included: 1) motivators to quit, 2) advantages of 
quitting, 3) disadvantages of smoking, and 4) reasons to smoke less or continue 
abstinence (see Appendix 2 for coding scheme).
Other speech units
The speech units of professionals which we did not code as related to the 5A’s 
and speech units of patient which we did not code as a negative or positive 
statement about quitting, were coded as follows: 1) other (non-)smoke-related 
questions/answers, e.g. “I smoke 10 cigarettes per day”, 2) other (non-)smoke-
related information, e.g. “These complaints might results from your smoking”, 
3) other (non-)smoke-related confirmations, e.g. “Yes, I agree”, 3) other (non-)
smoke-related speech units, e.g. “Thank you”. In contrast to ‘5A-related’ speech 
units, ‘other smoke-related’ speech units of professionals included general 
statements about smoking and its risks and were unrelated to quitting or the 










































Two researchers (MV and MC) independently coded five randomly selected dia-
logues (in total 153 speech units) which resulted in a moderate inter-rater agree-
ment (kappa 0.66). During this pretest of our coding scheme, we encountered two 
coding difficulties. Firstly, some disagreements occurred regarding differentiating 
between speech units of professionals related to ‘Assisting a quit attempt’ and to 
‘providing smoke-related information’. These disagreements were resolved via 
a third person (NC) and we decided to code a speech unit as ‘Assisting a quit 
attempt’ solely when it was related to the patients’ motivation to quit, such as 
an exploration of barriers and motivators to quit, e.g. “Can you tell me a bit more 
about the reasons why you want to quit?”. When professionals only made general 
statements about smoking unrelated to quitting or the patient’s motivation to 
quit, we coded the speech unit as ‘other, smoke-related: the provision of smoke-
related information’, e.g. “Your smoking has an impact on your vocal cords”.
Secondly, the pretest of our coding scheme showed that the number of coding 
categories for patients’ negative and positive statements about smoking cessa-
tion was too limited (it originally included only the coding categories ‘barriers to 
quit’ and ‘motivators to quit’). After consulting a third person (NC), we therefore 
decided to extend these coding categories, including ‘(dis)advantages of quit-
ting’, ‘(dis)advantages of smoking’, ‘reasons to relapse’, and ‘reasons to smoke 
less or continue abstinence’.
The remaining transcripts were coded by one researcher (MV) (see Appendix 2 
for coding scheme).
Statistical analyses
Firstly, we calculated the total number of speech units of both professionals 
and patients and the number of speech units per dialogue. Differences between 
GP- and PN-dialogues were analyzed with a chi-square test.
Secondly, we performed a number of sequential analyses which can be defined 
as ‘a set of techniques used to identify temporal patterns embedded within sequences of 
coded behaviours or stimulus events’.31-33 The main aim of sequential analysis is to 
determine if a particular sequence of behaviours or events occurs to a greater 
or lesser extent than can be expected by chance alone.31;32 This type of analysis 
can be regarded as a suitable method for exploring interaction patterns between 
healthcare professionals and patients.31
We prepared our data for these analyses by forming a chain of codes repre-
senting the speech units of professionals and patients (a total of 1424 speech 
units). Then, we examined the three speech units (three lags) following each 
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quitting. The existing literature gives only few indications for the optimal num-
ber of lags.30;31 Yet, because we focused on the immediate responses of patients 
on the provision of smoking cessation care, we limited our analyses to three 
lags. Lag 0 represented the 5A-related speech unit of a professional during the 
dialogue, lag 1 represented the speech unit of the patient immediately following 
the professional’s 5A-related speech unit at lag 0, lag 2 represented the second 
speech unit of the patient following the professional’s 5A-related speech unit 
at lag 0, and lag 3 represented the third speech unit of the patient following the 
professional’s 5A-related speech unit at lag 0.
Next, we calculated transitional probabilities, i.e. the likelihood that a patient 
expressed one or more negative and positive statements regarding quitting 
within the three lags following a 5 A-related speech unit of the professional (see 
Appendix 3). The transitional probabilities were uncorrected for the potential 
effects of clustering effects of speech units within dialogues. Therefore, we used 
generalized estimating equations to take into account the multilevel structure 
of the data. This resulted in corrected odds ratio’s (ORs), i.e. the likelihood that 
a negative or positive statement of the smoker about quitting was preceded by 
a 5A-related speech unit of the professional compared to any other preceding 
category of speech units of professionals.
The same method was used to compute the likelihood that a negative or positive 
statement about quitting of the patient was followed within 3 lags by one or more 5 A-
related, other-smoke-related or non-smoke-related speech units of the professional.
reSulTS
Sample characteristics
Table 1 shows the characteristics of the duration of the consultations and dia-
logues about smoking, and characteristics of the patients, GPs and PNs who en-
rolled in the study. In total, we coded 1424 speech units (mean 27.4 speech units 
per smoking dialogue, range 4-118) of which 727 were of professionals (51.1%, 
mean 14.0 speech units per smoking dialogue, range 2-55) and 697 of patients 
(48.9%, mean 13.4 speech units per smoking dialogue, range 1-63).
Speech units
Professionals’ smoking cessation care
Overall, half of the speech units of professionals were related to the 5 A’s for 









































significantly more speech units related to these 5 A’s than GPs (GPs: 37.8% versus 
PNs: 55.2%; p <.001). Within this category, GPs significantly more often asked 
about smoking and advised to quit compared to PNs. PNs significantly more often 
assisted with quitting compared to GPs.
The remaining speech units of professionals were coded as ‘other smoke-
related’ speech units (31.4%) and ‘other non-smoke-related’ speech units 
(17.2%). Although no significant differences were found in these coding catego-
ries between GPs and PNS overall, we found a significant difference in one of 
the subcategories of ‘other smoke-related’ speech units: GPs significantly more 
often provided general smoke-related information compared to PNs (GPs: 37.0% 
versus PNs: 12.6%, p<0.001, data not shown).
Table 1. Characteristics of video-recorded consultations between patients, GPs and PNs
Dialogues with
Consultation characteristics Total (n=52) GPs (n=20) PNs (n=32)
Total duration (min), M (SD) 22:41 (12:05) 12:29 (4:21) 29:04 (10:56)
Duration of smoking dialogue (min), M (SD) 2:57 (2:53) 1:28 (1:04) 3:53 (3:17)
Dialogues with
Patient characteristics Total (n=52) GPs (n=20) PNs (n=32)
Age in years, M (SD) 53.5 (14.8) 46.1 (15.7) 57.7 (12.6)
Gender, female 23 (44.2%) 9 (45.0%) 14 (43.8%)
Educational level
Low 11 (21.2%) 3 (15.0%) 8 (25.0%)
Middle 29 (55.8%) 8 (40.0%) 21 (65.6%)
High 3 (5.8%) 2 (10.0%) 1 (3.1%)
Reason for consultation
Respiratory 16 (30.8%) 8 (40.0%) 8 (25.0%)
Cardiovascular 14 (26.9%) 6 (30.0%) 8 (25.0%)
Diabetes mellitus 9 (17.3%) 0 (0.0%) 9 (28.1%)
Multiple smoke-related 10 (19.2%) 3 (15.0%) 7 (21.9%)
Other smoke-related 1 (1.9%) 1 (5.0%) 0 (0.0%)
Non-smoke-related 2 (3.8%) 2 (10.0%) 0 (0.0%)
Professional characteristics Total (n=33) GPs (n=17) PNs (n=16)
Age in years, M (SD) 46.4 (7.1) 49.9 (6.1) 42.4 (6.2)
Gender, female 22 (66.7%) 6 (35.3%) 16 (100.0%)
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Patients’ statements about smoking cessation
Overall, patients expressed significantly more often negative than positive state-
ments about quitting during an unsolicited dialogue about smoking (negative: 
25.3% versus positive: 11.9%; p<.001). We found no significant differences be-
tween the number of negative statements during dialogues with PNs compared 
to dialogues with GPs (Table 2).
A relative high number of patient’s speech units were coded as ‘other smoke-
related’ (49.2%). This category comprised numerous simple answers to and 
confirmations of the provision of smoke-related questions and information of 
the professional, e.g. “Yes, I smoke” or “Yes, I agree”).
Sequential analysis
Table 3 shows the transitional probabilities that smokers expressed negative or 
positive statements about quitting following the 5 A’s speech units of professionals. 
Overall, patients were more likely to express a negative than a positive statement, 
irrespective of the preceding 5A. The probability that smokers expressed a nega-
tive statement about quitting was lowest when professionals asked about smoking 
(11%) or arranged a follow-up (15%), and highest when professionals assessed the 
smoker’s motivation to quit (55%) or provided assistance with quitting (38%).
When adjusting for clustering effects, patients were overall significantly more 
likely to express a negative statement about quitting when professionals pre-
ceded with a speech unit related to assessing the patient’s motivation to quit 
(OR 3.61, 95% CI 1.44-9.01) or assisted with quitting (OR 2.23, 95% CI 1.43-3.48), 
compared to any other preceding speech unit of professionals. When profes-
sionals preceded with a speech unit related to providing assistance with quitting, 
patients were also significantly more likely to express a positive statement about 
quitting (OR 2.76, 95% CI 1.56-4.89), compared to any other preceding speech 
unit of professionals. Table 4 shows the results of comparable analyses, sepa-
rated for GP and PN dialogues. We found the above-mentioned effects only in PN 
dialogues. Due to data sparseness, it was not possible to compute all corrected 
odds ratio’s in GP and PN dialogues (Table 4).
Figure 1 illustrates the transitional probabilities that GPs and PNs expressed 
a 5A-related, other smoke-related, or non-smoke-related speech unit following 
patients’ negative and positive statements about quitting. Although we observed 
that GPs were less likely to continue with using the 5 A’s following patients’ 
negative statements compared to preceding positive statements (negative: 19% 
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dISCuSSIon
Main findings
The present study aimed to provide insight into the professional-patient interac-
tion during unsolicited dialogues about smoking. Firstly, we assessed the extent 
to which primary care professionals use the 5A’s for smoking cessation care 
during unsolicited dialogues about smoking. We found that GPs mainly focused 
on asking their patients about smoking and PNs on assisting patients with a quit 
attempt. Overall, little attention was paid to advising smokers to quit, to assess-
ing their motivation to quit, and to arranging follow-up. Secondly, we examined 
the extent to which smokers expressed positive and negative statements about 
quitting during these dialogues. Overall, we found that patients more frequently 
expressed negative statements compared to positive statements about quitting. 
These negative statements mainly consisted of quit-smoking barriers and were 
most likely expressed when PNs assessed the patients’ willingness to quit or 
when PNs assisted patients with a quit attempt. Finally, we explored the degree 
to which primary care professionals (dis)continued the 5 A’s following patients’ 
positive or negative statements about quitting. Although we observed that GPs 
were less likely to continue using the 5 A’s following patients’ negative state-
ments about quitting, analyses could not statistically confirm this finding.
Interpretation of the findings
In line with previous studies and assumptions underlying current guidelines, 
we found that GPs and PNs focus on different smoking cessation counseling 
activities.1;20;21;34;35 GPs tend to focus on identifying smokers and informing about 
risks, whereas stop-smoking support is more often provided by PNs. Although 
these differences might be explained by the different time-periods in which the 






































Figure 1. Transitional probabilities of GPs’ and PNs’ 5 A-related speech units (I), other smoke-related 
speech units (II), and non-smoke-related speech units (III) following patients’ positive and negative 









































that these differences can be explained by other factors, such as differences 
in patient population, characteristics of the professionals (e.g. training, skills, 
practice protocols), and consultation characteristics (e.g. time available).
Both GPs and PNs lacked focus on arranging a follow-up for quit-smoking sup-
port. This is in line with recent findings showing that GPs in the Netherlands 
experience a lack of overview of smoking cessation programs in their neighbor-
hood.12 In addition, smokers may lack motivation to quit, which seems a logi-
cal reason for not arranging follow-up care. However, even if smokers are not 
motivated to quit, guidelines recommend primary care professionals to ask the 
patient’s permission to discuss their smoking behaviour in a next consultation. 
Therefore, when GPs and PNs in our study would have followed these current 
guidelines, the rate of arranging follow-up should have been much higher than 
observed.
Although not statistically confirmed, we observed that GPs were less likely 
to proceed with a 5A-related speech unit following a negative statement of pa-
tients about quitting. We did not observe this in PN-patient dialogues. A possible 
explanation for this is that all PNs in the present study were trained in moti-
vational interviewing, and that GPs might lack such skills or have insufficient 
time to apply them.36;37 This might also explain why patients were more likely to 
respond both negatively and positively towards quitting during dialogues with 
PNs: exploring and resolving patients’ ambivalence towards behaviour change 
is an essential part of motivational interviewing.38 Another explanation might 
be that GPs and PNs encounter different types of patients. For example, patients 
who visit the GP might be more likely to perceive their complaints as not directly 
related to their smoking behaviour, resulting in less motivation to quit or discuss 
smoking. On the other hand, PNs provide care for patients with diabetes mel-
litus, asthma, or COPD, including routinely providing information, advice and 
counseling on lifestyle. These patients might be more inclined to relate their 
health complaints to their smoking behaviour, which results in a higher motiva-
tion to quit or discuss smoking.
Study strengths and limitations
Video-based observations provide an objective method to capture all modalities 
of the interaction between professionals and patients.26 In addition, sequence 
analysis exceeds a simple description of frequencies of spoken communication 
and provides further insight into practitioner-patient interactional processes. To 
our knowledge, this is the first study using sequence analysis to provide insight 
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patients thereby providing further insight into practitioner-patient interactional 
processes.
However, several limitations of our study have to be acknowledged. First, to 
guarantee the anonymity of the patients, the camera was positioned so that 
patients were only visible from behind or were not visible at all. Therefore, we 
were unable to observe non-verbal behaviour, which may also play a role when 
assessing patients’ responses towards smoking cessation. Yet, a recent study 
showed that communication ratings using only audio or video data are highly 
correlated.39 Second, due to the small samples it was not always possible to take 
into account that the possible cluster effects within the data . Third, using video-
based observations may limit the external validity of the findings, unless the 
sample is representative for the overall population.26 Although we were unable 
to compare our sample of PNs with the average Dutch population of PNs, the GPs 
in our study were representative for the average Dutch population of GPs with 
regard to gender and practice type.36 Moreover, none of the GPs and PNs were 
aware that the observations would focus on dialogues about smoking.
Practice implications
Our study findings support alternative approaches to smoking cessation care in 
healthcare settings where a successful implementation of the 5 A’s is lacking. 
These alternative approaches include the ‘Ask-Advise-Arrange’ (A-A-R) or ‘Ask-
Advise-Connect’ (A-A-C) approaches.40;41 These approaches instruct healthcare 
professionals to routinely ask patient about smoking, advise smokers to quit, and 
to refer (A-A-R) or proactively connect (A-A-C) smokers to a quit line or face-to-
face quit-smoking support. As shown by Vidrine et al., significantly more smok-
ers enrolled in quit-smoking treatment following the A-A-C approach (11.4%) 
compared to the A-A-R approach (0.6%) which is also likely to result in more 
smokers who successfully quit.41
Since we found that smokers are least likely to express negative statements 
about quitting when being asked about smoking, advised to quit and arranged with 
follow-up support, we recommend GPs to focus on implementing these alterna-
tive approaches. This might reduce the amount of impeding implementation 
barriers, such as the amount of time involved in discussing barriers to quitting. 
These approaches are also compatible with the lifestyle counseling tasks and 
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Appendix 1. Role of practice nurses (PNs) in general practice in the Netherlands
The standard general practice in the Netherlands comprises about 2,350 
patients and an average consultation lasts about 10 minutes42; this results in 
considerable time pressure and workload for general practitioners (GPs). There-
fore, in 1999 practice nurses (PN) were introduced in Dutch general practice to 
reduce the workload of GPs and to improve the quality of care for chronically ill 
patients.43 Nowadays, PNs are involved in multiple primary prevention activities 
(e.g. hypertension care) and secondary prevention activities (e.g. routine care for 
elderly patients and/or patients with diabetes mellitus, asthma, or COPD). PNs 
work under the supervision of GPs, manage their consultations independently, 
and base their clinical practice on guidelines developed by the Dutch College 
of General Practitioners (NHG) and on healthcare standards which specifically 
focus on the treatment of chronically ill patients. The collaboration between 
GPs and PNs provides a good basis for identifying smokers, for motivating them 









































Appendix 2. Coding scheme for speech units
Theme Category Subcategory Example
Professionals
5 A’s • Ask Smoking status “Do you smoke?”
Number of cigarettes “How many cigarettes do you smoke?”
Smoking history “At what age did you start smoking?”
• Advise To quit “The best prevention for not only 
your airways but also your coronary 
problems, is to quit smoking”
To smoke less [“The best thing to do is quit smoking”] 
“but at least cut down on your 
smoking”
• Assess Motivation to quit “Do you still not feel like quitting?”
• Assist Discuss previous quit 
attempt
“You quit smoking for almost a year, 
did you think of cigarettes every day in 
that period?”
Discuss quit plan “First, I want you to go home and think 
about it, ‘do I want to quit smoking, am 
I able to quit smoking’?”
Offer/discuss 
pharmacotherapy
“Nowadays, we have medication that 
decreases the craving for cigarettes”
Discuss advantages of 
smoking
“Well, you get some kind of peace from 
it.. especially during hard times, then 
you desire your cigarettes..”
Discuss risks of smoking “..when you continue your smoking, it’s 
far more likely that you will move from 
stage 2 to 3, and maybe to stage 4”
Discuss advantages of 
quitting
“When you say ‘I considered quitting’, 
what would be the reasons for this? 
What would be the positive side of 
this?”
Discuss barriers to 
quitting
“Maybe it is more like a habit, is that 
right?”
Discuss support options “We talked about it before, I also 
provide consultations for smoking 
cessation, so if you think you would 
like to quit smoking, then we could do 
that together…”
• Arrange Ask permission to discuss 
smoking next time
“Do you mind if we discuss your 
smoking again next time?”
Plan (telephone) follow-up “Yes, we’ll discuss that next time, do 








































Video-recorded practitioner-patient communication about smoking 147





•  Barriers to 
quit
•  Reasons for 
relapse
•  Advantages 
smoking
•  Disadvantages 
quitting






“I quit smoking for a year, but I 
started again.. I think it depends on 
your overall lifestyle, maybe a little 
unhealthy.. I would like to improve 
that…but that will require some 
discipline of course…”
Denial of consequences “Maybe when you’re smoking a 
package each day, then I should think 
‘yes, maybe you should cut down a 
little on your smoking…”
Social environment “Someday I have to quit, but my wife is 
a smoker as well..”
Stress “..but on the other hand, it helps to 
reduce my stress”
(Fear of) weight gain “Yes, I would like to quit smoking, but 
I’m worried about my weight, to gain 
weight again…”
Previous quit attempt 
failed
“ I already tried it 7 or 8 times…”
Not the right time “When I quit I’m not very pleasant, and 
we bought a new house, the transfer 
will be on the 4th”
Addiction “That’s the addiction to nicotine of 
course, it’s the same as with alcohol”
Smoking is tasteful/
enjoyable
“It’s stupid, but I really like it, especially 
in the weekends after breakfast…”
Satisfied smoker “I’m okay with being a smoker”
Lack of distraction/
daytime activities
“I sit at home for 3 weeks… and then 
you’ll start smoking again”





“I once did a treatment, I had to 
continue smoking for 10 days and after 
the pill it would be all over… but it did 
not work…”
No complaints of smoking [“What would be reasons for quitting 
smoking?”] “Well, I feel fine actually”
Long-time smoker [“Do you think about quitting or not?”] 
“Well, what do you want? I’m 70.. I only 
have a few years left so…”
Smoking cessation is not 
profitable
“When I don’t smoke I still have those 
complaints”
Stigma “Nowadays, if you have a sore knee 
they will ask you if you’re smoking…
as if you sprain your ankle because of 









































Theme Category Subcategory Example
Smoking is the only thing 
left
“I’ll never give up smoking, it’s the only 
thing I still have”
Withdrawal symptoms “In the morning I have to smoke a 
cigarette again, to feel fine again…”
Psychological complaints “I quit smoking, but now I go to a 
psychologist again for depression and I 
started smoking again..”





•  Motivators to 
quit
Health concerns “The main reason I would say is ‘it’s 
not good for your health’, that would 
be the reason to quit”
smoking 
cessation
Social environment “I will read that [leaflet], then we can 
look at it together at home, maybe he’ll 
also say ‘when you quit, I will quit’
Health of children “My daughter is pregnant, so nobody 
smokes anymore. I think I should quit, 
yes..”
Fear for disease/illness “But I’m actually not really afraid of 
getting lung cancer, but more of getting 
something here …[larynx]”
Quit-smoking advice of 
health professional
“Yes, you’re absolutely right… but, yes 
well… then I shall do that”
Smoke-free legislation “Once I was in prison for 18 months…
that was hard, 24 hours inside and 
not allowed to smoke…I then quitted 
smoking”
Costs “I’ve already thought about it for a 
while because, well cigarettes are 
expensive”




“When I’m busy, then it’s easy. For 
example, tomorrow my grandchild will 
visit me, then it’s going perfect”
Sufficient motivation/
discipline
“I definitely want to quit smoking”
Positive consequences of 
quitting
“I often have good results if I refrain 
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•  Other, smoke-
related
Question “So, coffee and smoking are two risk 
factors?” [patient]
Answer “I smoke one packet a day” [patient]
Provision information “People who smoke… this has its effect 
on the vocal cords” [professional]
Confirmation [“You are a smoker, that’s not good”] 
“No, that’s right” [patient]
Other [I don’t think you are a good example 
for your kids this way] “Well, I shall talk 
about it with my wife” [patient]
•  Other, non-
smoke-related
Question “Do you have a fever?” [professional]
Answer “This side is much more painful” 
[patient; during physical examination]
Provision information “With regard to your cholesterol, 
according to this table, you are still 
within the normal risk boundaries” 
[professional]
Confirmation [I can give you something to inhale] 
“Yes” [patient]
Other “Thank you, see you next time” 
[patient]






A 0.00 (0/7) 0.43 (3/7) 0.57 (4/7) 1.00 (7/7)
B 0.40 (2/5) 0.00 (0/5) 0.60 (3/5) 1.00 (5/5)
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To examine the impact of two national tobacco control interventions in the past 
decade on (dispensed) prescriptions of stop-smoking medication.
Design
Ecological study with interrupted time-series analyses of quarterly data points 
of three nationwide representative databases.
Setting
The Netherlands 2001-2012, with the introduction of the guideline for smoking 
cessation care in general practice (GP) in 2007 and full insurance coverage for 
smoking cessation treatment in 2011.
Participants
GPs, pharmacists and persons in the general population aged 15 years and older.
Measurements
Time-series plots were visually inspected and segmented regression analyses 
were performed to estimate the change in level and slope of (dispensed) pre-
scriptions of stop-smoking medication and smoking prevalence in the years 
preceding and after the tobacco control interventions.
Findings
No measurable effects of the GP guideline on (dispensed) prescriptions were 
observed. Shortly after the start of health insurance coverage, an estimated 
increase in primary care prescriptions of 6.3 per 1.000 smokers (95% CI 2.9-9.8; 
p=0.001) and 17.3 dispensed items per 1.000 smokers (95% CI 12.5-22.0; p<0.000) 
was accompanied by a sudden drop in smoking prevalence of 2.9% (95% CI 
4.6-1.1; p=0.002) in the first quarter of 2011. Immediately after the coverage 
abolition, smoking prevalence increased by 1.2% (95% CI 0.5-2.8; p=0.156) and 
dispensed prescription rates decreased with 21.6 per 1.000 smokers (95% CI 26.0-
17.2; p<0.000).
Conclusions
Full health insurance coverage for smoking cessation treatment in the Nether-
lands was accompanied by a significant increase in the number of (dispensed) 
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InTroduCTIon
In the past decade, cigarette consumption has declined in various high and 
middle-income countries.1 However, about 25% of the Dutch adult population 
still smokes.2 As a result, in the Netherlands, the attributive risk of smoking-
related mortality is estimated at 21% which is relatively high compared to 16% 
in Europe and 12% worldwide.3;4 Consequently, 13% of the Dutch disease burden 
and an annual 2 billion euros in healthcare costs are attributed to the use of 
tobacco.5;6
Therefore, in the last decade multiple national tobacco control interventions 
were implemented.7;8 The Dutch government initiated several policies aimed at 
reducing exposure to environmental tobacco smoke and discouraging tobacco 
use. Bans on tobacco advertisement (November 2002) and the sale of tobacco 
to minors (January 2003) were implemented, and legislation was introduced for 
smoke-free workplaces (January 2004) and public places (April 2006 and July 
2008). In addition, national guidelines for smoking cessation support in health 
care were developed and implemented. Moreover, in the year 2011, full health 
insurance coverage for evidence-based pharmacotherapy in combination with 
behavioural counseling was implemented.
These tobacco control interventions are likely to reduce smoking initiation, 
increase the number of quit attempts and/or use of effective treatments and 
therefore reduce smoking prevalence.9-16 For example, in the Netherlands, smok-
ing prevalence decreased from 30.1% in 2001 to 25.9% in 2012.2 However, the 
impact of national tobacco control interventions on primary care prescriptions 
of stop-smoking medication is not yet clear.
GPs are more likely to deliver successful smoking cessation treatment when 
they use a systematic approach and when structural barriers (e.g. lack of fi-
nancial reimbursement) are alleviated.17;18 Therefore, we examined the impact 
of two national tobacco control interventions on prescriptions of stop-smoking 
medication in general practice that were likely to have directly prompted GPs 
to support smokers to quit. These two interventions are the guideline for smok-
ing cessation care introduced in general practice and the full health insurance 











































To explore the hypotheses, we used an ecological study design in which the unit 
of analysis was the population rather than the individual. The main advantage 
of this type of study is the presence of available data which enabled a relatively 
fast and inexpensive study. However, the results cannot be extrapolated to the 
individual level and no confounder data were available. Moreover, inferences 
regarding causality need to be made with caution, taking into account other 
explanations for changes in outcomes. Nevertheless, this type of study is useful 
to generate new hypotheses based on the results.
National tobacco control interventions
We assessed the impact of potentially high-impact national tobacco control 
interventions on prescriptions of stop-smoking medication in general practice, 
i.e. i) the introduction of the GP guideline for smoking cessation care, ii) full 
health insurance coverage of evidence-based pharmaceuticals and behavioural 
treatment for smoking cessation.
Implementation of the first Dutch guideline ‘Treatment of Tobacco Depen-
dence’ started in 2004, accompanied by campaigns in which physicians and 
other healthcare providers were informed about the guideline and were pro-
vided with additional insight into the addictive character of smoking.19 This 
implementation period resulted in the first version of a guideline for treatment 
of tobacco use in general practice, developed by the Dutch College of General 
Practitioners in June 2007.20 This guideline recommends actively enquiring about 
a patient’s motivation for stopping smoking. When a patient smokes more than 
10 cigarettes/day and is motivated to quit, the first choice recommendation is to 
prescribe nicotine replacement therapy (NRT) in combination with behavioural 
treatment. If specifically requested by the patient, or in case of relapse after NRT, 
the antidepressant smoking cessation agents bupropion and nortriptyline are 
recommended. In December 2006 varenicline was introduced in the Netherlands 
and (after an evaluation period) was incorporated into the GP guideline in March 
2011.21
In January 2011, the Dutch government introduced full health insurance cov-
erage for evidence-based smoking cessation programs using pharmacotherapy 
in combination with behavioural counseling. Due to governmental changes, a 
shift of focus of the Ministry of Health on people’s autonomy regarding lifestyle 
choices and overall cutting in budget led to the cancellation of full health insur-
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pharmacological support for smoking cessation was reimbursed during the year 
2012.
We analysed the effects of both policies within the same regression model 
which allowed us to quantify the effects of one policy taking into account the 
effect of the other policy.
Data extraction
For a full overview of the number of primary care prescriptions of stop-smoking 
pharmaceuticals in the past decade we used two nationwide representative 
databases of i) prescribed medication in general practice and ii) prescriptions 
dispensed in outpatient pharmacies. The term ‘prescription’ refers to an order 
of the GP for the pharmacist to dispense and the patient to take the medication. 
The act of dispensing is defined as providing a patient with their labelled medi-
cation. In the Netherlands all stop-smoking medications are prescription drugs, 
with the exception of NRT which is also available over-the-counter.
At quarterly intervals, we extracted data on prescriptions and dispensed items 
of stop-smoking medication in general practices and pharmacies. Data on nor-
triptyline were excluded because this pharmaceutical is also used for various 
other indications. Finally, to explore the impact of the tobacco control interven-
tions on smoking prevalence a third database was used (see C. below).
The privacy regulation of the study was registered at the Dutch Data Protection 
Authority. According to current Dutch legislation, neither informed consent nor 
approval is required from a medical ethics committee for observational studies 
using anonymized data records.22
A. The number of quarterly prescribed stop-smoking medication in general prac-
tice was derived from the Netherlands Information Network of Primary Care 
(LINH) in the period 2001-2011. Data were retrieved from electronic medical 
patient records, kept in a representative sample of 84 general practices with 
approximately 350,000 listed patients. The characteristics of the study popu-
lation (GPs and patients) are comparable with the general Dutch population 
in terms of age and gender.23 We selected prescriptions of NRT, varenicline 
and bupropion in the period 2001-2011 and calculated prescription rates per 
1,000 smokers. These rates were calculated by dividing the absolute number 
of primary care prescriptions by the number of smokers, multiplied by 1,000. 
The number of smokers was based on the total population24 and smoking 
prevalence.25 In this database it was not possible to differentiate between 









































B. For prescriptions of stop-smoking medication dispensed in outpatient phar-
macies, we used quarterly data of the Dutch Foundation for Pharmaceutical 
Statistics (SFK) in the period 2001-2012. The SFK gathers data from a repre-
sentative panel of 95% of Dutch community pharmacies. Data were extrapo-
lated to nationwide figures. We selected dispensations of NRT, varenicline 
and bupropion in the period 2001-2012 and calculated dispensed rates per 
1,000 smokers.
C. We used quarterly data from the Dutch Continuous Survey of Smoking Habits 
(DCSSH) from 2001-2012 for smoking prevalence. The DCSSH assesses smok-
ing behaviour of the Dutch adult population (15 years and older). The DCSSH 
has been part of the CASI omnibus (Computer-Assisted Self-Interviewing) of 
TNS NIPO from 2001-2008. From 2009 onwards, the DCSSH has been perform-
ing an ad-hoc internet survey in which a representative sample of about 350 
subjects is selected from a database of 200,000 respondents every week. Up 
to 2008, the data of the DCSSH were weighted on the basis of respondents’ 
gender, age and education level, the province in which they lived, and their 
family and community size. Since January 2009, the data are also weighed on 
the basis of respondents’ social economic status. Smoking prevalence was 
assessed by asking participants ‘Do you (ever) smoke?’
Statistical methods
We drew and visually inspected time-series plots to detect marked changes in 
the number of (dispensed) prescriptions, and smoking prevalence in the past 
decade. Interrupted time-series analyses (SPSS 20.0) were used to evaluate the 
impact of the national tobacco control interventions on (dispensed) prescrip-
tions of stop-smoking medications and smoking prevalence.26 The advantages of 
these analyses are the fact that they allowed us to assess whether the interven-
tions changed the outcomes immediately as well as over a period of time, taken 
into account pre-existing trends in the data.26-28 Prior studies have shown that 
segmented regression analysis is a suitable method for analysing interrupted 
time-series data in order to assess the impact of extraneous events on smoking-
related outcomes.26;29-32 We examined the following linear regression equation:
Yt = B0 + B1* timet + B2* intervention1t + B3* time after intervention1t + B4* intervention2t 
+ B5* intervention3t + et
Time (in quarters) was included as a continuous predictor. Intervention indicated 
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insurance coverage of stop-smoking treatment; pre-intervention time points 
were coded 0 and post-intervention time points were coded 1. Time after inter-
vention was coded 0 up to the last time point before the intervention, and was 
sequentially coded from 1 thereafter.
In the model, Yt represents the outcome variable at time t (the number of (dis-
pensed) prescriptions per 1,000 smokers or smoking prevalence). B0 estimates 
the baseline level/intercept of the outcome at time point zero; B1 estimates 
the quarterly change in outcome prior to the interventions; B2 (introduction 
GP-guideline), B4 (introduction insurance coverage), and B5 (abolition insurance 
coverage) estimates the change in level immediately after the interventions; 
and B3 estimates the change in slope after the introduction of the GP-guideline 
compared with the slope before the intervention. We assessed both full and par-
simonious models in which we incorporated all parameters regardless of their 
significance and only significant covariates, respectively.
We did not assess the impact of the GP guideline introduction on the num-
ber of (dispensed) prescriptions of varenicline because this pharmaceutical 
was introduced in the Netherlands around the same time as the GP guideline 
(December 2006). Furthermore, we only assessed the immediate effect of the 
introduction and abolition of the insurance coverage in (dispensed) prescriptions 
and smoking prevalence, since we lacked sufficient time-points to estimate a 
change in trend.
Since time is a predictor in segmented regression analyses, it is likely that 
consecutive observations are correlated, which is called autocorrelation. Since 
regression analysis assumes independency between observations and autocor-
relation can overestimate or underestimate significance, we examined autocor-
relation by visually inspecting residual plots. Autocorrelation was judged to be 
present if there were statistically significant spikes in the correlogram. In addi-
tion, the Durbin-Watson statistic was used to test serial autocorrelation; based 
on the number of observations and regressors in the model we determined an 
upper and lower bound and tested the null hypothesis of zero autocorrelation 
in the data.33 We found first-order autocorrelation in the time-series of the total 
prescription rate, prescription rate of NVM, and of the number of (dispensed) 
prescription of bupropion and varenicline. These time-series were differenced 
by subtracting the value of an earlier observation from the value of a later ob-
servation in order to control for autocorrelation.26;28 The regression models were 
re-checked after time-series were differenced in order to confirm that autocor-










































Figure 1 shows the time-series plots of primary care prescriptions of stop-
smoking medication and dispensed items in pharmacies in the past decade. 
It highlights the introduction of the smoking cessation guideline in general 
practice and the period of the full health insurance coverage of smoking ces-
sation treatment. Both time-series were relatively low in the period 2001-2006, 
but show a small increase after 2007. Next, both time series increased steeply in 
2011, especially in the first and last quarter. Thereafter, dispensed prescriptions 
in pharmacies show a decrease in 2012. Overall, the number of stop-smoking 
medication prescribed in general practices is lower than dispensed in pharma-
cies. This can probably be explained by other clinical specialists also prescribing 
these pharmaceuticals. Further explanations are that GPs sometimes prescribe 
multiple doses of stop-smoking medications at the same time, and pharmacists 
sometimes dispense the labelled medication at multiple moments to be able to 
check for possible side-effects.34
Figure 2 shows the number of primary care prescriptions and dispensed items 
of NRT, varenicline, and bupropion. Visual inspection points out that between 
2001-2008, the number of primary care prescriptions of NRT increased in the 
first quarter of every year, which can be defined as seasonality in the time-series. 
In this period, the prescription rates of NRT show little change, with a single 
small increase in 2008. Both time-series of NRT show a steep increase in 2011, 
especially in the first and last quarter.
After the introduction of varenicline in December 2006, visual inspection of 
figure 2 shows that both prescriptions and dispensed items of this pharmaceu-
tical rapidly increased, particularly in the first and last quarter of 2011. Next, 
dispensed items of varenicline show a steep decrease in 2012.
With regard to bupropion, we observed a discrepancy between primary care pre-
scriptions and dispensed items from 2007 (Figure 2). At that time, bupropion was 
registered in the Netherlands as an anti-depressant in addition to stop-smoking 
medication.35 The observed discrepancy can be explained by the fact that the pri-
mary care prescriptions in this study represent the total number of prescriptions 
for both depression and quit smoking and the dispensed items represent only stop-
smoking medication. Both prescriptions and dispensed items of bupropion show a 
single slight increase in 2004. Subsequently, primary care prescriptions of bupropion 
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Figure 2. The number of primary care prescriptions and dispensed prescriptions of nicotine replace-
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GP guideline
When accounting for the effect of the introduction of the health insurance 
coverage, there was no statistically significant immediate (B2) and long-term (B3) 
effect of the introduction of the GP guideline on the number of primary care 
prescriptions and dispensed items (Table 1).
Health insurance coverage
According to the segmented regression analysis, the total number of stop-
smoking medication prescribed in general practices and dispensed in pharma-
cies showed a significant increase in 2011, the year in which smoking cessation 
treatment was reimbursed (Table 1). In the first quarter of 2011, prescriptions 
and dispensed items increased by 6.3 per 1.000 smokers (95% CI: 2.0-9.8; p = 
0.001) and 17.3 per 1.000 smokers (95% CI:12.5-22.0; p= <0.000), respectively 
(Table 2). This change also occurred in the number of primary care prescriptions 
and dispensed items of NRT and varenicline (Table 1). Subsequently, a significant 
decrease in the number of dispensed items of stop-smoking medication was 
established of 21.6 items per 1.000 smokers (95% CI: -25.9 - -17.2; p <0.000) in the 
first quarter of 2012, immediately after the abolition of the coverage. This effect 
also occurred in the number of dispensed items of varenicline and NRT.
Smoking prevalence
Visual inspection of figure 1 shows a steady overall decline in smoking prevalence 
in the period 2001-2012, with a more prominent decrease in 2004, 2007 and 2011. 
Thereafter, smoking prevalence shows a marked increase in 2012. Segmented 
regression analyses confirmed a significant decrease in the first quarter of 2011, 
immediately after the introduction of the health insurance coverage (Table 1).
dISCuSSIon
In the past decade, the number of primary care prescriptions of stop-smoking 
medication in general practices and dispensed items in pharmacies increased. 
We found a significant change in (dispensed) prescriptions following full health 
insurance coverage of stop-smoking support in the year 2011. Moreover, our data 
suggest a positive impact of this tobacco control policy on smoking prevalence. 
We did not find measurable effects of the introduction of a guideline for smoking 
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Current results compared to previous research
These results complement other Dutch reports indicating an upward trend in the 
use of pharmacological aids for smoking cessation in recent years.36 Nevertheless, 
relatively few stop-smoking prescriptions are actively suggested by GPs and guide-
lines for cessation support are often implemented suboptimal in general prac-
tice.16;37;38 Moreover, these guidelines also comprise behavioural cessation support, 
which we did not addressed in our study, which may explain why we did not found 
effects of the introduction of the GP guideline introduction on prescription rates.
Regarding our findings related to the effect of full health insurance coverage on 
prescription rates and smoking prevalence, latest research also shows a strong 
association between this policy and a more than ten-fold increase in telephone 
counseling for smoking cessation.39 Moreover, a recent review of 11 randomized 
controlled trials of four countries found a positive effect of full health insurance 
coverage on the use of smoking cessation treatment.18
Strengths and weaknesses
A strength of our study is that three large nationwide representative databases 
were used with regard to prescriptions in general practice, dispensed items in 
pharmacies and smoking prevalence. With regard to the SFK database, in 2011 
an unknown and possibly substantial part of Dutch health insurance companies 
covered dispensed prescriptions of stop-smoking medications only of specific 
(online) pharmacies; therefore, the precise number of dispensed items was un-
known in this year. This implies that these data might underestimate the actual 
situation and that the impact of health insurance coverage might be even larger. 
Another strength of the study is the fact that in the Dutch healthcare system, 
almost all non-institutionalized Dutch citizens are registered with a general 
practice, which resulted in data with strong external validity.
Regarding the analyses, we assessed the impact of tobacco control interven-
tions with quarterly data points, which enables us to detect subtle temporary 
effects in the period prior to or immediately after the interventions. Additionally, 
we included the most recent available data in order to analyse changes in trends 
following the abolition of the health insurance coverage.
However, some limitations of the study have to be mentioned. First, it was not 
possible to differentiate between bupropion prescriptions for treating depres-
sion and those used as a quit-smoking aid in general practice. Furthermore, we 
did not include data regarding NRT distributed over-the-counter. Because the 
estimated mean costs of NRT are 2.57 Euro per day40, this may have been an 
incentive for patients to get a prescription of the GP during the period smoking 









































large increase in the number of (dispensed) prescriptions of NRT in the period 
2011-2012 is partially caused by the fact that over-the-counter distribution of 
these aids are not included into the analyses in the pre-intervention period.
With regard to the segmented regression analyses, when assessing the impact 
of an intervention on time series, the impact of extraneous events on the observed 
changes in the series must be taken into account.29 In the past decade, multiple 
tobacco control policies have been implemented in the Netherlands which might 
have had an (indirect) effect on the number of prescriptions; for example, tax 
increases, and smoke-free legislation in the workplace (2004) and other public 
areas (2008). However, in 2011 no other tobacco control measures were introduced 
in the Netherlands. Although caution is required in assuming causal relations, it 
seems likely that the increase in (dispensed) prescriptions and decrease in smok-
ing prevalence in 2011 can be attributed to the introduction of the health insur-
ance coverage. This assumption is supported by the fact that we visually detected 
a marked increase in smoking prevalence and statistically confirmed a decrease 
in dispensed items immediately after the abolition of the coverage.
Conclusion and practical implications
The results of this study suggest that health insurance coverage for smoking ces-
sation treatment prompt GPs to prescribe evidence-based pharmaceuticals for 
smoking cessation and have positive effects on smoking prevalence. Therefore, 
these results are a relevant addition to the existing evidence demonstrating the 
importance of tobacco control policies in the effective tackling of the tobacco 
epidemic.10-15;29;41;42
We argue that policy makers and the tobacco-control community consider this 
evidence in developing future tobacco control policy. Given the limitations of our 
study, we recommend replication of population based studies to further evaluate 
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This general discussion provides further explanations for the observed findings 
of the presented studies, discusses the practical implications of the study results, 
and provides recommendations for future research. Furthermore, the empirical 
studies in this dissertation will be put into the context of the socio-ecological 
model that was introduced in the first chapter.
ImprovIng gpS’ ImplemenTaTIon oF SmokIng CeSSaTIon Care
Successful implementation of innovations within healthcare, including a guide-
line for smoking cessation care in general practice, is a complex and often long-
lasting process.1 The factors that influence this implementation process operate 
on several levels, including the general practitioner (GP), patient, organization, 
community, and public policy level. These levels are summarized in a five-level 
socio-ecological model depicted in the introductory chapter of this dissertation. 
This model constitutes the conceptual framework that guided this dissertation; 
all empirical studies addressed factors related to one or more of these levels.
GP level
Chapter three of this dissertation 
presented the effectiveness of a 
pragmatic, practice-tailored train-
ing programme for GPs that aimed 
to influence the determining GP-
related factors of implementation. 
The trained GPs increased the 
number of times they asked their 
patients about smoking and ad-
vised smokers to quit compared to the untrained GPs. In addition, they reported 
a higher perceived self-efficacy and intention towards routinely implementing 
smoking cessation care. However, in additional analyses we could not confirm 
that an increased self-efficacy or an increased intention to implement smok-
ing cessation care was related to improved delivery of such care. There may 
be several explanations for this lack of a relation between GPs’ self-efficacy, 
intention and behaviour. The first possible explanations entail methodological 
considerations. The relatively small GP sample may have resulted in low sta-
tistical power and an inadequate way of operationalizing the self-efficacy and 
intention constructs may have violated the construct validity within the study. 




















































that cognitive determinants of behaviour may be too parsimonious to predict 
complex human volitional behaviour, such as GPs’ advices to quit, prescriptions 
for quit-smoking medication, and referrals to follow-up quit smoking support.2 
As a result, GPs’ provision of such guideline-recommended smoking cessation 
care may be influenced by other behavioural attributes than cognitive determi-
nants alone, such as perceived self-efficacy and intention.
GP action planning
Because the gap between an individual’s intention and actual behaviour can be 
closed by formulating action plans3-5, chapter four of this dissertation presented 
the effects of this strategy among GPs. Based on these results, no conclusions can 
yet be drawn on the effectiveness of action planning on GPs’ advices to quit and 
follow-up arrangements. This might be due to the previously mentioned small 
GP and smoker sample sizes. In addition, coping planning might result in more 
positive effects on GPs’ provision of quit-smoking advices and arrangements of 
follow-up support. This type of planning is known to anticipate behavioural bar-
riers that impede action plans from working.6
Patient level
Chapter five reports a study in which 
a quantitative approach to video-
recorded communication was 
used to examine the interaction 
between primary care profession-
als and patients during unsolicited 
dialogues about smoking. Overall, 
this study showed that the prob-
ability that smokers expressed a 
negative statement about quitting 
was lowest when primary care professionals asked about smoking (11%), advised 
to quit (27%), or arranged a follow-up (15%), compared to assessing the smoker’s 
motivation to quit (55%), or providing assistance with quitting (38%). GPs seemed 
less likely to continue their use of these 5 A’s following smokers’ negative state-
ments about quitting (19%) compared to smokers’ positive statements about 
quitting (47%), which might relate to GPs’ fear of harming the doctor-patient 
relationship when discussing smoking unsolicited.7 Nevertheless, we could not 
confirm this last finding statistically. This could be explained by several method-
ological issues. Within multilevel modelling it is desirable to include a sufficient 




















































confirm effects when these are present.8 Our two-level model (GP and speech 
unit level) included 17 GP consultations on the highest level. Literature suggests, 
however, a minimum sample size of and a sample size of 100 as sufficient at the 
highest level of such models.9;10 Including a small sample size might have led to 
biased estimates of the effects.8 Nevertheless, some suggest that the appropriate 
sample size depends on the area of research; a sample size on the highest level 
of 30 is, for instance, appropriate in educational research, whereas a sample size 
of 5 at the highest level is appropriate in family and longitudinal research.9 Until 
now, multilevel techniques to examine physician-patient communication are 
rarely used in general practice11, which makes an estimation of the appropriate 
GP sample size difficult.
GP-patient communication
Studies have shown that emphasizing a link between the patient’s (possible fu-
ture) health status and his/her current smoking behaviour, as recommended by 
the current GP-guideline12, may evoke resistance in a patient.13 Achieving mutual 
agreement on the importance of smoking cessation might reduce this resis-
tance.13 Following the basic principles of motivational interviewing, GPs may use 
this resistance, or ‘sustain talk’, to evoke ‘change-talk’ in which the patient is en-
couraged to verbalize arguments to quit smoking. As shown by a meta-analysis 
of 14 studies, such motivational interviewing techniques significantly increase 
smoking abstinence rates when compared to a brief quit-smoking advice.14 In 
addition, this approach might result in a more balanced relationship between the 
GP and patient.15 As a result, patients will feel engaged in the decision-making 
process, which is known to result in more positive patient outcomes.16;17
Nevertheless, GPs and practice nurses (PNs) apply motivational interviewing 
techniques only to a minor extent.18 In addition, it has been suggested that train-
ing during and after medical school may not be sufficient for adequately apply-
ing these techniques in practice.19 Although it is still unknown which training 
components and frequencies are most profitable for healthcare professionals 
to improve motivational interviewing techniques20;21, previous studies have sug-
gested that the provision of systematic (video-)feedback might be effective.18;22 
Therefore, it is recommended to examine the effects of (long-term) (video-)
feedback on GPs’ usage of motivational interviewing techniques in dealing with 
negative statements of smokers about quitting and reaching mutual agreement 









































Organization and community level
Chapter two of this dissertation 
recommended more focus on or-
ganizational factors within train-
ing programmes for health profes-
sionals in smoking cessation care. 
It may facilitate implementation 
of such care when the conditions 
in which these professionals work 
are addressed. This was recently 
confirmed by a study by Geense et al., which reports on the organizational and 
community barriers primary care professionals perceive as impeding for a 
full implementation of lifestyle interventions.23 The GP training programme 
presented in chapter three of this dissertation attempted to target such organi-
zational factors, including referral opportunities to quit-smoking programmes 
in the community, and possibilities to register the smoking status of patients in 
their electronic medical file. Nevertheless, our trained GPs did not refer smok-
ers to follow-up care more often. Since we do not know whether the trained 
GPs improved the organization of smoking cessation care in their practice, we 
are unable to draw further conclusions regarding the effectiveness of including 
organizational barriers of implementation in training programmes for GPs based 
on these findings. Future process evaluations of such training programmes 
might improve our knowledge about effective strategies tackling organizational 
and community implementation barriers.
Public policy level
Chapter six reported the results of 
a population-based study in which 
we examined the effects of the in-
troduction of full health insurance 
coverage of quit-smoking support 
in the Netherlands (2011) on GP 
prescriptions of stop-smoking 
medication and on smoking 
prevalence. As shown in this 
chapter, this public policy was accompanied by an increase in GP prescriptions 
of stop-smoking medication. Unfortunately, this registration-based study was 
unable to examine the influence of this policy on the provision of other smoking 































































support. Another population-based study in the Netherlands, however, showed 
that the number of smokers who called the national smoking-cessation quit line 
increased more than tenfold; from 848 smokers that enrolled in telephone treat-
ment in 2010 to 9091 smokers in 2011, the year the coverage was introduced.24 
We also found a significant decrease in smoking prevalence in 2011, which is in 
line with recent published findings of a longitudinal four-wave web-based survey 
among a national representative sample of adult smokers.25 This study found 
that the self-reported number of quit attempts increased in this year as well as 
the number of smokers who gave up their smoking successfully. However, this 
study did not find a significant increase in the self-reported use of stop-smoking 
medication as a result of the health insurance coverage.25 As argued by the au-
thors, this is probably due to a time-lag in reporting.25
ConCluSIonS
It can be concluded that the implementation of smoking cessation care in gen-
eral practice can be improved by targeting factors on multiple levels. Neverthe-
less, challenges remain for the future. In particular, there is considerable room 
for improvement regarding GPs’ referrals for follow-up quit-smoking support. In 
addition, GPs seem to discontinue their use of guideline-recommended smoking 
cessation care when smokers express negative statements about quitting, which 
may indicate the importance of improving (the use of) motivational interviewing 
techniques. These conclusions lead to the following implications.
praCTICal ImplICaTIonS
This section discusses the practical implications of the study findings for current 
Dutch GP training programmes, GP guidelines, and tobacco control policies that 
have the potential to facilitate a successful implementation of smoking cessa-
tion care in future general practice.
GP training programmes
In the Netherlands, various GP training programmes for improving smoking ces-
sation care are currently available. To our knowledge, no evidence exists on the 
effectiveness of these training programmes, which makes it difficult to compare 
them with the GP training programme discussed in chapter three of this disserta-









































duration, and content of these training programmes. In contrast to our indi-
vidual, one-hour GP training programme, these programmes most often have a 
longer duration, ranging from 1.5 hours to four days, and are delivered to a group 
of professionals. Whereas our GP training programme focused on tailored guid-
ance regarding individual implementation barriers, including organizational and 
community factors, only a minority of other training programmes thoroughly 
incorporate such implementation aspects.
As elaborated upon in chapter two, organizational factors should be consid-
ered within GP training programmes in order to facilitate a full implementa-
tion of guideline-recommended smoking cessation care. Although the training 
programme discussed in chapter three incorporated such organizational factors, 
it is not clear whether the organization with regard to smoking cessation care 
in general practice improved. Nevertheless, a majority of the GPs addressed 
organizational barriers during our training, underpinning its importance. There-
fore, we recommend current Dutch training programmes to focus more on the 
implementation aspects of smoking cessation care in general practice, including 
organizational factors, such as a clear task distribution and a supportive work 
environment. In addition, providing a follow-up meeting for GPs and monitoring 
their progress after the training may ensure that smoking cessation care is suc-
cessfully implemented in the long term.
To ensure a routine approach to lifestyle counseling in future general practice, 
it is recommendable to put more emphasis on this during medical school and GP 
residency. Currently, GP residents are trained in basic motivational interviewing 
techniques. We recommend to incorporate ongoing (video-)feedback and moni-
toring of these GP skills within consultations in which smoking is unsolicited 
discussed (this approach may also be applied to other aspects of lifestyle coun-
seling). Including this feedback in their portfolios can encourage GP residents to 
reflect on their progress concerning these skills and develop personal learning 
goals.26
In addition, forming action plans on who, when, where, and how to implement 
such techniques and other smoking cessation activities, such as advising to quit 
and referring for follow-up, might link situational cues in consultations and 
other aspects of daily practice to these activities. This strategy may especially 
alleviate implementation barriers operating on an organizational level since it 
specifies a clearer task allocation within the practice. Coping planning might 
further stimulate GPs to anticipate obstacles to implementation that might 
impede action plans from working. Taking into consideration the importance 
of achieving mutual agreement with the patient regarding the importance of 









































tions, (future) GPs should be prepared thoroughly in order to provide adequate 
smoking cessation care.
GP guideline
As discussed in the chapter one of this dissertation, current guidelines for smok-
ing cessation care in general practice are based on the 5A-Model, which entails 
Asking about smoking, Advising to quit, Assessing motivation to quit, Assisting 
with quitting, and Arranging follow-up.12;27-29 Although these guidelines seem to 
focus on a full implementation of the 5A-Model by the GP, some recommenda-
tions are provided with regard to specifically delegating quit-smoking assistance 
to trained PNs. In line with these recommendations, chapter five showed a clear 
division of tasks between GPs and PNs with regard to the provision of smoking 
cessation care; when using the 5 A’s, GPs focussed on Asking about smoking and 
Advising to quit, while PNs focussed on Assisting with quitting. Nevertheless, 
both GPs and PNs lacked sufficient focus on Advising smokers to quit, Assessing 
their motivation to quit, and Arranging referrals or follow-up appointments.
Recently, the (dis)advantages of the 5A-Model were summarized.30 On the 
one hand, this model is a rather straightforward approach for busy healthcare 
settings. Additionally, the 5A-Model matches existing practices and patients’ ex-
pectations well. On the other hand, the 5A-Model is tied to only one professional, 
in particular to physicians. Yet, smoking cessation interventions have shown the 
added value of involvement of multiple members of a practice team.31 Moreover, 
various factors impede GPs’ implementation of the full 5A-Model, some of which 
can be considered as insurmountable, such as a lack of sufficient consultation 
time. Therefore, it may be argued that alternative approaches to the treatment 
of tobacco addiction should be developed which do not solely rely on the GP, but 
rather involve multiple members of the practice team.
Alternatives to the 5A-Model
A smoking cessation initiative on cardiology wards recommends a simplified 
Ask-Advise-Refer (A-A-R) approach.32 When applying this approach in general 
practice, busy GPs solely address the patients’ smoking behaviour and refer 
them to effective smoking cessation treatments provided by PNs. Yet, as shown 
in a previous study19 and confirmed in chapter five of this dissertation, GPs do not 
frequently refer patients for quit-smoking support. Moreover, the vast majority 
of smokers who are passively referred to quit lines fail to call for quit-smoking 
assistance.33;34
Therefore, Vidrine et al. developed an approach to smoking cessation care in 









































to the A-A-R approach in which patients are passively referred to follow-up sup-
port, the A-A-C approach proactively connects patients’ with follow-up support. 
Connections were made by clicking on an automated link in the patient’s elec-
tronic medical file that sent the smoker’s name and phone number to a quit line. 
Within 48 hours, the patient was then proactively called and quit-smoking sup-
port was scheduled. A group-randomized controlled study showed a significant 
larger proportion of identified smokers that enrolled in quit-smoking treatment 
within the A-A-C approach compared to the A-A-R approach (A-A-C: 100% versus 
A-A-R: 68.7%).35 Although evidence of the A-A-C on smoking abstinence rates is 
still lacking, previous studies have suggested that such proactive approaches 
to smoking cessation are just as or even more effective than reactive strate-
gies, such as the A-A-R approach.36 In addition, it might be argued that GPs are 
more inclined to proactively connect smokers with follow-up support, because 
they perceive this approach as more effective when compared to a passive A-A-R 
approach.
Tobacco control policy
Based on previous studies, we hypothesized that the implementation of smoking 
cessation treatment in general practice could be facilitated by full health insur-
ance coverage of quit-smoking programmes.23;37 Following the findings presented 
in chapter six, it is highly recommended to continue the current full health in-
surance coverage for quit-smoking programmes. This public policy is likely to 
further stimulate GPs to provide smoking cessation care (e.g. prescriptions and 
referrals for behavioural counseling), thereby decreasing smoking prevalence.
ImplICaTIonS For FuTure reSearCh
The empirical studies within this dissertation generate a number of hypotheses 
for future research. In this section, we will address these theoretical consider-
ations and measurement instruments, methodological and statistical consider-
ations, and further research ideas for facilitating the implementation of smoking 
cessation care in general practice.
Theoretical considerations and measurement instruments
In chapter three we used a screening questionnaire to examine the implemen-
tation barriers GPs experience. This questionnaire was based on the Theory of 
Planned Behaviour38 and examined GPs’ attitudes, social norms, self-efficacy, 









































however, other ways to explore underlying theoretical concepts of professional 
behaviour. Huijg et al. recently developed a theory-based screening questionnaire 
to examine factors that influence implementation processes within healthcare, 
in particular healthcare professionals’ clinical behaviours.39;40 This question-
naire is based on the Theoretical Domain Framework, which was developed by 
a consensus group of behavioural and implementation research experts and 
integrates multiple behaviour change theories.41 This framework has been used 
to identify factors that influence the implementation of smoking cessation care 
in dental healthcare.42 This study showed that the constructs “memory, attention 
and decision processes” and “professionals’ role and identity” were significantly 
associated with dentists’ adherence to smoking cessation guidelines. Identifying 
such determining constructs among GPs may further improve our understand-
ing of the implementation of guideline-recommended smoking cessation care 
within general practice. As a result, this knowledge can inform future behaviour 
change techniques that aim to improve GPs’ provision of smoking cessation care.
Methodological and statistical considerations
Experimental studies with larger GP samples are recommended to further exam-
ine the effects of incorporating organizational factors, as well as action planning 
and coping planning in GP training programmes on their provision of smoking 
cessation care. An example of such a study is a recently published protocol of 
a cluster randomized controlled trial of Presseau et al., who will examine the 
effects of action planning on GPs’ provision of guideline-recommended care for 
patients with diabetes.43 In addition, future quantitative studies on the commu-
nication between professionals and patients, using sequence analysis and mul-
tilevel modelling, are recommended to ensure sufficient power on both levels of 
the model. Moreover, adding a third level in the model which incorporates char-
acteristics of the healthcare professional may result in more reliable outcomes. 
Finally, a replication of our population-based study on the effects of full health 
insurance coverage of stop-smoking programmes (chapter six) is recommended 
in order to examine the long-term effects on GP prescription rates and smoking 
prevalence. In addition, future studies are needed on the effects of this public 
policy on GPs’ provision of other guideline-recommended smoking cessation 
care, such as quit-smoking advices, quit-smoking assistance, and referrals for 
quit-smoking support. Such studies may contribute to our knowledge of the 
facilitating role of public policies on the implementation of smoking cessation 










































We recommend an alternative approach to smoking cessation care in general 
practice, i.e. an A-A-C approach. Future (qualitative) studies should explore the 
overall willingness of patients and GPs towards this approach. It is anticipated 
that several patient groups are reluctant to such a proactive approach.44 Iden-
tification of these patients allows primary care professionals to tune in to their 
reluctance by using motivational interviewing techniques. Additionally, we 
recommend studies that assess the feasibility and effectiveness of this A-A-C 
approach in Dutch general practice.
whaT ThIS dISSerTaTIon addS
The empirical studies in this dissertation provide insight in a variety of method-
ological approaches that can be used to describe and facilitate the implementa-
tion of smoking cessation care in general practice. This resulted in study findings 
which show that training GPs has the potential to facilitate the implementa-
tion of smoking cessation care, in particular the degree to which smokers are 
identified and advised to quit. In addition, full health insurance coverage of 
stop-smoking programmes increased GP prescription behaviour. Yet challenges 
remain to incorporate smoking cessation care as a routine procedure in general 
practice, with a special focus on arranging follow-up support by GPs. This dis-
sertation provided several new ideas for future research in order to overcome 
these challenges. Multifaceted strategies, based on a socio-ecological approach 
to guideline implementation and including behavioural change theories, have 
the potential to facilitate a successful implementation of smoking cessation 
care in general practice. In the end, the delivery of lifestyle counseling, with a 
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The WHO acclaimed the tobacco epidemic as one of the biggest public health 
threats the world has ever faced. Therefore, tobacco control has been identified 
as the most urgent and immediate priority intervention to reduce the prevalence 
of non-communicable disease. Chapter one elaborates on the current state-of-
the-art evidence with regard to pharmacological and behavioural quit-smoking 
support and stresses the importance of a routine approach to smoking cessa-
tion care in general practice. Nevertheless, a substantial gap exists between 
the evidence-based knowledge on the treatment of tobacco dependence and 
real-world practices of primary care professionals. Therefore, the aim of this 
dissertation was to examine the implementation of smoking cessation care in 
general practice. A five-level socio-ecological model is introduced as the con-
ceptual framework that guided this dissertation; all empirical studies in this 
dissertation adressed one or more factors related to the general practitioner 
(GP), patient, organization, community, or public policy level which determine 
the implementation of smoking cessation care in general practice.
The aim of chapter two was to examine the overall effectiveness of training 
health professionals in the delivery of smoking cessation interventions to their 
patients. In addition, this chapter aimed to examine which training character-
istics are most likely to be effective, such as the content, delivery method and 
intensity. In a systematic review, 17 randomized controlled trials were included 
in which the intervention was training of health care professionals in providing 
smoking cessation care, and in which outcomes for patient smoking behaviour at 
least six months after the intervention were reported. These studies were found 
during a systematic search procedure using the Cochrane Tobacco Addiction 
Group’s Specialised Register, electronic databases and the bibliographies of iden-
tified studies. Two independent reviewers extracted information relating to the 
characteristics of each included study for interventions, participants, outcomes 
and methods. Raw data of studies was requested from the study authors where 
needed. Studies were combined in a meta-analysis where possible and reported 
in narrative synthesis in text and table. A meta-analysis of 14 studies for point 
prevalence of smoking produced a statistically and clinically significant effect 
in favour of the intervention. A meta-analysis of eight studies that reported 
continuous abstinence was also statistically significant in favour of the interven-
tion. In addition, healthcare professionals who had received training were more 
likely to perform tasks of smoking cessation than untrained controls, including 
asking patients to set a quit date, make follow-up appointments, counseling of 
smokers, providing self-help material, and prescribing a quit date. No evidence 









































With regard to the training characteristics, we found that health professionals 
who were trained using only a single session and in a group setting were just as 
likely if not more likely to have patients quit smoking as those being trained with 
multiple delivery sessions and one-on-one training (i.e., face to face with the 
trainer). Similarly, the duration of training for the health professional of between 
40 minutes to two hours was just as effective, and in some cases more so, than 
a duration of greater than two hours. To conclude, this study found evidence 
for training health professionals to provide smoking cessation interventions on 
the point prevalence of smoking, continuous abstinence and professional per-
formance. The one exception was the provision of nicotine gum or replacement 
therapy, which did not differ between groups.
We developed a one-hour, practice-tailored training for GPs which aimed to alle-
viate GP-related and organizational barriers that arise when routinely asking pa-
tients’ smoking status, advising to quit, and arranging follow-up. Chapter three 
reports the effectiveness of this GP training programme which we examined in 
a cluster-randomized controlled trial including with 49 GPs and 3,401 patients 
(677 smokers). Two patient groups participated: 2,068 patients (433 smokers) at 
baseline and 1,333 patients (244 smokers) post-intervention. At follow-up, 225 
smokers of both groups participated. The primary outcome was GPs’ smoking 
cessation counseling (asking about smoking status, advising to quit, prescribing 
pharmacotherapy, and referring for behavioural support). Secondary outcomes 
were GPs’ attitudes toward smoking cessation care, patients’ intention to quit, 
and long-term quit rates. Outcomes were measured with GP self-report and pa-
tient report. Multilevel regression analyses showed that patients of trained GPs 
more often reported being asked about smoking behaviour compared to patients 
of untrained GPs. According to GP self-report, the training also increased the 
provision of quit-smoking advices and improved GPs’ perceived self-efficacy 
and intention to routinely implement smoking cessation care. No effects of the 
training were found on GPs’ arrangement of follow-up quit-smoking support, 
smokers’ intention to quit, and long-term quit rates.
One of the training components consisted of action planning among the GPs. 
Chapter four reports the results of a study that examined if this strategy in-
creased the provision of smoking cessation care among the GPs, with a special 
focus on the quality of the action plans. During the training programme, the 
GPs formulated action plans related to i) enquiring about smoking, ii) advising 
to quit smoking, and iii) arranging follow-up for smokers motivated to quit. The 









































quit. The quality of these plans (i.e. plan specificity) was rated and, 6 weeks after 
the training, GPs reported on the performance of these plans (i.e. plan enact-
ment). Multilevel regression analysis was used to examine the effects of plan 
specificity and plan enactment on patient-reported smoking cessation activities 
of the GPs before the training compared with these activities after the train-
ing. These analyses showed that GPs who formulated an action plan of high 
specificity more often asked their patient about smoking, especially when these 
professionals also enacted this plan. This effect was most prominent among GPs 
who intended to provide smoking cessation care prior to the intervention. No 
effects of (the quality of) action planning were found on GPs’ advices to quit 
and arrangements for follow-up quit-smoking support. Based on these study 
findings, recommendations are made in additional training in devising coping 
plans to further increase GPs’ provision of advice to quit smoking and arranging 
follow-up support to quit smoking.
In order to provide more insight in the interaction between primary care profes-
sionals and patients during consultations in which smoking is unsolicited dis-
cussed, chapter five presents the results of sequential analyses of communication 
obtained from video-recorded consultations. In this study, 52 video-recordings of 
consultations in primary care were collected, in which 17 GPs and 16 practice 
nurses (PNs) initiated a conversation about smoking. Dialogues about smoking 
were transcribed verbatim. Professionals’ speech units were coded according to 
the core aspects of the GP guideline. Patients’ speech units were coded as either 
positive or negative statements about smoking cessation. All other speech units 
of professionals and patients were coded as other smoke- or non-smoke-related. 
Descriptive and sequential analyses (two-level multilevel modeling) were used 
to determine if particular sequences of speech units occurred to a greater or 
lesser extent than could be expected by chance alone. These analyses showed 
that, compared to PNs, GPs focused more on asking about smoking and advising 
to quit. PNs focused more on assisting patients with quitting. In addition, the 
analyses showed that smokers responded more often negatively than positively 
towards quitting, especially when PNs assessed their willingness to quit or as-
sisted them with a quit attempt. Moreover, we found that GPs seemed more likely 
to discontinue their use of guideline-recommended smoking cessation care fol-
lowing patients’ negative statements about quitting. However, this finding could 
not be statistically confirmed. Based on these findings, this chapter concludes 
with the recommendation to limit GPs’ tasks for smoking cessation care to iden-









































approach seems the least likely to evoke negative responses of patients and is 
complimentary to lifestyle counseling tasks and skills of PNs.
Next to factors on a GP, patient, organization, and community level, we know 
from previous literature that the implementation of smoking cessation care 
may also be influenced by factors operating on a public policy level. Therefore, 
chapter six discusses the results of a population-based study on the effects of 
two national tobacco control interventions (the introduction of the GP guideline 
for smoking cessation care in 2007 and the introduction of full health insurance 
coverage for stop-smoking medication in 2011) on the number of (dispensed) 
prescriptions of stop-smoking medication in general practice. This ecological 
study analysed quarterly data points of three nation-wide representative data-
bases using interrupted time-series analyses. These analyses showed no effects 
of the introduction of the GP guideline on (dispensed) prescriptions. Shortly after 
the introduction of the health insurance coverage, an estimated significant in-
crease in primary care prescriptions of 6.3 per 1,000 smokers and 17.3 dispensed 
items per 1,000 was accompanied by a sudden drop in smoking prevalence of 
2.9% in the first quarter of 2011. Immediately after the coverage abolition, smok-
ing prevalence significantly increased by 1.2% and dispensed prescription rates 
decreased with 21.6 per 1,000 smokers. This chapter concludes with recommen-
dations for policy makers and the tobacco control community to consider these 
findings in developing future tobacco control policy.
The general discussion in chapter seven provides further explanations for the 
observed findings of the presented studies, discusses the practical implications 
of the study results, and provides recommendations for future research. Theory-
based screening questionnaires are recommended to further explore factors that 
influence the implementation process of smoking cessation care, in particular 
GPs’ clinical behaviours. This knowledge can inform future behaviour change 
techniques that aim to improve GPs’ provision of smoking cessation care. In ad-
dition, experimental studies with larger GP samples are recommended to further 
examine the effects of incorporating organizational factors, action planning 
and coping planning in GP training programmes on their provision of smoking 
cessation care and on patient smoking behaviour. Furthermore, a replication of 
our population-based study on the effects of full health insurance coverage of 
stop-smoking programmes is recommended in order to examine the long-term 
effects on GP prescription rates and smoking prevalence. Finally, we discuss an 
alternative approach to smoking cessation care in general practice, i.e. an ask-









































overall willingness of patients and GPs towards this approach. Additionally, we 
recommend studies that assess the feasibility and effectiveness of this A-A-C 


















































































De Wereldgezondheidsorganisatie heeft de tabaksepidemie uitgeroepen tot een 
van de grootste bedreigingen voor de publieke gezondheid die de wereld ooit 
heeft gekend. Om die reden wordt het ontmoedigen van tabaksgebruik gezien als 
de meest urgente interventie om de prevalentie van niet-overdraagbare ziekten 
terug te dringen. In hoofdstuk één van dit proefschrift wordt wetenschappelijk 
onderzoek besproken dat de positieve effecten van farmacologische en gedrags-
matige stoppen-met-rokenbegeleiding heeft aangetoond. Onderzoek laat tevens 
zien dat zorgprofessionals in de huisartspraktijk een belangrijke rol kunnen 
spelen bij tabaksontmoediging door deze vormen van begeleiding routinematig 
aan patiënten aan te bieden. De literatuur laat echter ook zien dat er een kloof 
bestaat tussen enerzijds de wetenschappelijk aangetoonde positieve effecten van 
stoppen-met-rokenbegeleiding en anderzijds de implementatie hiervan in de da-
gelijkse praktijkvoering van huisartsen; rokers worden niet structureel door hun 
huisarts geadviseerd en begeleid bij het stoppen met roken. Om die reden is het 
doel van dit proefschrift de implementatie van stoppen-met-rokenbegeleiding in 
de huisartspraktijk te onderzoeken. De implementatie van onderzoeksbevindin-
gen in de praktijk wordt door tal van factoren beïnvloed. Deze factoren worden 
in een sociaalecologisch model in vijf niveaus ingedeeld: het niveau van de 
zorgprofessional, de patiënt, de organisatie, de community, en het beleid. Op elk 
niveau zijn er factoren die de implementatie van stoppen-met-rokenbegeleiding 
in de huisartspraktijk kunnen belemmeren of verbeteren. Dit sociaalecologisch 
model vormt het raamwerk van dit proefschrift; alle empirische studies in het 
proefschrift behandelen een of meerdere factoren gerelateerd aan een of meer-
dere niveaus van dit model.
Hoofdstuk twee, drie en vier van dit proefschrift richten zich op het niveau 
van de huisarts en de huisartspraktijk. In hoofdstuk twee wordt nagegaan wat 
het effect is van een training aan zorgprofessionals in het begeleiden van hun 
patiënten bij het stoppen met roken. Ook wordt nagegaan welke eigenschappen 
van dergelijke trainingen het meest effectief zijn, zoals de inhoud van de trai-
ning, de wijze van trainen en de intensiteit van de training. In totaal werden 17 
studies samengevoegd waarin het effect van een training aan zorgprofessionals 
in het begeleiden van patiënten bij het stoppen met roken werd vergeleken met 
een controlegroep waarin zorgprofessionals niet getraind werden. Alle studies 
bekeken het effect van de training van zorgprofessionals op het rookgedrag van 
patiënten minimaal zes maanden na de training. Alle studies zijn gevonden door 
middel van een systematische zoekprocedure waarbij gebruik werd gemaakt van 
een gespecialiseerd register van de Cochrane Tobacco Addiction Group, elektronische 









































extraheerden onafhankelijk van elkaar informatie over de studies met betrek-
king tot de eigenschappen van de participanten, uitkomstmaten en onderzoeks-
methoden. Waar mogelijk werden de bevindingen van de studies samengevoegd 
in een meta-analyse. Deze analyses toonden een statistisch en klinisch signi-
ficant effect aan van de training van zorgprofessionals op het rookgedrag van 
patiënten. Bovendien bleek dat getrainde zorgprofessionals vaker stoppen-met-
rokenactiviteiten ontplooiden dan ongetrainde professionals, zoals samen met 
de patiënt een stopdatum bespreken en het maken van een vervolgafspraak. 
Geen effect werd gevonden op het voorschrijven van nicotinevervangende mid-
delen. Wat betreft de eigenschappen van de training vonden we dat patiënten 
van zorgprofessionals die een training gevolgd hadden bestaande uit een enkele 
sessie en in groepsverband even vaak gestopt waren met roken als patiënten van 
professionals die een training gevolgd hadden van meerdere één-op-één sessies 
(face-to-face met de trainer). Ook vonden we dat een training van tussen de 40 
minuten en twee uur even effectief was, en in sommige studies zelfs effectiever, 
als een training die langer dan twee uur duurde. Op basis van deze bevindingen 
kan geconcludeerd worden dat het trainen van zorgprofessionals in het bege-
leiden van hun patiënten bij het stoppen met roken positieve effecten heeft op 
de prevalentie van roken en op de prestaties van de zorgprofessionals. De enige 
uitzondering hierop was het voorschrijven van nicotinevervangende middelen. 
Dit verschilde niet tussen getrainde en ongetrainde gezondheidsprofessionals.
Vervolgens ontwikkelden we voor huisartsen een één-uur-durende, op de praktijk 
afgestemde training in het begeleiden van patiënten bij het stoppen met roken. 
Deze training had tot doel het verminderen van barrières die huisartsen ervaren 
bij het structureel vragen naar de rookstatus van patiënten, het adviseren van 
rokers om te stoppen, en het doorverwijzen van rokers naar stopondersteuning. 
In hoofdstuk drie van dit proefschrift wordt de effectiviteit van deze training 
besproken. In een cluster gerandomiseerde, gecontroleerde trial werden 49 
huisartsen en 3.401 patiënten (677 rokers) geïncludeerd. Twee patiëntengroepen 
namen deel: 2.068 patiënten (433 rokers) voor de interventie en 1.333 patiënten 
(244 rokers) na de interventie. Aan de vervolgmeting (na 9 maanden) namen nog 
225 rokers van beide groepen deel. De primaire uitkomstmaat vormde de mate 
waarin de huisarts tijdens het consult aandacht besteedde aan het rookgedrag 
van de patiënt (vragen naar de rookstatus, adviseren om te stoppen met roken, 
het voorschrijven van farmacotherapie en doorverwijzen naar stopondersteu-
ning). Secondaire uitkomstmaten waren de attitude, gepercipieerde eigenef-
fectiviteit en intentie van de huisarts om patiënten routinematig stoppen-met-









































roken en het rookgedrag van de patiënt op de lange termijn. Deze uitkomstmaten 
werden gemeten door middel van zelfrapportage van de huisartsen en patiënten 
en vervolgens geanalyseerd met behulp van multilevel regressie-analyses. Deze 
analyses toonden aan dat patiënten van getrainde huisartsen vaker gevraagd 
werden naar hun rookgedrag dan patiënten van ongetrainde huisartsen. Volgens 
de zelfrapportage van huisartsen werden rokende patiënten van getrainde 
huisartsen ook vaker geadviseerd om te stoppen dan patiënten van ongetrainde 
huisartsen. Ook verbeterde de training de eigeneffectiviteit en intentie van de 
huisartsen. We vonden geen effect van de training op het voorschrijven van 
farmacotherapie, doorverwijzen naar stopondersteuning, intentie van de patiënt 
om te stoppen met roken en het rookgedrag van de patiënt op de lange termijn.
Een van de onderdelen van de hierboven beschreven training aan huisartsen 
was het maken van actieplannen. Voor deze actieplannen beschreven de huis-
artsen de wijze waarop zij van plan waren enkele zorgtaken op het gebied van 
stoppen-met-rokenbegeleiding in de toekomst te gaan implementeren. Deze 
actieplannen waren gerelateerd aan de volgende taken: 1) het vragen naar de 
rookstatus, 2) het adviseren om te stoppen met roken, en 3) het regelen van 
stopondersteuning voor rokers die gemotiveerd zijn om te stoppen. De huis-
artsen formuleerden ook een copingplan waarin zij weergaven wat ze zouden 
doen als zij rokers spraken die ongemotiveerd bleken te zijn om te stoppen 
met roken. De huisartsen beschreven wie deze verschillende taken zou gaan 
uitvoeren, wanneer deze plannen zouden worden uitgevoerd en hoe deze taken 
in het huisartsinformatiesysteem geregistreerd zouden gaan worden. Eerdere 
studies lieten zien dat wanneer het gaat om gezondheidsgedrag (zoals stoppen 
met roken, meer bewegen, deelname aan kankerscreening) het formuleren van 
dergelijke plannen een positief effect had op het uitvoeren van het gewenste 
(gezondheids)gedrag. In hoofdstuk vier van dit proefschrift wordt nagegaan of 
deze gedragsveranderingsstrategie ook een positief effect had op het aanbieden 
van stoppen-met-rokenbegeleiding door de huisartsen. Hierbij lag de nadruk op 
de kwaliteit van de plannen die de huisartsen maakten. De kwaliteit van deze 
plannen, met andere woorden de specificiteit van de plannen, werd bepaald 
door de onderzoekers. Daarnaast rapporteerden de huisartsen zes weken na de 
training in hoeverre zij de plannen hadden uitgevoerd zoals beschreven. Multi-
level regressie-analyses werden gebruikt om het effect van de specificiteit en de 
uitvoering van de plannen op de daadwerkelijke stoppen-met-rokenactiviteiten 
van de huisartsen voor en na de training te bepalen. Deze analyses toonden aan 
dat patiënten vaker gevraagd werden naar hun rookgedrag indien huisartsen 









































tevens aangaven dit plan te hebben uitgevoerd. Dit effect was het sterkst onder 
huisartsen die voorafgaand aan de training al een hoge intentie hadden om rou-
tinematig stoppen-met-rokenbegeleiding te bieden. We vonden geen significant 
effect van de (kwaliteit van de) actieplannen op het aantal rokende patiënten dat 
geadviseerd werd om te stoppen, of waarvoor stopondersteuning was geregeld 
door de huisarts. Voor toekomstige trainingen wordt om die reden aanbevolen 
om voor de implementatie van deze activiteiten op maat gesneden copingplan-
nen als onderdeel van een training toe te voegen. Deze plannen kunnen mogelijk 
leiden tot meer positieve effecten op de stopadvisering en doorverwijzing van 
rokers naar stopondersteuning door huisartsen.
Hoofdstuk vijf verschaft meer inzicht in de interactie tussen professionals in de 
huisartsenpraktijk en hun patiënten tijdens consulten waarin het rookgedrag 
van de patiënt besproken wordt. Oftewel, in hoeverre beïnvloeden factoren op 
het niveau van de patiënt de implementatie van stoppen-met-rokenbegeleiding 
in de huisartsenpraktijk? Hiertoe werden 52 video-opnames van consulten in de 
huisartspraktijk geobserveerd (van 17 huisartsen en 16 praktijkondersteuners 
(POH’s)). In alle consulten initieerden de professionals het gesprek over het rook-
gedrag van de patiënt. De dialogen tussen professionals en patiënten werden 
letterlijk uitgeschreven. Gesprekseenheden van professionals werden vervolgens 
gecodeerd op basis van de kernaspecten van de NHG-Standaard Stoppen met 
roken (5 A’s; Ask, Advise, Assess, Assist en Arrange). Gesprekseenheden van de 
patiënten werden gecodeerd als positieve of negatieve uitlatingen over stoppen 
met roken. Alle andere gesprekseenheden van professionals en patiënten werden 
gecodeerd als ‘anders (niet-)rookgerelateerd’. Met behulp van beschrijvende en 
sequentieanalyses werd nagegaan of bepaalde volgorden van gesprekseenheden 
vaker of minder vaak voorkwamen dan verwacht zou kunnen worden op basis 
van toeval. Deze analyses toonden aan dat huisartsen vaker naar de rookstatus 
van hun patiënten vroegen en rokers adviseerden om te stoppen dan POH’s. POH’s 
assisteerden daarentegen de rokers vaker bij het stoppen. Daarnaast toonden de 
analyses aan dat rokende patiënten zich tijdens de consulten vaker negatief dan 
positief uitlaten over stoppen met roken, met name wanneer POH’s vroegen naar 
de motivatie om te stoppen of hen assisteerden bij het stoppen. Na een negatieve 
uitlating over het stoppen met roken van de patiënt leken huisartsen minder 
vaak het gebruik van de richtlijn voort te zetten dan na een positieve uitlating 
van de patiënt. Deze bevinding kon echter niet statistisch bevestigd worden. Op 
basis van de bevindingen wordt aanbevolen om de taken van de huisartsen te 
beperken tot het vaststellen van de rookstatus van de patiënt, het adviseren van 









































het minst te leiden tot negatieve uitlatingen van de patiënt over het stoppen met 
roken en sluit goed aan bij de taken en vaardigheden van POH’s ten aanzien van 
leefstijlbegeleiding.
De voorgaande onderzoeken zijn met name gericht op kenmerken van de 
patiënt, huisarts en huisartsenpraktijk die de implementatie van stoppen-met-
rokenbegeleiding in de huisartspraktijk kunnen beïnvloeden. Maatregelen op be-
leidsniveau kunnen hierin echter tevens een rol spelen. In hoofdstuk zes wordt 
daarom een populatieonderzoek beschreven naar de effecten van twee nationale 
maatregelen om tabaksgebruik te ontmoedigen op het aantal voorschriften van 
stoppen-met-rokenmiddelen vanuit de huisartspraktijk alsook de prevalentie 
van roken. Het betreft de invoering van de NHG-Standaard Stoppen met roken in 
2007 en de invoering van de vergoeding van het stoppen-met-rokenprogramma 
in 2011. Deze laatste beleidsmaatregel betrof een vergoeding voor een combi-
natie van farmacologische en gedragsmatige begeleiding van rokers bij het 
stoppen met roken vanuit de basiszorgverzekering, waar de roker een keer per 
kalenderjaar gebruik van kan maken. Deze vergoeding werd een jaar later, in 
januari 2012, afgeschaft en in 2013 weer ingevoerd. In dit ecologisch onderzoek 
werden data (kwartaalcijfers) van drie nationaal representatieve databases 
geanalyseerd door middel van tijdreeksanalyses. Deze analyses toonden geen 
effect aan van de invoering van de NHG-Standaard Stoppen met roken op het 
aantal voorschriften en uitgiften van stoppen-met-rokenmiddelen door respec-
tievelijk de huisarts en apotheker. Kort na de invoering van de vergoeding van 
het stoppen-met-rokenprogramma in 2011 steeg echter het aantal voorschriften 
en uitgiften van stoppen-met-rokenmiddelen significant met respectievelijk 6,3 
en 17,3 per 1.000 rokers. Deze stijging in het aantal voorschriften en uitgiften van 
hulpmiddelen in het eerste kwartaal van 2011 ging gepaard met een significante 
daling van 2,9% van de prevalentie van roken. Onmiddellijk nadat de vergoeding 
van het stoppen-met-rokenprogramma werd afgeschaft (eerste kwartaal 2012) 
steeg de prevalentie van roken weer met 1,2% en daalde het aantal uitgiften 
van stoppen-met-rokenmiddelen door apothekers met 21,6 per 1.000 rokers. 
Dit hoofdstuk sluit dan ook af met aanbevelingen voor beleidsmakers om deze 
bevindingen in overweging te nemen bij de ontwikkeling van toekomstig beleid 
op het gebied van de ontmoediging van tabaksgebruik.
De algemene discussie in hoofdstuk zeven bespreekt de onderzoeksbevindin-
gen beschreven in dit proefschrift. Daarnaast biedt dit hoofdstuk inzicht in 
hetgeen de onderzoeksbevindingen voor de praktijk en toekomstig onderzoek 









































van stoppen-met-rokenbegeleiding in de huisartspraktijk beïnvloeden worden 
theoriegestuurde determinantenvragenlijsten aanbevolen. Op basis van deze 
kennis kunnen in de toekomst strategieën verder ontwikkeld worden die het kli-
nisch handelen van huisartsen volgens de richtlijn verder verbeteren. Daarnaast 
worden experimentele studies met grotere steekproeven aanbevolen om na te 
gaan wat de effecten zijn van trainingsprogramma’s voor huisartsen waarin or-
ganisatorische factoren alsook actie- en coping planning geïncorporeerd worden. 
Tevens wordt in dit hoofdstuk aanbevolen om het populatieonderzoek naar de 
effecten van de vergoeding van stoppen-met-rokenprogramma’s te herhalen. Op 
die manier kunnen ook de langetermijneffecten van deze beleidsmaatregel op 
het voorschrijven van stoppen-met-rokenmiddelen en op de prevalentie van ro-
ken onderzocht worden. Ten slotte wordt een alternatieve aanpak voor stoppen-
met-rokenbegeleiding in de huisartspraktijk besproken, de zogenaamde Ask-
Advise-Connect (A-A-C) aanpak. In vergelijking met het huidige 5A-Model worden 
de taken van de huisarts binnen de A-A-C aanpak beperkt tot het routinematig 
identificeren en adviseren van rokers. Daarnaast worden rokers op proactieve 
wijze doorverwezen voor stopondersteuning. Amerikaans onderzoek laat zien 
dat door middel van deze proactieve aanpak significant meer rokers uiteindelijk 
gebruikmaken van professionele stopondersteuning. Toekomstig (kwalitatief) 
onderzoek zou kunnen nagaan hoe patiënten en huisartsen in Nederland tegen 
deze aanpak aankijken. Tevens worden studies aanbevolen die de haalbaarheid 
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